Chaishen的个人主页 - 老虎社区

Chaishen

Chaishen

暂无个人介绍

IP属地：未知

45关注

18粉丝

0主题

0勋章

2021-12-22

Ok support 1K each

Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now

2021-12-21

$Limelight Networks(LLNW)$Get ready to the moon [Allin]

2021-12-20

The sky is falling, the sky is falling [Grin]

抱歉，原内容已删除

2021-12-15

Damn it!!Struggle for 10 mths but just need one news o collapse it

Solar Stocks Alert: Why ENPH, RUN, SPWR Stocks Are Falling

2021-12-13

They hard sell you to buy, what’s next 😂

3 Growth Stocks to Fuel Your 2022 Financial Freedom

2021-12-13

Buy buy buy

Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd

2021-11-28

How about just 3yrs 😂

$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement

2021-11-28

5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]

Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022

2021-11-22

Spreading fear again [Anger]

Is the Stock Market Going to Crash Again?

2021-11-22

LMND a good bargain now

抱歉，原内容已删除

2021-11-21

Took up small position for long term growth

Missed Out on Lucid and Rivian? 2 EV Stocks To Buy Now

2021-11-19

$Ascent Solar Technologies, Inc.(ASTI)$you are not alone[Spurting]

2021-11-12

Jushi is the right choice [Miser]

The Smartest Stocks to Buy With $20 Right Now

2021-11-12

Support BABA

Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%

2021-11-10

Repitive article spreading fear

Don't Get Too Comfortable: The Crash May Be Coming

2021-11-08

$Jushi Holdings Inc.(JUSHF)$Go go go to the moon 🌙

2021-11-08

Overall getting 6% only, are you contented to that?Do day scraping can get more than that wahahah [Happy]

Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income

2021-11-05

Stay sideline first, thanks 😊

2 Biotech Companies That Might Be on Pfizer's Radar Right Now

2021-11-01

It’s just keep repeating the same article [Spurting]

3 Warren Buffett Stocks to Buy in November

2021-10-26

$Clean Energy Technologies, Inc.(CETY)$small nibble

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3575102877976288","uuid":"3575102877976288","gmtCreate":1612009227983,"gmtModify":1613657252670,"name":"Chaishen","pinyin":"chaishen","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":18,"headSize":45,"tweetSize":188,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.05","exceedPercentage":"93.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"60.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691149081,"gmtCreate":1640154432654,"gmtModify":1640154497883,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Ok support 1K each&nbsp;","listText":"Ok support 1K each&nbsp;","text":"Ok support 1K each","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691149081","repostId":"1161530074","repostType":4,"repost":{"id":"1161530074","kind":"news","pubTimestamp":1640138921,"share":"https://www.laohu8.com/m/news/1161530074?lang=&edition=full","pubTime":"2021-12-22 10:08","market":"us","language":"en","title":"Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1161530074","media":"Motley Fool","summary":"Twilio and Roku have been hit hard, but these are strong businesses ready to hit back even harder.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Twilio and Roku are down more than 40% since their all-time highs.</li>\n <li>Both companies are posting double-digit revenue growth.</li>\n <li>Twilio and Roku are leaders in growing industries. You want to pick them -- not kick them -- when they're down.</li>\n</ul>\n<p>A lot of stocks have been hit hard in recent months, and not all of them are going to bounce back. Some downticks have been fully earned, but that doesn't seem to be the case with&nbsp;<b>Twilio</b>&nbsp;(NYSE:TWLO)&nbsp;or&nbsp;<b>Roku</b>(NASDAQ:ROKU).</p>\n<p>Twilio is the leading provider of in-app communication solutions, making your smartphone even smarter. Roku is the top dog among streaming video hubs for TVs, commanding nearly double the U.S. market share of its closest competitor.</p>\n<p>You're probably going to spend a lot of time on mobile apps and streaming video in the future, making the recent sell-off in Twilio and Roku that much more appetizing. Even if you have just $2,000 to invest, let's go over why splitting that between Twilio and Roku may be the right choice right now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ce6deb412b3fed5120808b8c5d1bc735\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>Twilio</b></p>\n<p>Twilio shares have fallen by more than 40% since peaking in February, but it's not as if its business is suffering a similar fate. Revenue soared 65% for&nbsp;its latest quarter, and even if you factor out needle-moving acquisitions, you still have a healthy organic top-line growth rate of 38% for the quarter.</p>\n<p>Developers lean on Twilio's platform to let users get more done without having to leave the app. From two-way communication without revealing either side's contact info -- like when you're chatting with your food-delivery driver or trying to book a holiday vacation rental home -- to simple things like resetting passwords, you're probably contributing to Twilio's growth without realizing it. There are now more than 250,000 developers as active Twilio customers, and they're spending 31% more on the platform than they were a year ago.</p>\n<p>Red ink is a problem, and investors are concerned enough about the losses to detract from the spectacular top-line gains that Twilio is producing in a booming niche. We're only going to be spending more time on smartphone apps, and with that comes the challenge for app developers to make sure they beef up their in-app communication solutions. Twilio's future is bright, even if the stock is now 41% below the all-time high it established earlier this year.</p>\n<p><b>Roku</b></p>\n<p>We're streaming a lot of video from the biggest screen in the house -- our smart TV -- and that's not going to change anytime soon. Roku is the top solution, available freely as the default operating system in 38% of the smart TVs sold in North America. Folks can also buy Roku dongles for as little as $20 that plug into their TVs for access to Roku's free-to-use platform.</p>\n<p>Business is strong. Platform revenue soared 82% in its latest quarter. Hardware sales haven't been as kind, and supply-chain constraints and rising costs on that front will linger into the year ahead. The audience continues to grow despite the hardware hiccups, thankfully due to its market leadership in factory-installed new TVs.</p>\n<p>Roku plays nice with thousands of streaming apps. It's had a few tense negotiations with media and tech giants to keep them on its hub -- more recently with YouTube and YouTube TV -- but they have&nbsp;always been resolved&nbsp;before starting to get in the way of user growth. Advertisers and providers of streaming apps know that they have to work with Roku if they want to reach younger audiences who aren't consuming traditional marketing outposts.</p>\n<p>Roku stock has fallen 54% from this year's summertime highs. This would be an alarming sight if we hadn't seen&nbsp;similar drawdowns&nbsp;before. The stock has fallen between 43% and 61% every year since going public in 2017, only to hit a fresh all-time high the following year. History tells us that buying Roku when the leader amongstreaming service stocks&nbsp;is down is a smart thing to do.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 10:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/21/got-2000-here-are-2-beaten-down-growth-stocks-to-b/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nTwilio and Roku are down more than 40% since their all-time highs.\nBoth companies are posting double-digit revenue growth.\nTwilio and Roku are leaders in growing industries. You want to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/21/got-2000-here-are-2-beaten-down-growth-stocks-to-b/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc","TWLO":"Twilio Inc"},"source_url":"https://www.fool.com/investing/2021/12/21/got-2000-here-are-2-beaten-down-growth-stocks-to-b/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161530074","content_text":"Key Points\n\nTwilio and Roku are down more than 40% since their all-time highs.\nBoth companies are posting double-digit revenue growth.\nTwilio and Roku are leaders in growing industries. You want to pick them -- not kick them -- when they're down.\n\nA lot of stocks have been hit hard in recent months, and not all of them are going to bounce back. Some downticks have been fully earned, but that doesn't seem to be the case with Twilio (NYSE:TWLO) or Roku(NASDAQ:ROKU).\nTwilio is the leading provider of in-app communication solutions, making your smartphone even smarter. Roku is the top dog among streaming video hubs for TVs, commanding nearly double the U.S. market share of its closest competitor.\nYou're probably going to spend a lot of time on mobile apps and streaming video in the future, making the recent sell-off in Twilio and Roku that much more appetizing. Even if you have just $2,000 to invest, let's go over why splitting that between Twilio and Roku may be the right choice right now.\nIMAGE SOURCE: GETTY IMAGES.\nTwilio\nTwilio shares have fallen by more than 40% since peaking in February, but it's not as if its business is suffering a similar fate. Revenue soared 65% for its latest quarter, and even if you factor out needle-moving acquisitions, you still have a healthy organic top-line growth rate of 38% for the quarter.\nDevelopers lean on Twilio's platform to let users get more done without having to leave the app. From two-way communication without revealing either side's contact info -- like when you're chatting with your food-delivery driver or trying to book a holiday vacation rental home -- to simple things like resetting passwords, you're probably contributing to Twilio's growth without realizing it. There are now more than 250,000 developers as active Twilio customers, and they're spending 31% more on the platform than they were a year ago.\nRed ink is a problem, and investors are concerned enough about the losses to detract from the spectacular top-line gains that Twilio is producing in a booming niche. We're only going to be spending more time on smartphone apps, and with that comes the challenge for app developers to make sure they beef up their in-app communication solutions. Twilio's future is bright, even if the stock is now 41% below the all-time high it established earlier this year.\nRoku\nWe're streaming a lot of video from the biggest screen in the house -- our smart TV -- and that's not going to change anytime soon. Roku is the top solution, available freely as the default operating system in 38% of the smart TVs sold in North America. Folks can also buy Roku dongles for as little as $20 that plug into their TVs for access to Roku's free-to-use platform.\nBusiness is strong. Platform revenue soared 82% in its latest quarter. Hardware sales haven't been as kind, and supply-chain constraints and rising costs on that front will linger into the year ahead. The audience continues to grow despite the hardware hiccups, thankfully due to its market leadership in factory-installed new TVs.\nRoku plays nice with thousands of streaming apps. It's had a few tense negotiations with media and tech giants to keep them on its hub -- more recently with YouTube and YouTube TV -- but they have always been resolved before starting to get in the way of user growth. Advertisers and providers of streaming apps know that they have to work with Roku if they want to reach younger audiences who aren't consuming traditional marketing outposts.\nRoku stock has fallen 54% from this year's summertime highs. This would be an alarming sight if we hadn't seen similar drawdowns before. The stock has fallen between 43% and 61% every year since going public in 2017, only to hit a fresh all-time high the following year. History tells us that buying Roku when the leader amongstreaming service stocks is down is a smart thing to do.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1067,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693781870,"gmtCreate":1640080127544,"gmtModify":1640080229453,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LLNW\">$Limelight Networks(LLNW)$</a>Get ready to the moon [Allin]&nbsp;","listText":"<a href=\"https://laohu8.com/S/LLNW\">$Limelight Networks(LLNW)$</a>Get ready to the moon [Allin]&nbsp;","text":"$Limelight Networks(LLNW)$Get ready to the moon [Allin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693781870","isVote":1,"tweetType":1,"viewCount":853,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693837785,"gmtCreate":1639998493331,"gmtModify":1639998510432,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"The sky is falling, the sky is falling [Grin]&nbsp;","listText":"The sky is falling, the sky is falling [Grin]&nbsp;","text":"The sky is falling, the sky is falling [Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693837785","repostId":"1160299527","repostType":2,"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607664818,"gmtCreate":1639534249800,"gmtModify":1639535871395,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Damn it!!Struggle for 10 mths but just need one news o&nbsp;collapse it","listText":"Damn it!!Struggle for 10 mths but just need one news o&nbsp;collapse it","text":"Damn it!!Struggle for 10 mths but just need one news o collapse it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607664818","repostId":"1170177429","repostType":2,"repost":{"id":"1170177429","kind":"news","pubTimestamp":1639533771,"share":"https://www.laohu8.com/m/news/1170177429?lang=&edition=full","pubTime":"2021-12-15 10:02","market":"us","language":"en","title":"Solar Stocks Alert: Why ENPH, RUN, SPWR Stocks Are Falling","url":"https://stock-news.laohu8.com/highlight/detail?id=1170177429","media":"InvestorPlace","summary":"The green energy sector has drawn much attention throughout 2021 as both elected officials and busin","content":"<p>The green energy sector has drawn much attention throughout 2021 as both elected officials and business professionals work to confront the threats posed by climate change. The recent passing of President Joe Biden’s Build Back Better package gave Wall Street reason to believe that sectors such as construction and infrastructure might see gains in 2022. However, a new report has recently pointed toward a future for certain clean energy players that is less bright, especially for the solar energy sector. The supply chain crisis is creating bigger problems for the companies producing new energy solutions than some realized. As a result, solar stocks have taken a beating today.</p>\n<p>Released this morning, the report in question was compiled by the&nbsp;<b>Solar Energy Industries Association</b>&nbsp;and&nbsp;<b>Wood Mackenzie</b>. As&nbsp;<i>CNBC</i>&nbsp;reports, it forecasts that the U.S. solar energy industry will experience&nbsp;a growth rate less than 25%of what had been previously forecasted. This is largely due to the supply chain crisis and increasing costs of raw materials. Solar stocks were quick to fall upon the release of this news.</p>\n<p>Unsurprisingly, it hasn’t been a good day for the companies of the solar energy sector.<b>Enphase Energy</b>(NASDAQ:<b><u>ENPH</u></b>) is down 5.25% at market close, but for its competitors, things have been worse.&nbsp;<b>SunPower</b>(NASDAQ:<b>SPWR</b>) has seen shares fall by almost 10.78% as of this writing, while&nbsp;<b>Sunrun’s</b>(NASDAQ:<b><u>RUN</u></b>) is down 15.7% at market close. All three solar stocks had seen some slight downticks in the week leading up to this. However, nothing has been as severe as the drop-off all three have seen today.</p>\n<p>ENPH and SPWR were recently named to a list of&nbsp;energy stocks to buy&nbsp;for the coming winter. The way it looks from here, that might be a strategy to rethink.</p>\n<p><b>Why It Matters</b></p>\n<p>There’s no getting around the fact that this news casts some dark clouds over an industry that looked poised for growth in 2022. At the same time, it’s hardly surprising. As the report noted, costs of materials necessary for all types of manufacturing have risen sharply throughout the year. This makes it difficult for the companies doing the building to operate and meet deadlines. Additionally, we’ve also seen trade uncertainty rise throughout 2021 as the supply chain crisis has strained areas such as international trade. We saw the solar energy sector grapple with the&nbsp;constraints imposed&nbsp;by the 2018 trade war caused when former president Donald Trump imposed tariffs on some of America’s trading partners. The sector was vulnerable then, just like it is now.</p>\n<p>None of this is to say that the solar energy sector doesn’t have significant potential. It absolutely does. And the importance of its technology should not be understated, particularly as the area of energy storage emerges as a field worth watching for investors.</p>\n<p>“Want to still have a planet to call home in 50 years?” asks<i>InvestorPlace’</i>s Luke Lango in a&nbsp;recent analysis&nbsp;of the utility of energy storage. “We need solar, wind and hydrogen. It’s that simple.”</p>\n<p><b>What It Means</b></p>\n<p>He’s certainly right that alternative energy solutions are becoming increasingly necessary. Naturally, the demand for the services of the companies producing them will only grow. That said, it’s clear that our government will need to find solutions to deal with the supply chain crisis.</p>\n<p>It’s worth noting that it isn’t just solar stocks that are feeling the strain caused by today’s news. Some of their alternative energy peers such as&nbsp;<b>NextEra Energy</b>(NYSE:<b><u>NEE</u></b>) have also been falling today. At a time when we need alternative energy solutions most, external factors are threatening innovation. Until there are solutions, the future won’t be bright for solar stocks.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Solar Stocks Alert: Why ENPH, RUN, SPWR Stocks Are Falling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSolar Stocks Alert: Why ENPH, RUN, SPWR Stocks Are Falling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 10:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/solar-stocks-alert-why-enph-run-spwr-stocks-are-falling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The green energy sector has drawn much attention throughout 2021 as both elected officials and business professionals work to confront the threats posed by climate change. The recent passing of ...</p>\n\n<a href=\"https://investorplace.com/2021/12/solar-stocks-alert-why-enph-run-spwr-stocks-are-falling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ENPH":"Enphase Energy","SPWR":"SunPower","RUN":"Sunrun Inc.","NEE":"新纪元能源"},"source_url":"https://investorplace.com/2021/12/solar-stocks-alert-why-enph-run-spwr-stocks-are-falling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170177429","content_text":"The green energy sector has drawn much attention throughout 2021 as both elected officials and business professionals work to confront the threats posed by climate change. The recent passing of President Joe Biden’s Build Back Better package gave Wall Street reason to believe that sectors such as construction and infrastructure might see gains in 2022. However, a new report has recently pointed toward a future for certain clean energy players that is less bright, especially for the solar energy sector. The supply chain crisis is creating bigger problems for the companies producing new energy solutions than some realized. As a result, solar stocks have taken a beating today.\nReleased this morning, the report in question was compiled by the Solar Energy Industries Association and Wood Mackenzie. As CNBC reports, it forecasts that the U.S. solar energy industry will experience a growth rate less than 25%of what had been previously forecasted. This is largely due to the supply chain crisis and increasing costs of raw materials. Solar stocks were quick to fall upon the release of this news.\nUnsurprisingly, it hasn’t been a good day for the companies of the solar energy sector.Enphase Energy(NASDAQ:ENPH) is down 5.25% at market close, but for its competitors, things have been worse. SunPower(NASDAQ:SPWR) has seen shares fall by almost 10.78% as of this writing, while Sunrun’s(NASDAQ:RUN) is down 15.7% at market close. All three solar stocks had seen some slight downticks in the week leading up to this. However, nothing has been as severe as the drop-off all three have seen today.\nENPH and SPWR were recently named to a list of energy stocks to buy for the coming winter. The way it looks from here, that might be a strategy to rethink.\nWhy It Matters\nThere’s no getting around the fact that this news casts some dark clouds over an industry that looked poised for growth in 2022. At the same time, it’s hardly surprising. As the report noted, costs of materials necessary for all types of manufacturing have risen sharply throughout the year. This makes it difficult for the companies doing the building to operate and meet deadlines. Additionally, we’ve also seen trade uncertainty rise throughout 2021 as the supply chain crisis has strained areas such as international trade. We saw the solar energy sector grapple with the constraints imposed by the 2018 trade war caused when former president Donald Trump imposed tariffs on some of America’s trading partners. The sector was vulnerable then, just like it is now.\nNone of this is to say that the solar energy sector doesn’t have significant potential. It absolutely does. And the importance of its technology should not be understated, particularly as the area of energy storage emerges as a field worth watching for investors.\n“Want to still have a planet to call home in 50 years?” asksInvestorPlace’s Luke Lango in a recent analysis of the utility of energy storage. “We need solar, wind and hydrogen. It’s that simple.”\nWhat It Means\nHe’s certainly right that alternative energy solutions are becoming increasingly necessary. Naturally, the demand for the services of the companies producing them will only grow. That said, it’s clear that our government will need to find solutions to deal with the supply chain crisis.\nIt’s worth noting that it isn’t just solar stocks that are feeling the strain caused by today’s news. Some of their alternative energy peers such as NextEra Energy(NYSE:NEE) have also been falling today. At a time when we need alternative energy solutions most, external factors are threatening innovation. Until there are solutions, the future won’t be bright for solar stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":728,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604642570,"gmtCreate":1639393772508,"gmtModify":1639394158406,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"They hard sell you to buy, what’s next 😂&nbsp;","listText":"They hard sell you to buy, what’s next 😂&nbsp;","text":"They hard sell you to buy, what’s next 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604642570","repostId":"2190467769","repostType":2,"repost":{"id":"2190467769","kind":"highlight","pubTimestamp":1639367630,"share":"https://www.laohu8.com/m/news/2190467769?lang=&edition=full","pubTime":"2021-12-13 11:53","market":"us","language":"en","title":"3 Growth Stocks to Fuel Your 2022 Financial Freedom","url":"https://stock-news.laohu8.com/highlight/detail?id=2190467769","media":"Motley Fool","summary":"This basket of industrial and electric vehicle stocks is primed to pole vault your portfolio.","content":"<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.</p>\n<p><b>Corteva</b> (NYSE:CTVA), <b>Amyris</b> (NASDAQ:AMRS), and <b>ChargePoint Holdings</b> (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F656760%2Fgettyimages-1304258192.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Investor confidence is growing in the agriscience company</h2>\n<p><b>Lee Samaha (Corteva):</b> After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner <b>Bayer</b>, <b>BASF</b>, and <b>Syngenta</b>.</p>\n<p>The potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.</p>\n<p>The good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.</p>\n<p>As such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.</p>\n<h2>Supply chain woes knocked this stock down, but it's poised to get back up again</h2>\n<p><b>Scott Levine (Amyris): </b>Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.</p>\n<p>One of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"</p>\n<p>The company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.</p>\n<p>As companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.</p>\n<h2>This EV charging stock is off to the races</h2>\n<p><b>Daniel Foelber (ChargePoint Holdings): </b>America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.</p>\n<p>The growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.</p>\n<p>Although still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Growth Stocks to Fuel Your 2022 Financial Freedom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Growth Stocks to Fuel Your 2022 Financial Freedom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 11:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4096":"电气部件与设备","BK4093":"化肥与农用药剂","CHPT":"ChargePoint Holdings Inc.","BK4551":"寇图资本持仓","BK4535":"淡马锡持仓","BK4109":"特种化学制品","AMRS":"阿米瑞斯","CAGR":"California Grapes International, Inc.","CTVA":"Corteva, Inc.","BK4542":"充电桩"},"source_url":"https://www.fool.com/investing/2021/12/12/3-growth-stocks-to-fuel-your-2022-financial-freedo/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190467769","content_text":"2021 is nearly over, and that means it's time to plan for 2022. With stocks, crypto, real estate, and several other asset classes hovering around all-time highs, there's certainly a lot to be grateful for this year. However, those gains have come and gone. The challenge now is finding the best places to invest for 2022 and beyond.\nCorteva (NYSE:CTVA), Amyris (NASDAQ:AMRS), and ChargePoint Holdings (NYSE:CHPT) are three growth stocks that could bring you closer to securing financial freedom. Here's what makes each a great buy now.\nImage source: Getty Images.\nInvestor confidence is growing in the agriscience company\nLee Samaha (Corteva): After a few years of questionable performance, it looks like Corteva is starting to realize the potential in its business. The company was created out of the DowDuPont merger and subsequent breakup. As such, it's the leading U.S. player in seed and crop protection, competing with international companies such as Monsanto owner Bayer, BASF, and Syngenta.\nThe potential in the business lies in the expectation that Corteva can improve productivity and catch up to the kind of margins enjoyed by its peers. Among the ways it can enhance margin is by selling more of its products under its patents. This means Corteva will lower the share of revenue it pays in royalty costs to other companies, and Corteva's profit margin will go up.\nThe good news is the company is making progress on all fronts. For example, management recently reaffirmed its target of $2.8 billion to $3.1 billion in adjusted earnings before interest, taxation, depreciation, and amortization (EBITDA) in 2022, rising from $2.5 billion to $2.6 billion in 2021. Moreover, management noted that the adoption rate of its Enlist (seed and crop protection) system was better than it had expected in 2021. In addition, there's a strong pipeline of other products under Corteva's patents coming through in the next few years.\nAs such, a combination of mid-single-digit revenue growth and margin expansion promises to deliver double-digit earnings growth over the medium term for Corteva.\nSupply chain woes knocked this stock down, but it's poised to get back up again\nScott Levine (Amyris): Shares of synthetic biology specialist Amyris have both thrilled and devastated investors in 2021. While the stock skyrocketed more than 209% through the first three months of the year, it came back to earth in the second half -- particularly last month, when it fell 54%. Although it's the bears who are most interested in the stock at the moment, the company has several catalysts on the horizon in 2022 that could propel it considerably higher.\nOne of the primary reasons for the stock's sell-off last month was concern related to supply chain headwinds facing Amyris and fear that they'd continue to plague the company in the coming months. But Amyris is working to shore up its supply chain, developing two facilities in Brazil and Nevada, both of which are expected to commence operations in the first half of 2022. According to John Melo, the company's CEO, the importance of the two facilities will have a material impact on its finances. On the company's third-quarter conference call, Melo said, \"These facilities will not only provide us much more resilience on the supply chain, they will also reduce our operating costs significantly and improve our gross margin by about 1,000 basis points.\"\nThe company's growth, however, transcends an improvement in its gross margin as management forecasts revenue will rise to over $500 million in 2022 and $1 billion in 2023. For some perspective, Amyris reported $173 million on the top line in 2020, and it has booked sales of $357 million over the past 12 months. Looking toward the bottom of the income statement, investors can expect the company to report positive earnings before interest, taxes, depreciation, and amortization (EBITDA) -- a feat it last achieved in 2014.\nAs companies look to source their products with sustainable ingredients, Amyris and its line of synbio-based products will likely become increasingly appealing. For forward-looking investors who have the patience to let this growth story play out, the stock's recent sell-off offers a great opportunity to pick up shares on the cheap, leaving more money available to splurge on presents for friends and loved ones.\nThis EV charging stock is off to the races\nDaniel Foelber (ChargePoint Holdings): America's largest electric vehicle (EV) charging infrastructure company, ChargePoint, reported third-quarter fiscal year 2022 earnings on Tuesday that exceeded expectations. After generating $65 million in revenue, ChargePoint now expects to earn between $73 million and $78 million in fourth-quarter revenue, bringing its full-year sales to between $235 million and $240 million. If it hits its target, ChargePoint would have grown its top line by 63% compared to last year. For context, consider that ChargePoint earned $146 million in revenue in fiscal year 2021 and $144.5 million in fiscal year 2020 revenue.\nThe growth rate is impressive, but even if ChargePoint hits its revenue target it would still have a price-to-sales ratio of 28.7, which is more expensive than some of the market's hottest growth stocks. However, COVID-19 stunted its fiscal year 2021 growth and the company could now be off to the races now that EV investment is increasing. ChargePoint expects its rise to be directly proportional to the growth rate of U.S. passenger EV sales. Between 2020 to 2026, ChargePoint expects U.S. passenger EV sales to rise at a compound annual growth rate (CAGR) of 41% as more affordable EVs come on stream and consumer demand for EVs increases.\nAlthough still a long way from profitability, ChargePoint is an excellent catch-all way to expose your portfolio to the growth of EVs without having to risk picking a particular automaker to win out.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1090,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604816503,"gmtCreate":1639369042399,"gmtModify":1639369042569,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Buy buy buy","listText":"Buy buy buy","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604816503","repostId":"2191708046","repostType":2,"repost":{"id":"2191708046","kind":"news","pubTimestamp":1639366317,"share":"https://www.laohu8.com/m/news/2191708046?lang=&edition=full","pubTime":"2021-12-13 11:31","market":"us","language":"en","title":"Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd","url":"https://stock-news.laohu8.com/highlight/detail?id=2191708046","media":"MoneyWise","summary":"Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and c","content":"<p><img src=\"https://static.tigerbbs.com/5664762597a5b9b6b53168b267173a39\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.</p>\n<p>Munger didn’t mince words when he said earlier this month that he considers today’s stock market environment “even crazier than the dot-com era.”</p>\n<p>\"I just can't stand participating in these insane booms,” Munger said at the Sohn Hearts &amp; Minds Investment Leaders Conference. “There's no great company that can't be turned into a bad investment just by raising the price.\"</p>\n<p>Munger, as usual, had harsh words for cryptocurrencies. He praised China’s crackdown on crypto and said he wished the technology “had never been invented.”</p>\n<p>One way to avoid both crypto and getting burned by an overvalued market is to look at companies with stock that has dropped but seems poised for a rebound.</p>\n<p>Here are three stocks with some bruises that fit that category. You might even be able to include some undervalued stocks in your portfolio with a little spare change.</p>\n<h2>Walt Disney Co. (DIS)</h2>\n<p><img src=\"https://static.tigerbbs.com/1eb7ad7f596bcaa16827853ace850b05\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">AFM Visuals/Shutterstock</p>\n<p>Disney’s stock got hammered in the pandemic’s early days, shedding about 38% of its value in the month ending March 20, 2020. After rallying for much of last year, it’s down almost 15% since the beginning of 2021. Disney’s earnings in the fiscal fourth quarter, which ended Oct. 2, came in about $200 million short of expectations. Its theme parks are still operating at reduced capacity, so Q4’s results could have been much worse.</p>\n<p>Streaming platform Disney+ is up to 118.1 million subscribers, and the company projects that figure will grow to more than 230 million by 2024. While the company says Disney+ subscriber growth slowed, revenue from subscriptions across Disney+, ESPN+ and Hulu was $4.6 billion in Q4 — 38% higher than a year before.</p>\n<p>Disney remains a beloved global brand and says it expects international visitors to parks to pick up later in 2022 as restrictions ease. JPMorgan Chase predicts a full economic rebound from COVID-19 in 2022, and if that’s true, Disney’s theme parks could once again be packed.</p>\n<h2>Mastercard (MA)</h2>\n<p><img src=\"https://static.tigerbbs.com/aed78bfcce51f38789bf91a87e4815ed\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">garmoncheg/Shutterstock</p>\n<p>Mastercard’s stock has been mostly trending downward since July, and it recently hit the skids, shrinking by 17% from Nov. 16 through Dec. 1. However, it’s trending upward over the last week or so, recovering most of that recent loss.</p>\n<p>The sell-off of Mastercard’s stock doesn’t appear to have anything to do with the company’s performance. Q3 net revenue was $5 billion, a year-over-year increase of 30%. Purchase volume was up 23% over the same period.</p>\n<p>Mastercard’s in a tricky position. Buy now, pay later apps are doing their best to disrupt the credit card space, and the company doesn’t currently seem to have an answer that will help increase the company’s cache with younger users.</p>\n<p>But that could be more of a long-term issue. In the short-term, inflation-jacked prices mean customers are paying more, and a rebound in tourism and credit card spending should have the company’s users — there’s almost a billion of them — ringing up purchases left and right.</p>\n<h2>AT&amp;T (T)</h2>\n<p><img src=\"https://static.tigerbbs.com/2584b9217af4e8f8876958e9a7bf34a2\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">Jonathan Weiss/Shutterstock</p>\n<p>AT&amp;T’s stock has been on a downward tumble for a while now. Its share price is 45% lower than it was five years ago, and is down more than 22% this year alone.</p>\n<p>AT&amp;T has taken some big swings that haven’t paid off. Its purchase of DirecTV and Time Warner in 2015 and 2018, respectively, added more than $130 billion in debt to the company’s balance sheet. Last year, T-Mobile replaced AT&amp;T as America’s second-largest wireless carrier.</p>\n<p>None of that sounds particularly enticing, but the company knows changes need to be made. It divested a number of its smaller businesses and some of its real estate holdings and sold 30% of DirecTV to streamline operations and free up capital for the expansion of its 5G network, which could be huge.</p>\n<p>AT&amp;T is still a risky buy with its stumbles this year, but if you believe in the turnaround plan, the anxiety might be worthwhile. Big picture, AT&amp;T continues to boast the scale advantages required to compete in the high-growth wireless space long term.</p>\n<h2>If your faith in the market is flagging …</h2>\n<p><img src=\"https://static.tigerbbs.com/eedd4d7004b766d5dc2e8fe34b4c1922\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\">MartinLueke/Shutterstock</p>\n<p>With elite investors like Charlie Munger, Michael Burry and Jeremy Grantham all saying the market is due for a correction, it might be worth looking into investments other than stocks.</p>\n<p>There’s no shortage of unique alternative assets you can invest in that have little correlation with the stock market, including luxury vehicles, commercial real estate, blue-chip artworks or even marine finance.</p>\n<p>Traditionally, many alternative asset classes have only been available to millionaires because of the enormous costs involved. But a new platform is making these opportunities available to retail investors too.</p>\n<p><i>This article provides information only and should not be construed as advice. It is provided without warranty of any kind.</i></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Charlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCharlie Munger: This market is 'even crazier' than the dot-com bust — here are 3 contrarian stocks to help you sidestep the herd\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 11:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.\nMunger didn’t mince words when he said earlier ...</p>\n\n<a href=\"https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4551":"寇图资本持仓","DIS":"迪士尼","BK4561":"索罗斯持仓","BK4548":"巴美列捷福持仓","MA":"万事达","BK4106":"数据处理与外包服务","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4108":"电影和娱乐","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","T":"美国电话电报","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4550":"红杉资本持仓","BK4115":"综合电信业务"},"source_url":"https://finance.yahoo.com/news/charlie-munger-market-even-crazier-164000236.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2191708046","content_text":"Berkshire Hathaway Vice Chairman Charlie Munger tends to be much more direct with his warnings and criticisms than his business partner, Warren Buffett.\nMunger didn’t mince words when he said earlier this month that he considers today’s stock market environment “even crazier than the dot-com era.”\n\"I just can't stand participating in these insane booms,” Munger said at the Sohn Hearts & Minds Investment Leaders Conference. “There's no great company that can't be turned into a bad investment just by raising the price.\"\nMunger, as usual, had harsh words for cryptocurrencies. He praised China’s crackdown on crypto and said he wished the technology “had never been invented.”\nOne way to avoid both crypto and getting burned by an overvalued market is to look at companies with stock that has dropped but seems poised for a rebound.\nHere are three stocks with some bruises that fit that category. You might even be able to include some undervalued stocks in your portfolio with a little spare change.\nWalt Disney Co. (DIS)\nAFM Visuals/Shutterstock\nDisney’s stock got hammered in the pandemic’s early days, shedding about 38% of its value in the month ending March 20, 2020. After rallying for much of last year, it’s down almost 15% since the beginning of 2021. Disney’s earnings in the fiscal fourth quarter, which ended Oct. 2, came in about $200 million short of expectations. Its theme parks are still operating at reduced capacity, so Q4’s results could have been much worse.\nStreaming platform Disney+ is up to 118.1 million subscribers, and the company projects that figure will grow to more than 230 million by 2024. While the company says Disney+ subscriber growth slowed, revenue from subscriptions across Disney+, ESPN+ and Hulu was $4.6 billion in Q4 — 38% higher than a year before.\nDisney remains a beloved global brand and says it expects international visitors to parks to pick up later in 2022 as restrictions ease. JPMorgan Chase predicts a full economic rebound from COVID-19 in 2022, and if that’s true, Disney’s theme parks could once again be packed.\nMastercard (MA)\ngarmoncheg/Shutterstock\nMastercard’s stock has been mostly trending downward since July, and it recently hit the skids, shrinking by 17% from Nov. 16 through Dec. 1. However, it’s trending upward over the last week or so, recovering most of that recent loss.\nThe sell-off of Mastercard’s stock doesn’t appear to have anything to do with the company’s performance. Q3 net revenue was $5 billion, a year-over-year increase of 30%. Purchase volume was up 23% over the same period.\nMastercard’s in a tricky position. Buy now, pay later apps are doing their best to disrupt the credit card space, and the company doesn’t currently seem to have an answer that will help increase the company’s cache with younger users.\nBut that could be more of a long-term issue. In the short-term, inflation-jacked prices mean customers are paying more, and a rebound in tourism and credit card spending should have the company’s users — there’s almost a billion of them — ringing up purchases left and right.\nAT&T (T)\nJonathan Weiss/Shutterstock\nAT&T’s stock has been on a downward tumble for a while now. Its share price is 45% lower than it was five years ago, and is down more than 22% this year alone.\nAT&T has taken some big swings that haven’t paid off. Its purchase of DirecTV and Time Warner in 2015 and 2018, respectively, added more than $130 billion in debt to the company’s balance sheet. Last year, T-Mobile replaced AT&T as America’s second-largest wireless carrier.\nNone of that sounds particularly enticing, but the company knows changes need to be made. It divested a number of its smaller businesses and some of its real estate holdings and sold 30% of DirecTV to streamline operations and free up capital for the expansion of its 5G network, which could be huge.\nAT&T is still a risky buy with its stumbles this year, but if you believe in the turnaround plan, the anxiety might be worthwhile. Big picture, AT&T continues to boast the scale advantages required to compete in the high-growth wireless space long term.\nIf your faith in the market is flagging …\nMartinLueke/Shutterstock\nWith elite investors like Charlie Munger, Michael Burry and Jeremy Grantham all saying the market is due for a correction, it might be worth looking into investments other than stocks.\nThere’s no shortage of unique alternative assets you can invest in that have little correlation with the stock market, including luxury vehicles, commercial real estate, blue-chip artworks or even marine finance.\nTraditionally, many alternative asset classes have only been available to millionaires because of the enormous costs involved. But a new platform is making these opportunities available to retail investors too.\nThis article provides information only and should not be construed as advice. It is provided without warranty of any kind.","news_type":1},"isVote":1,"tweetType":1,"viewCount":707,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600104127,"gmtCreate":1638079360217,"gmtModify":1638079360352,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"How about just 3yrs 😂&nbsp;","listText":"How about just 3yrs 😂&nbsp;","text":"How about just 3yrs 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600104127","repostId":"2186432895","repostType":2,"repost":{"id":"2186432895","kind":"highlight","pubTimestamp":1638069921,"share":"https://www.laohu8.com/m/news/2186432895?lang=&edition=full","pubTime":"2021-11-28 11:25","market":"us","language":"en","title":"$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2186432895","media":"Motley Fool","summary":"A little money can go a long way.","content":"<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the&nbsp;average stock market return&nbsp;over the last 50 years of nearly 11%.&nbsp;</p>\n<p>Many companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are&nbsp;<a href=\"https://laohu8.com/S/BEP\"><b>Brookfield Renewable</b>&nbsp;</a>,&nbsp;<a href=\"https://laohu8.com/S/CCI\"><b>Crown Castle International</b>&nbsp;</a>, and&nbsp;<a href=\"https://laohu8.com/S/NEE\"><b>NextEra Energy</b>&nbsp;</a>. Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.</p>\n<h2>Benefiting from a powerful megatrend</h2>\n<p>Brookfield Renewable has enriched its investors over the years. Since its inception, the&nbsp;renewable energy&nbsp;producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. </p>\n<p>However, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.</p>\n<p>The company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. </p>\n<p>Meanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come.&nbsp;</p>\n<h2>Connected to the data supercycle</h2>\n<p>Crown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. </p>\n<p>A major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014.&nbsp; &nbsp;</p>\n<p>The company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of&nbsp;5G networks&nbsp;represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. </p>\n<p>Crown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years.&nbsp;</p>\n<h2>Plugged into several growth catalysts</h2>\n<p>NextEra Energy has also created an enormous amount of wealth for its investors over the years. The&nbsp;utility&nbsp;has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&amp;P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. </p>\n<p>A major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and&nbsp;solar energy&nbsp;producers.&nbsp;</p>\n<p>That leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's&nbsp;tapping into other sources of growth&nbsp;like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.</p>\n<h2>Grow rich slowly</h2>\n<p>Compound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCI":"冠城","NEE":"新纪元能源","BEP":"Brookfield Renewable Partners LP"},"source_url":"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186432895","content_text":"Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. \nMany companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are Brookfield Renewable , Crown Castle International , and NextEra Energy . Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.\nBenefiting from a powerful megatrend\nBrookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. \nHowever, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.\nThe company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. \nMeanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. \nConnected to the data supercycle\nCrown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. \nA major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014.   \nThe company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. \nCrown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. \nPlugged into several growth catalysts\nNextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. \nA major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. \nThat leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.\nGrow rich slowly\nCompound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600972130,"gmtCreate":1638061720309,"gmtModify":1638061720402,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]&nbsp;","listText":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]&nbsp;","text":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600972130","repostId":"2186340224","repostType":2,"repost":{"id":"2186340224","kind":"highlight","pubTimestamp":1638059445,"share":"https://www.laohu8.com/m/news/2186340224?lang=&edition=full","pubTime":"2021-11-28 08:30","market":"us","language":"en","title":"Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2186340224","media":"Motley Fool","summary":"Both of these businesses could be in much better shape a year from now.","content":"<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.</p>\n<p>That's exactly what I think of with&nbsp;<a href=\"https://laohu8.com/S/AZN\"><b>AstraZeneca&nbsp;</b></a> and&nbsp;<a href=\"https://laohu8.com/S/BYND\"><b>Beyond Meat&nbsp;</b></a>. Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.</p>\n<h4><b>1. AstraZeneca</b></h4>\n<p>Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the <b>S&amp;P 500</b> has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.</p>\n<p>But next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.</p>\n<p>That means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.</p>\n<p>For the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker <b>Moderna</b> reported $4.8 billion in product sales for the same period, and <b>Pfizer</b>'s COVID-19 vaccine generated $13 billion in revenue, also during the same interval.</p>\n<p>While it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.</p>\n<p>Although AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)</p>\n<p>As it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.</p>\n<h4><b>2. Beyond Meat</b></h4>\n<p>Beyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.</p>\n<p>The company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.</p>\n<p>There's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.</p>\n<p>Beyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.</p>\n<p>However, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant <b>McDonald's</b> recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.</p>\n<p>Although the growth stock is beaten up today, a year from now, today's price could look like a bargain.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 2 Stocks Could Be Bargain Buys in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","BYND":"Beyond Meat, Inc."},"source_url":"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186340224","content_text":"Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.\nThat's exactly what I think of with AstraZeneca  and Beyond Meat . Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.\n1. AstraZeneca\nShares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.\nBut next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.\nThat means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.\nFor the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker Moderna reported $4.8 billion in product sales for the same period, and Pfizer's COVID-19 vaccine generated $13 billion in revenue, also during the same interval.\nWhile it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.\nAlthough AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)\nAs it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.\n2. Beyond Meat\nBeyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.\nThe company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.\nThere's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.\nBeyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.\nHowever, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant McDonald's recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.\nAlthough the growth stock is beaten up today, a year from now, today's price could look like a bargain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872758223,"gmtCreate":1637579375915,"gmtModify":1637579445690,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Spreading fear again [Anger]&nbsp;","listText":"Spreading fear again [Anger]&nbsp;","text":"Spreading fear again [Anger]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872758223","repostId":"2185826772","repostType":4,"repost":{"id":"2185826772","kind":"highlight","pubTimestamp":1637573760,"share":"https://www.laohu8.com/m/news/2185826772?lang=&edition=full","pubTime":"2021-11-22 17:36","market":"us","language":"en","title":"Is the Stock Market Going to Crash Again?","url":"https://stock-news.laohu8.com/highlight/detail?id=2185826772","media":"Motley Fool","summary":"The next market crash is inevitable. Prepare while you can.","content":"<p>The market will crash again. That is inevitable. The only real question is when will it happen?</p>\n<p>Let's be clear: there are <i>lots </i>of reasons to believe the market could crash soon. Skyrocketing inflation&nbsp;, stretched valuations&nbsp;, and a critical labor shortage &nbsp;each could pose risks to the market on their own. Put them all together in a situation like we have today, and the danger certainly seems to multiply.</p>\n<p>Just because the market <i>could </i>crash soon doesn't mean it <i>will</i>, however. If it somehow manages to keep climbing, would you really want to be sitting on the sidelines, watching the purchasing power of your money evaporate to inflation?</p>\n<p>That combination of factors makes now <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the toughest times in most of our investing lifetimes to know what the best course of action should be. That might actually mean that there is no <i>single </i>best path forward and that the right approach could be to build a balance across the five options discussed here.</p>\n<h2>No. 1: Get out of (expensive) debt</h2>\n<p>If the market's massive run has left you in the position where you <i>could </i>pay off your debts, maybe that provides a good opportunity to <i>actually </i>do so. If not your entire debt burden, perhaps you could pay off everything but your fixed-rate, low interest mortgage?</p>\n<p>It might seem crazy to pay off debt when interest rates are so low and the market has seen such huge recent rises, but that could very well be the best time to do so. After all, if interest rates rise, that could both increase your debt service costs <i>and </i>cause at least some of your stocks to drop, catching you with a double-whammy. When you add in the fact your debt service costs need to be paid even if your stocks are way down, you get a situation where reducing or eliminating debt looks like a smart move.</p>\n<h2>No. 2: Build a cash buffer</h2>\n<p>In a world where inflation is running over 6%, &nbsp;having a lot of cash sitting around earning less than 1% &nbsp;might seem crazy. When viewed only on that basis, it is. When you recognize that market crashes and job losses often go hand in hand, having a decent cash buffer can be viewed as an insurance policy. At least for a little while, it can keep you from being forced to sell at the low due to lost income and buy you time to find alternatives.</p>\n<p>That said, with inflation running as hot as it is and cash returns failing to keep up, it might not be a good idea to hold too much cash. As a result, consider the standard guidance of three-to-six months' worth of basic living expenses&nbsp; as a reasonable \"goldilocks\" target.</p>\n<h2>No. 3: Plan for the big expenses coming your way soon</h2>\n<p>As a general rule, money you expect to spend within the next five years does not belong in stocks. If you have a big purchase coming up in that time window -- say a new car, a child's college education, or a bucket list vacation -- a market sitting near all-time highs can give you a great opportunity to sell.</p>\n<p>It's OK to sell enough stock to cover the costs of what you're buying in that window and any taxes you'll owe on your stock sale. Then, put the remaining money in something like a CD or Treasury or investment grade bonds that mature just before you'll need the money.</p>\n<p>No, you won't make stupendously high returns on that money, but you will also sleep more soundly knowing that a mere market crash won't automatically derail your near-term plans for that cash.</p>\n<h2>No. 4: Know a decent estimate of the value of what you own</h2>\n<p>Ultimately, stocks are nothing more than fractional ownership stakes in companies. Yes, their market prices can rise or fall a whole bunch in a very short period of time, but in the long run, stocks are tied to the cash generating capability of the businesses behind those shares.</p>\n<p>Using the discounted cash flow model and reasonable projections for the future of the company, you can estimate what that fair value would be. You can easily adjust your assumptions for a more aggressive growth future or a more pessimistic one as well, to get a feel for a range of potential values. You can then compare your model with the market's price and use that to inform your buy, sell, or hold decisions.</p>\n<p>If a company you own is priced so high by the market that even your most aggressive estimates for its future can't keep up, then it might be a good idea to sell it. On the flip side, if a company you own is available for such a dirt cheap price that even your pessimistic estimate is above the market's price for it, you might want to consider buying even more.</p>\n<p>The beauty of the discounted cash flow model is that it can help you make those buy/sell/hold decisions regardless of what the overall market is doing. As a result, it can help you both prepare for a crash by figuring out which companies to consider selling and invest through a crash by figuring out which ones are the biggest bargains worthy of buying.</p>\n<h2>No. 5: Invest with the long term in mind</h2>\n<p>With the first three options, you've taken great steps to protect yourself against many of the short term disruptions that can come from market crashes. With the fourth option, you've given yourself a tool to make smarter investing decisions around the time of a crash. Together, they free you up to truly have a long-term perspective when you invest in stocks.</p>\n<p>That long-term perspective is important because it provides the foundation of the biggest advantage you have against Wall Street: your patience. With a long-term perspective, the rest of your financial house in order, and decent valuations at your disposal, you can stay invested during and after a crash. That is absolutely key to being invested during any subsequent recovery, which is where the next round of wealth can be built.</p>\n<h2>Get ready now for the next crash</h2>\n<p>None of us really know when the next stock market crash will happen, but we can be pretty sure that there will be another one headed our way. With the market near all-time highs &nbsp;and so many very clear economic risks in front of us, now could be a great time to make the adjustments you need to get prepared for that crash.</p>\n<p>By balancing the tools you need to survive the next crash with a long term perspective for the money you're able to keep invested, you can be prepared no matter when that crash takes place. Get yourself ready now, and you will have the advantage of being ready before it happens, rather than trying to clean up after the fact.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is the Stock Market Going to Crash Again?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs the Stock Market Going to Crash Again?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 17:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The market will crash again. That is inevitable. The only real question is when will it happen?\nLet's be clear: there are lots of reasons to believe the market could crash soon. Skyrocketing inflation...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.fool.com/investing/2021/11/21/is-the-stock-market-going-to-crash-again/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185826772","content_text":"The market will crash again. That is inevitable. The only real question is when will it happen?\nLet's be clear: there are lots of reasons to believe the market could crash soon. Skyrocketing inflation , stretched valuations , and a critical labor shortage  each could pose risks to the market on their own. Put them all together in a situation like we have today, and the danger certainly seems to multiply.\nJust because the market could crash soon doesn't mean it will, however. If it somehow manages to keep climbing, would you really want to be sitting on the sidelines, watching the purchasing power of your money evaporate to inflation?\nThat combination of factors makes now one of the toughest times in most of our investing lifetimes to know what the best course of action should be. That might actually mean that there is no single best path forward and that the right approach could be to build a balance across the five options discussed here.\nNo. 1: Get out of (expensive) debt\nIf the market's massive run has left you in the position where you could pay off your debts, maybe that provides a good opportunity to actually do so. If not your entire debt burden, perhaps you could pay off everything but your fixed-rate, low interest mortgage?\nIt might seem crazy to pay off debt when interest rates are so low and the market has seen such huge recent rises, but that could very well be the best time to do so. After all, if interest rates rise, that could both increase your debt service costs and cause at least some of your stocks to drop, catching you with a double-whammy. When you add in the fact your debt service costs need to be paid even if your stocks are way down, you get a situation where reducing or eliminating debt looks like a smart move.\nNo. 2: Build a cash buffer\nIn a world where inflation is running over 6%,  having a lot of cash sitting around earning less than 1%  might seem crazy. When viewed only on that basis, it is. When you recognize that market crashes and job losses often go hand in hand, having a decent cash buffer can be viewed as an insurance policy. At least for a little while, it can keep you from being forced to sell at the low due to lost income and buy you time to find alternatives.\nThat said, with inflation running as hot as it is and cash returns failing to keep up, it might not be a good idea to hold too much cash. As a result, consider the standard guidance of three-to-six months' worth of basic living expenses  as a reasonable \"goldilocks\" target.\nNo. 3: Plan for the big expenses coming your way soon\nAs a general rule, money you expect to spend within the next five years does not belong in stocks. If you have a big purchase coming up in that time window -- say a new car, a child's college education, or a bucket list vacation -- a market sitting near all-time highs can give you a great opportunity to sell.\nIt's OK to sell enough stock to cover the costs of what you're buying in that window and any taxes you'll owe on your stock sale. Then, put the remaining money in something like a CD or Treasury or investment grade bonds that mature just before you'll need the money.\nNo, you won't make stupendously high returns on that money, but you will also sleep more soundly knowing that a mere market crash won't automatically derail your near-term plans for that cash.\nNo. 4: Know a decent estimate of the value of what you own\nUltimately, stocks are nothing more than fractional ownership stakes in companies. Yes, their market prices can rise or fall a whole bunch in a very short period of time, but in the long run, stocks are tied to the cash generating capability of the businesses behind those shares.\nUsing the discounted cash flow model and reasonable projections for the future of the company, you can estimate what that fair value would be. You can easily adjust your assumptions for a more aggressive growth future or a more pessimistic one as well, to get a feel for a range of potential values. You can then compare your model with the market's price and use that to inform your buy, sell, or hold decisions.\nIf a company you own is priced so high by the market that even your most aggressive estimates for its future can't keep up, then it might be a good idea to sell it. On the flip side, if a company you own is available for such a dirt cheap price that even your pessimistic estimate is above the market's price for it, you might want to consider buying even more.\nThe beauty of the discounted cash flow model is that it can help you make those buy/sell/hold decisions regardless of what the overall market is doing. As a result, it can help you both prepare for a crash by figuring out which companies to consider selling and invest through a crash by figuring out which ones are the biggest bargains worthy of buying.\nNo. 5: Invest with the long term in mind\nWith the first three options, you've taken great steps to protect yourself against many of the short term disruptions that can come from market crashes. With the fourth option, you've given yourself a tool to make smarter investing decisions around the time of a crash. Together, they free you up to truly have a long-term perspective when you invest in stocks.\nThat long-term perspective is important because it provides the foundation of the biggest advantage you have against Wall Street: your patience. With a long-term perspective, the rest of your financial house in order, and decent valuations at your disposal, you can stay invested during and after a crash. That is absolutely key to being invested during any subsequent recovery, which is where the next round of wealth can be built.\nGet ready now for the next crash\nNone of us really know when the next stock market crash will happen, but we can be pretty sure that there will be another one headed our way. With the market near all-time highs  and so many very clear economic risks in front of us, now could be a great time to make the adjustments you need to get prepared for that crash.\nBy balancing the tools you need to survive the next crash with a long term perspective for the money you're able to keep invested, you can be prepared no matter when that crash takes place. Get yourself ready now, and you will have the advantage of being ready before it happens, rather than trying to clean up after the fact.","news_type":1},"isVote":1,"tweetType":1,"viewCount":965,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872435142,"gmtCreate":1637558039494,"gmtModify":1637558039625,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"LMND a good bargain now","listText":"LMND a good bargain now","text":"LMND a good bargain now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/872435142","repostId":"2185120826","repostType":4,"isVote":1,"tweetType":1,"viewCount":864,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872118326,"gmtCreate":1637457494160,"gmtModify":1637459389685,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Took up small position for long term growth&nbsp;","listText":"Took up small position for long term growth&nbsp;","text":"Took up small position for long term growth","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872118326","repostId":"2184828468","repostType":4,"repost":{"id":"2184828468","kind":"highlight","pubTimestamp":1637456376,"share":"https://www.laohu8.com/m/news/2184828468?lang=&edition=full","pubTime":"2021-11-21 08:59","market":"us","language":"en","title":"Missed Out on Lucid and Rivian? 2 EV Stocks To Buy Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2184828468","media":"Motley Fool","summary":"Electric vehicle growth stocks have flare, but there are value names out there too.","content":"<p>Even after slipping on Wednesday and Thursday, share prices of <b>Rivian Automotive</b> (NASDAQ:RIVN) and <b>Lucid Group</b> (NASDAQ:LCID) are up big over the last week as investors cheer newcomers to the electric vehicle (EV) scene.Both companies are bursting with potential but are a long way from profitability.</p>\n<p>If you feel like you missed out on Lucid and Rivian, or are simply looking for a better value in the EV sector, then<b> Ford</b> (NYSE:F)and <b>Nio</b> (NYSE:NIO) could be better options right now.</p>\n<h2>Sink or swim</h2>\n<p><b>Daniel Foelber (Ford): </b>10 years ago, <b>Tesla </b>(NASDAQ:TSLA) was a new, unproven, and heavily criticized EV company. Legacy automakers doubted the feasibility of EVs and continued with their established businesses. Today, the script has flipped as new and existing automakers clamor for a slice of the ever-growing EV pie.</p>\n<p>It takes humility to admit that you were wrong. And no legacy automaker is doing it better than Ford. Although Ford is a well-known brand, many folks aren't aware of the extent of its EV investments. Investors can use this misconception to their advantage as Ford is valued like a low growth legacy automaker when in reality its growth is set to accelerate thanks to EVs. Ford plans on spending $40 billion to $45 billion on strategic capital expenditures between 2020 and 2025 -- $30 billion of which is earmarked for battery EVs. However, it's worth mentioning that as EVs grow to comprise a larger share of Ford's sales mix, there should be a decline in sales from its legacy models over time. The challenge for Ford will be growing profits off of a larger EV mix, whether that's from higher margins from the vehicles themselves or software and other streams.</p>\n<p>Investors may be wondering why Ford is diving headfirst into EVs after years of resistance. The simplest answer is motive, as well as CEO Jim Farley who took over in October 2020.</p>\n<p>Business decisions are based on incentives. While companies like Tesla have spent the last decade growing, Ford has languished due to fierce competition and unsuccessful expansions into the sedan market. Without its core F-Series pickup line, it would likely have been toast. However, Ford is quickly becoming <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the biggest supporters of EVs. Similar to oil and gas, where the struggling companies like <b>BP</b> and <b>Royal Dutch Shell </b>are quick to embrace renewables while the more successful ones like <b>ExxonMobil </b>and <b>Chevron </b>are slow to change, Ford is the ideal car company to embrace EVs. It's investing in EVs at a faster rate than <b>Toyota</b>, <b>Honda</b>, <b>Mercedes-Benz, </b>and other internal combustion engine (ICE) automakers because, quite frankly, Ford is arguably not as good as those companies in the ICE field.</p>\n<p>Incentivized to avoid sinking, Ford is swimming toward EVs on the back of its F-150 Lightning and Mustang Mach-E. With the electric truck and SUV market still relatively young, Ford is poised to become a contender and maybe even a leader in both classes.</p>\n<h2>Next leg of growth</h2>\n<p><b>Howard Smith&nbsp;(Nio):</b> Many investors thought they missed out on Chinese EV maker Nio in the early months of 2021 after the stock shot up to more than $60 per share, giving the company a market cap close to $100 billion. The frenzy came as people thought they needed to get into the next big EV stock. That scenario is starting to look familiar again as Rivian and Lucid garner much investor adoration and shares have soared.</p>\n<p>But Nio shares were subsequently cut in half, even though its business continued to drive ahead. The stock has recovered some, but it still has a lower valuation than both Rivian and Lucid currently. And with it already moving its business into Europe and working on doubling its production capacity, Nio could be the EV stock to buy for those that feel they've missed out on the recent run from those two U.S. start-ups.</p>\n<p>By the time Nio reports its next vehicle delivery data, it will likely have sold more than 150,000 of its electric SUVs. And while investor excitement around Rivian and Lucid is understandable, it shouldn't be lost that neither has produced any meaningful volume as of yet.</p>\n<p>While Nio has hit some recent bumps from supply chain disruptions, it continues to push forward on its next leg of growth. It sent its first export shipment to Norway this summer and is working to grow its community there. That consists of Nio House studios used by its customer communities, and its network of charging solutions which includes its unique battery swap stations that also help bring the company a stream of subscription revenue. Nio expects to sell its newest offering, the luxury ET7 sedan, into both Norway and Germany in 2022 as it expands to its next European market. This expansion comes as the company and its manufacturing partner are constructing new lines to more than double capacity as demand continues to grow. For those that missed out on the recent run in shares of Rivian or Lucid, Nio makes a good alternative EV investment right now.</p>\n<h2>Companies that are built to last</h2>\n<p>If you're tired of hearing about growth stocks like Rivian and Lucid, Ford and Nio could be good electric car options now. Both companies are established businesses generating real sales and ramping production. Ford's established and profitable business gives it the stability and extra cash needed to fund its EV exploits. Nio is a market leader in China and is growing at a breakneck pace. When valuations stray from fundamentals, sometimes it's best to ignore the limelight in search of hidden gems like Ford and Nio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Missed Out on Lucid and Rivian? 2 EV Stocks To Buy Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMissed Out on Lucid and Rivian? 2 EV Stocks To Buy Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-21 08:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/20/missed-out-on-lucid-and-rivian-try-these-2-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even after slipping on Wednesday and Thursday, share prices of Rivian Automotive (NASDAQ:RIVN) and Lucid Group (NASDAQ:LCID) are up big over the last week as investors cheer newcomers to the electric ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/20/missed-out-on-lucid-and-rivian-try-these-2-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","LCID":"Lucid Group Inc","BK4531":"中概回港概念","BK4534":"瑞士信贷持仓","F":"福特汽车","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","BK4509":"腾讯概念","BK4527":"明星科技股","TSLA":"特斯拉","BK4526":"热门中概股","BK4550":"红杉资本持仓","BK4551":"寇图资本持仓","EV":"MAST GLOBAL BATTERY RECYCLING & PRODUCTION ETF","RIVN":"Rivian Automotive, Inc.","BK4505":"高瓴资本持仓","BK4504":"桥水持仓","BK4099":"汽车制造商","ICE":"洲际交易所","BK4112":"金融交易所和数据","BK4548":"巴美列捷福持仓","NIO":"蔚来"},"source_url":"https://www.fool.com/investing/2021/11/20/missed-out-on-lucid-and-rivian-try-these-2-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184828468","content_text":"Even after slipping on Wednesday and Thursday, share prices of Rivian Automotive (NASDAQ:RIVN) and Lucid Group (NASDAQ:LCID) are up big over the last week as investors cheer newcomers to the electric vehicle (EV) scene.Both companies are bursting with potential but are a long way from profitability.\nIf you feel like you missed out on Lucid and Rivian, or are simply looking for a better value in the EV sector, then Ford (NYSE:F)and Nio (NYSE:NIO) could be better options right now.\nSink or swim\nDaniel Foelber (Ford): 10 years ago, Tesla (NASDAQ:TSLA) was a new, unproven, and heavily criticized EV company. Legacy automakers doubted the feasibility of EVs and continued with their established businesses. Today, the script has flipped as new and existing automakers clamor for a slice of the ever-growing EV pie.\nIt takes humility to admit that you were wrong. And no legacy automaker is doing it better than Ford. Although Ford is a well-known brand, many folks aren't aware of the extent of its EV investments. Investors can use this misconception to their advantage as Ford is valued like a low growth legacy automaker when in reality its growth is set to accelerate thanks to EVs. Ford plans on spending $40 billion to $45 billion on strategic capital expenditures between 2020 and 2025 -- $30 billion of which is earmarked for battery EVs. However, it's worth mentioning that as EVs grow to comprise a larger share of Ford's sales mix, there should be a decline in sales from its legacy models over time. The challenge for Ford will be growing profits off of a larger EV mix, whether that's from higher margins from the vehicles themselves or software and other streams.\nInvestors may be wondering why Ford is diving headfirst into EVs after years of resistance. The simplest answer is motive, as well as CEO Jim Farley who took over in October 2020.\nBusiness decisions are based on incentives. While companies like Tesla have spent the last decade growing, Ford has languished due to fierce competition and unsuccessful expansions into the sedan market. Without its core F-Series pickup line, it would likely have been toast. However, Ford is quickly becoming one of the biggest supporters of EVs. Similar to oil and gas, where the struggling companies like BP and Royal Dutch Shell are quick to embrace renewables while the more successful ones like ExxonMobil and Chevron are slow to change, Ford is the ideal car company to embrace EVs. It's investing in EVs at a faster rate than Toyota, Honda, Mercedes-Benz, and other internal combustion engine (ICE) automakers because, quite frankly, Ford is arguably not as good as those companies in the ICE field.\nIncentivized to avoid sinking, Ford is swimming toward EVs on the back of its F-150 Lightning and Mustang Mach-E. With the electric truck and SUV market still relatively young, Ford is poised to become a contender and maybe even a leader in both classes.\nNext leg of growth\nHoward Smith (Nio): Many investors thought they missed out on Chinese EV maker Nio in the early months of 2021 after the stock shot up to more than $60 per share, giving the company a market cap close to $100 billion. The frenzy came as people thought they needed to get into the next big EV stock. That scenario is starting to look familiar again as Rivian and Lucid garner much investor adoration and shares have soared.\nBut Nio shares were subsequently cut in half, even though its business continued to drive ahead. The stock has recovered some, but it still has a lower valuation than both Rivian and Lucid currently. And with it already moving its business into Europe and working on doubling its production capacity, Nio could be the EV stock to buy for those that feel they've missed out on the recent run from those two U.S. start-ups.\nBy the time Nio reports its next vehicle delivery data, it will likely have sold more than 150,000 of its electric SUVs. And while investor excitement around Rivian and Lucid is understandable, it shouldn't be lost that neither has produced any meaningful volume as of yet.\nWhile Nio has hit some recent bumps from supply chain disruptions, it continues to push forward on its next leg of growth. It sent its first export shipment to Norway this summer and is working to grow its community there. That consists of Nio House studios used by its customer communities, and its network of charging solutions which includes its unique battery swap stations that also help bring the company a stream of subscription revenue. Nio expects to sell its newest offering, the luxury ET7 sedan, into both Norway and Germany in 2022 as it expands to its next European market. This expansion comes as the company and its manufacturing partner are constructing new lines to more than double capacity as demand continues to grow. For those that missed out on the recent run in shares of Rivian or Lucid, Nio makes a good alternative EV investment right now.\nCompanies that are built to last\nIf you're tired of hearing about growth stocks like Rivian and Lucid, Ford and Nio could be good electric car options now. Both companies are established businesses generating real sales and ramping production. Ford's established and profitable business gives it the stability and extra cash needed to fund its EV exploits. Nio is a market leader in China and is growing at a breakneck pace. When valuations stray from fundamentals, sometimes it's best to ignore the limelight in search of hidden gems like Ford and Nio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876350887,"gmtCreate":1637275916350,"gmtModify":1637275916495,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASTI\">$Ascent Solar Technologies, Inc.(ASTI)$</a>you are&nbsp;not alone[Spurting]&nbsp;","listText":"<a href=\"https://laohu8.com/S/ASTI\">$Ascent Solar Technologies, Inc.(ASTI)$</a>you are&nbsp;not alone[Spurting]&nbsp;","text":"$Ascent Solar Technologies, Inc.(ASTI)$you are not alone[Spurting]","images":[{"img":"https://static.tigerbbs.com/6291d2dd944382e007fd02463e134c85","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876350887","isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":879288807,"gmtCreate":1636728393263,"gmtModify":1636728393353,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Jushi is the right choice [Miser]&nbsp;","listText":"Jushi is the right choice [Miser]&nbsp;","text":"Jushi is the right choice [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879288807","repostId":"2182094779","repostType":2,"repost":{"id":"2182094779","kind":"highlight","pubTimestamp":1636723680,"share":"https://www.laohu8.com/m/news/2182094779?lang=&edition=full","pubTime":"2021-11-12 21:28","market":"us","language":"en","title":"The Smartest Stocks to Buy With $20 Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2182094779","media":"Motley Fool","summary":"A small amount of money can go a long way when invested in these top-notch stocks.","content":"<p>Time and again, Wall Street has shown investors the power of patience.</p>\n<p>Over the past 71 years, the broad-based <b>S&amp;P 500</b> has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.</p>\n<p>Best of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.</p>\n<h2>Exelixis</h2>\n<p>One of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer <b>Exelixis</b> (NASDAQ:EXEL).</p>\n<p>Last week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.</p>\n<p>However, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"</p>\n<p>Although the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.</p>\n<p>More importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.</p>\n<p>Additionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.</p>\n<p>It's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.</p>\n<h2>Jushi Holdings</h2>\n<p>Some of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) <b>Jushi Holdings</b> (OTC:JUSHF) makes for a smart buy with $20.</p>\n<p>To start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.</p>\n<p>In relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.</p>\n<p>The reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.</p>\n<p>Something else impressive about Jushi, and <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.</p>\n<p>Jushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.</p>\n<h2>Viatris</h2>\n<p>On the other hand, if value runs through your blood, generic-drug giant <b>Viatris</b> (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.</p>\n<p>Roughly a year ago, Viatris was born from the combination of <b>Pfizer</b>'s established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.</p>\n<p>There were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.</p>\n<p>As a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.</p>\n<p>Beyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.</p>\n<p>Viatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Smartest Stocks to Buy With $20 Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Smartest Stocks to Buy With $20 Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 21:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JUSHF":"Jushi Holdings Inc.","EXEL":"伊克力西斯","VTRS":"Viatris Inc."},"source_url":"https://www.fool.com/investing/2021/11/12/the-smartest-stocks-to-buy-with-20-right-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2182094779","content_text":"Time and again, Wall Street has shown investors the power of patience.\nOver the past 71 years, the broad-based S&P 500 has undergone 38 double-digit percentage corrections. Despite the regularity of these moves lower, every crash and correction throughout this period was eventually erased by a bull market rally. To put things succinctly, if investors buy great companies and allow their investment theses to play out over long periods of time, their chances of building wealth is very high.\nBest of all, with most online brokerages discarding minimum deposit requirements and commission fees, investors can begin or further their trek to financial independence with any amount of cash -- even $20. If you have $20 ready to put to work in the market, and it won't be needed to cover bills or other essential costs, the following trio of companies are the smartest stocks to buy right now.\nExelixis\nOne of the savviest stocks patient investors can buy right now with $20 is cancer-drug developer Exelixis (NASDAQ:EXEL).\nLast week, Exelixis announced its third-quarter operating results, which failed to hit the mark and sent its shares down by more than 10%. Sales of lead-drug Cabometyx were shy of Wall Street's expectations, which caused Exelixis to lower the upper end of its full-year sales outlook. Generally, lowering sales expectations will be met with frowns on Wall Street.\nHowever, this short-term weakness should be viewed as an opportunity, especially with the company's price-to-earnings-growth ratio (PEG ratio) below 0.4. A PEG ratio below 1 is typically considered \"undervalued.\"\nAlthough the landscape for first-line advanced renal cell carcinoma (RCC) is competitive, Cabometyx has demonstrated the ability to grow sales by a sustained double-digit percentage in RCC and advanced hepatocellular carcinoma. On an annual run-rate basis, Cabometyx is pacing more than $1 billion in sales -- and it's not done growing.\nMore importantly, Exelixis' lead drug is being examined in close to six dozen clinical trials as a monotherapy or combination treatment. If even a handful of these trials yield a positive result, label-expansion opportunities and organic growth could send Cabometyx to north of $2 billion in peak annual sales.\nAdditionally, Exelixis' robust cash position ($1.8 billion in cash, cash equivalents, and restricted cash) and healthy operating cash flow have allowed it to reignite its internal research engine. This includes advancing internally developed compounds into phase 1 studies, as well as signing collaboration agreements to potentially expand its cancer-drug pipeline.\nIt's not often you can marry growth and value with the same company, but that's exactly what investors can do with biotech stock Exelixis.\nJushi Holdings\nSome of the most deeply discounted growth stocks can be found in the marijuana industry, which is why U.S. multi-state operator (MSO) Jushi Holdings (OTC:JUSHF) makes for a smart buy with $20.\nTo start with, don't be concerned about a lack of cannabis reform in Washington. While life would undoubtedly be easier for pot stocks if lawmakers would simply follow the overwhelming will of the public and legalize cannabis, allowing individual states to legalize and regulate their pot industries is working fine. Thus far, 36 states have given the green light to weed in some capacity, which is providing growth opportunities for MSOs like Jushi.\nIn relative terms, Jushi is a small fry, with only 26 operating dispensaries at the moment. Comparatively, a handful of MSOs have in the neighborhood of (or more than) 100 open locations. But Jushi isn't about reckless expansion. Its management team favors methodical expansion in core markets. For Jushi, these core states are Pennsylvania, Illinois, and Virginia.\nThe reason management has chosen these states is due to their billion-dollar sales potential (Illinois hit $1 billion in legal pot revenue in 2020) and their limited-license status. In limited-license cannabis markets, regulators purposely limit how many dispensary licenses are issued in total, as well as to a single business. For a smaller player like Jushi, this competitive protection ensures it'll have a fair shot to build up its brand(s) and garner a loyal following in these core markets.\nSomething else impressive about Jushi, and one of the reasons I plan to be a long-term shareholder, is the participation of management and insiders. Of the first $250 million raised by the company, $45 million came from insiders and execs. When leadership has skin in the game right alongside their investors, good things tend to happen.\nJushi is expected to turn the corner to recurring profitability in 2022 and the company's growing sales faster than virtually all other MSOs. The company checks all the appropriate boxes for growth investors.\nViatris\nOn the other hand, if value runs through your blood, generic-drug giant Viatris (NASDAQ:VTRS) is one of the smartest stocks you can buy right now with $20.\nRoughly a year ago, Viatris was born from the combination of Pfizer's established drug unit Upjohn with generic-drug developer Mylan. Due to generic-drug price weakness throughout the industry, the company's first year as a public company has been one to forget. However, this near-term underperformance represents the perfect opportunity for patient investors to nab an exceptionally inexpensive and profitable drug stock.\nThere were a number of reasons Upjohn and Mylan tied the knot. First off, there were clear-cut cost synergies. The company expects to recognize more than $500 million in cost synergies this year, with well over $1 billion in annual cost reductions by 2023.\nAs a combined company, Viatris is also in a better position to tackle its outstanding debt. Through the first six months of 2021, $1.15 billion in debt was repaid. By the end of 2023, $6.5 billion in debt should be repaid, which represents a quarter of the company's combined debt ($26 billion), as of November 2020.\nBeyond just trimming the fat, Viatris should be able to kick-start its internal drug research in 2024 once debt levels are reduced to more favorable levels. Keep in mind that new drug research would come atop existing biosimilar clinical trials, which are expected to generate billions of dollars in future sales.\nViatris won't deliver jaw-dropping growth like Jushi, or even double-digit annual sales upside like Exelixis. But with a steadiness to generic-drug demand and an improving balance sheet, Viatris' forward price-to-earnings ratio below 4 simply doesn't do its stock justice.","news_type":1},"isVote":1,"tweetType":1,"viewCount":477,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879156743,"gmtCreate":1636694218794,"gmtModify":1636694472903,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Support BABA","listText":"Support BABA","text":"Support BABA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879156743","repostId":"1137718483","repostType":2,"repost":{"id":"1137718483","kind":"news","pubTimestamp":1636677707,"share":"https://www.laohu8.com/m/news/1137718483?lang=&edition=full","pubTime":"2021-11-12 08:41","market":"hk","language":"en","title":"Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137718483","media":"Motley Fool","summary":"$Alibaba$ Group has plummeted 49% since peaking 13 months ago.Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.Alibaba and two other U.S. former market darlings have a strong chance to bounce back from here.Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day c","content":"<p>Key Points</p>\n<ul>\n <li><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> Group has plummeted 49% since peaking 13 months ago.</li>\n <li>Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.</li>\n <li>Alibaba&nbsp;and two other U.S. former market darlings have a strong chance to bounce back from here.</li>\n</ul>\n<p>The market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.</p>\n<p>Shares of<b><a href=\"https://laohu8.com/S/09988\">Alibaba</a> Group Holding</b>(NYSE:BABA),<b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</b>, and&nbsp;<a href=\"https://laohu8.com/S/PINS\"><b>Pinterest</b></a>&nbsp;have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.</p>\n<p>1. Alibaba</p>\n<p>Thursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.</p>\n<p>Singles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.</p>\n<p>Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.</p>\n<p>2. <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</p>\n<p>The rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?</p>\n<p>The market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.</p>\n<p>However, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.</p>\n<p>3. Pinterest</p>\n<p>A year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.</p>\n<p>Everything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.</p>\n<p>Last month&nbsp;<b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.</p>\n<p>PayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.</p>\n<p>Alibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PINS":"Pinterest, Inc.","BABA":"阿里巴巴","ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137718483","content_text":"Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. former market darlings have a strong chance to bounce back from here.\n\nThe market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.\nShares ofAlibaba Group Holding(NYSE:BABA),Zoom Video, and Pinterest have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.\n1. Alibaba\nThursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.\nSingles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.\nAlibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.\n2. Zoom Video\nThe rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?\nThe market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.\nHowever, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.\n3. Pinterest\nA year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.\nEverything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.\nLast month PayPal Holdings was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.\nPayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.\nAlibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847499980,"gmtCreate":1636542095796,"gmtModify":1636542096052,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Repitive article spreading fear&nbsp;","listText":"Repitive article spreading fear&nbsp;","text":"Repitive article spreading fear","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847499980","repostId":"1179287524","repostType":2,"repost":{"id":"1179287524","kind":"news","pubTimestamp":1636532973,"share":"https://www.laohu8.com/m/news/1179287524?lang=&edition=full","pubTime":"2021-11-10 16:29","market":"us","language":"en","title":"Don't Get Too Comfortable: The Crash May Be Coming","url":"https://stock-news.laohu8.com/highlight/detail?id=1179287524","media":"seekingalpha","summary":"Summary\n\nTech stocks are surging left and right like it's 1999 all over again.\nThe S&P 500's cyclica","content":"<p>Summary</p>\n<ul>\n <li>Tech stocks are surging left and right like it's 1999 all over again.</li>\n <li>The S&amp;P 500's cyclically adjusted P/E ratio was higher just once before now. Yes, you guessed it, leading up to the 2000 market top.</li>\n <li>While technology is leading the charge, sky-high valuations seem to be widespread amongst multiple sectors.</li>\n <li>A correction in ultra-high multiple names combined with multiple compression in more mature companies could cause a market meltdown soon.</li>\n <li>Looking for a helping hand in the market? Members of The Financial Prophet get exclusive ideas and guidance to navigate any climate.</li>\n</ul>\n<p>There is extensive froth in the stock market right now, and you don't have to go far or dig deep to see what I mean.</p>\n<p><b>The S&amp;P 500/SPX</b>(SP500)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2323fa4ed6b27420f5433954b61f797b\" tg-width=\"727\" tg-height=\"772\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com</span></p>\n<p>The S&amp;P 500 has now gained about 10% since I&nbsp;began calling to an end&nbsp;to the recent pullback at the lows several weeks ago. We've seen remarkable gains in a short time frame, as the SPX has appreciated in 18 out of its last 20 trading sessions. Moreover, the major stock average is up by about 35% over the previous year.</p>\n<p>Technically, the image is significantly overheated right now. The relative strength index (\"RSI\") is nearing 80, the highest level in over a year. The last time the RSI surged to 80 was right before the 10% correction last September. Moreover, the full stochastic is elevated and looks ready to turn downward, implying a possible shift in sentiment.</p>\n<p><b>Invesco Nasdaq 100 ETF</b>(QQQ)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4fc9224a93768c8e3e6fca68a191e0da\" tg-width=\"721\" tg-height=\"772\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com</span></p>\n<p>The Nasdaq 100 is even worse. QQQ looks like it topped out at $400, about a 15% gain from recent lows just several weeks ago. The RSI reached the absurdly high 80 levels and is hovering around 77, signaling highly overbought technical conditions. Incredibly, were looking at about a 43% gain over the last year here. Several other technical elements jump out. QQQ's price is now about 7% above its 50-day moving average. Again, the last time we saw anything close to this disconnect was the short-term top going into September 2020. Now we see the full stochastic turning downward, and the black candle at the recent top could mean that high-flying tech stocks are ready to head lower for now.</p>\n<p>Tech Stocks Gone Wild</p>\n<p>There is no shortage of froth in the tech sector today. I don't mean just technically, as fundamentally, some valuations seem absurd right now.</p>\n<p><b>NVIDIA</b>(NVDA)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5fee6e0df3997c0eb900abe5f6c0fc89\" tg-width=\"723\" tg-height=\"772\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com</span></p>\n<p>Nvidia is a great company, and the stock has performed exceptionally well lately. Possibly too well, as shares have nearly tripled in just about one year, and the company is approaching a forward&nbsp;P/E valuation of 80 now. Also, if you thought an RSI of 80 was high, check out Nvidia pushing up to around 90 right now. In some cases, an 80 P/E ratio could make sense, but Nvidia is not likely to show exceptional earnings growth in future years. On the contrary, projections illustrate the probability of modest EPS growth in upcoming years.</p>\n<p>Therefore, Nvidia with a forward P/E ratio of 80 doesn't make sense in my mind. Additionally, the company is now around a $750 billion valuation with just about $25 billion in revenues set to come in this year. Thus, Nvidia is trading at about 30 times sales right now.</p>\n<p>Thirty times sales, what? Is Nvidia a rapidly growing small-cap tech or biotechnology firm? No, it is not. Nvidia is the top tech stock gone wild lately. It is now a mega-cap tech name, the&nbsp;number 7 weight wise&nbsp;company in the S&amp;P 500, and it looks hugely overvalued at this point.</p>\n<p>I am no Nvidia bear, and I owned shares in prior quarters. Possibly the only reason I don't own Nvidia now is that I have AMD in my portfolio. However, with the stock now 36% above its 50-day MA on essentially no news, things are getting absurd.</p>\n<p>Nvidia could drop by 33% from here, and it would still be relatively expensive at $200 with a forward multiple above $50.</p>\n<p><b>Tesla</b>(TSLA)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c21876fcb512c6599d06c5e93452165\" tg-width=\"726\" tg-height=\"771\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com</span></p>\n<p>If you thought Nvidia's valuation was an end to the madness, it's not, likely only the beginning. Let's talk about Tesla for a minute. Now, I am a long-term supporter of Tesla, I've owned the company's shares for a long time, and I've written many positive articles about the company. The first article I ever wrote on Seeking Alpha was \"Will Tesla Become A Trillion Dollar Company?\" Now, Tesla became a trillion-dollar company much sooner than I anticipated, and I took profits in the stock at around $1,200 recently.</p>\n<p>I still like Tesla longer-term, but let's face it, we're dealing with a stock that has expanded by about 4.5X over the last year (this is on top of a remarkable runup the previous year). While it might not be fair to judge Tesla's valuation on its 190 forward P/E multiple, I think the stock is richly priced at 22 times sales.</p>\n<p>Technically, the image is mind-boggling, as Tesla recently surged to 50% above its 50-day MA and hit an RSI level well above 90. Tesla is now the fifth-largest S&amp;P 500 component and accounts for about 2.5% of the major average's weight.</p>\n<p>Tesla is not the only stock to go wild in the EV space. We see other players like Lucid (LCID) hitting ludicrous valuations. Lucid now trades at a valuation of&nbsp;around $70 billion, while analysts anticipate the company to bring in about $1.7 billion in revenues next year. We're looking at a forward P/S ratio of about 40 here now. Lucid is another stock that has been up by about 4.5X over the last year, and this is another nameI took profits in recently.</p>\n<p>Tesla could drop to around $800 - 900 support, roughly around a 25-33% pullback from recent highs. The stock would look far more attractive then.</p>\n<p><b>Advanced Micro Devices</b>(AMD)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/008840326856d3681371b0d0f4f384d4\" tg-width=\"727\" tg-height=\"773\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com</span></p>\n<p>AMD has been one of my favorite stocks recently, and this is one that I'm still long for now. However, the recent runup has been intense. We see an RSI closing in on 90, and this name has nearly doubled over the last year. Yet, at about&nbsp;ten times sales&nbsp;and a forward P/E below 50, it seems relatively cheap to names like Nvidia and others right now. Incredibly, right?</p>\n<p>The list of big tech stocks surging lately can go on and on, but I want to look at the most prominent tech stock in the world that is not surging lately. I think it is pretty telling what Apple's stock is doing right now.</p>\n<p>AMD could use about a 20% discount around here. A forward P/E ratio closer to 40 would make the stock much more attractive at approximately $120 a share. I am using spreads to hedge my position here. Otherwise, I would take profits now.</p>\n<p><b>Apple</b>(AAPL)</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/63d6d781b612860c8e34e5d7f53f2988\" tg-width=\"731\" tg-height=\"771\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com - Apple could get its P/E ratio compressed to around 20, implying a price of about $112 for its shares.</span></p>\n<p>So, what is Apple doing lately? Well, not much, as the stock is not skyrocketing to new ATHs as many other technology names are right now. It appears that Apple topped out in early September and has failed to make new highs since. Now, we see a lower high being put in, and Apple looks like it could trade sideways or even head lower for now.</p>\n<p>Now, I spoke about&nbsp;Apple being dead money&nbsp;in my previous article on the company, but there is a good reason for this, in my view. While Apple is not trading at 80 or 50 times forward earnings projections, the company is trading at about27 times forward earning&nbsp;sexpectations. The problem is that while AMD, Nvidia, Tesla, and others are still strong growth stories, Apple likely has minimal growth potential in the next few years.</p>\n<p>Analysts are typically bullish on Apple but predict low single-digit revenue and EPS growth in future years. So, why is Apple trading at such a premium multiple? After all, 27 times forward earnings are not cheap, and even in the current environment, a company should have robust growth prospects for the next several years.</p>\n<p>Apple seems overvalued here, and the company does not deserve such a premium multiple given the probability for stagnant growth in the next several years. Therefore, we could see multiple compression in Apple from now on, and the company's downturn could drag the broader down as well.</p>\n<p>The problem is that Apple accounts for a substantial portion of the S&amp;P 500's weight (6%). Another problem is that Apple is not alone, and this may come as a surprise to many people, but Apple is not even the most significant component of the SPX.</p>\n<p><b>Microsoft</b>(MSFT):</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9788532fa13a3b90f86289660c2cb238\" tg-width=\"726\" tg-height=\"771\" width=\"100%\" height=\"auto\"><span>Source: StockCharts.com -Microsoft's stock would look much more attractive with a forward P/E ratio of about 30, suggesting a 20% correction for the stock. Microsoft at $270 looks like a much better buy than it is now.</span></p>\n<p>Talk about being overbought technically. Just look at Microsoft. The RSI here is approaching 80, the stock is up by nearly 60% over the last year, and Microsoft is now the most valuable company globally. Yes, this $2.52 trillion behemoth now accounts for around 6.35% of the SPX's weight. Now, I wish I could say that Microsoft is relatively inexpensive, but that is far from true. On the contrary, Microsoft trades at a whopping37 times forward earnings&nbsp;expectations.</p>\n<p>Granted, Microsoft offers better growth prospects than Apple in future years, but nearly 40 times forward estimates for a stock that could increase earnings by about 10-15% next year is very expensive. We don't typically value huge companies relative to their sales, but Microsoft now trades at a ridiculously high 15 times TTM sales.</p>\n<p>I also want to emphasize the growing influence of big tech in the S&amp;P 500 and other major averages. The top seven weighted holdings in the S&amp;P 500 are seven giant tech companies that account for a whopping27% of the index's weight. It's not difficult to imagine what will happen to the S&amp;P 500 and other major stock indexes when this massive tech bubble unwinds or corrects down the line.</p>\n<p><b>S&amp;P 500 Shiller P/E ratio</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2758adbaf32d04dd18b08589062e6f62\" tg-width=\"1669\" tg-height=\"739\" width=\"100%\" height=\"auto\"><span>Source:multpl.com</span></p>\n<p>I spoke about Microsoft's lofty forward P/E ratio, but it is essentially in line with the Shiller/cyclically adjusted P/E ratio on the entire S&amp;P 500 right now. So, we see that this phenomenon of remarkably high valuations is not only concentrated in tech but is widespread right now. We also see that similar valuations have only been observed once before in history. Yes, around the height of the dot-com bubble, some of us know how that turned out, and the outcome was unfavorable for stocks.</p>\n<p>Another factor I want to go over is that while I use a forward P/E in many instances, no one knows what company earnings will be next year. We saw quite a few&nbsp;misses last quarter, far more disappointing results than was expected. Apple and Amazon (AMZN) are just a couple of examples, but many more big names missed guidance.</p>\n<p><b>Therefore, if we look at TTM P/E multiples:</b></p>\n<ul>\n <li>Microsoft: 42</li>\n <li>Apple: 27</li>\n <li>Nvidia: 90</li>\n <li>Tesla: 228</li>\n <li>AMD: 63</li>\n <li>Lucid: N/A</li>\n</ul>\n<p>The Bottom Line</p>\n<p>We see many names trading at extremely high valuations right now. Moreover, many prominent companies and major stock market averages are grossly overbought technically. While I focused primarily on the dominant tech companies that account for a massive part of the S&amp;P 500's total weight, the frothy valuations go well beyond technology. The stock market, in general, looks frothy here technically, as well as from a fundamental perspective. Now, we could see a dynamic where the ultra-high multiple names that have skyrocketed lately begin to pull back. Simultaneously, we could see companies like Apple trade sideways or ever move lower due to growth concerns and subsequent multiple contractions. The result could be a \"deflation\" of the current bubble, which could cause a correction or even a mini-crash to occur as we advance into next year.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Get Too Comfortable: The Crash May Be Coming</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Get Too Comfortable: The Crash May Be Coming\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 16:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4467619-dont-get-too-comfortable-the-crash-is-coming><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nTech stocks are surging left and right like it's 1999 all over again.\nThe S&P 500's cyclically adjusted P/E ratio was higher just once before now. Yes, you guessed it, leading up to the 2000 ...</p>\n\n<a href=\"https://seekingalpha.com/article/4467619-dont-get-too-comfortable-the-crash-is-coming\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://seekingalpha.com/article/4467619-dont-get-too-comfortable-the-crash-is-coming","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1179287524","content_text":"Summary\n\nTech stocks are surging left and right like it's 1999 all over again.\nThe S&P 500's cyclically adjusted P/E ratio was higher just once before now. Yes, you guessed it, leading up to the 2000 market top.\nWhile technology is leading the charge, sky-high valuations seem to be widespread amongst multiple sectors.\nA correction in ultra-high multiple names combined with multiple compression in more mature companies could cause a market meltdown soon.\nLooking for a helping hand in the market? Members of The Financial Prophet get exclusive ideas and guidance to navigate any climate.\n\nThere is extensive froth in the stock market right now, and you don't have to go far or dig deep to see what I mean.\nThe S&P 500/SPX(SP500)\nSource: StockCharts.com\nThe S&P 500 has now gained about 10% since I began calling to an end to the recent pullback at the lows several weeks ago. We've seen remarkable gains in a short time frame, as the SPX has appreciated in 18 out of its last 20 trading sessions. Moreover, the major stock average is up by about 35% over the previous year.\nTechnically, the image is significantly overheated right now. The relative strength index (\"RSI\") is nearing 80, the highest level in over a year. The last time the RSI surged to 80 was right before the 10% correction last September. Moreover, the full stochastic is elevated and looks ready to turn downward, implying a possible shift in sentiment.\nInvesco Nasdaq 100 ETF(QQQ)\nSource: StockCharts.com\nThe Nasdaq 100 is even worse. QQQ looks like it topped out at $400, about a 15% gain from recent lows just several weeks ago. The RSI reached the absurdly high 80 levels and is hovering around 77, signaling highly overbought technical conditions. Incredibly, were looking at about a 43% gain over the last year here. Several other technical elements jump out. QQQ's price is now about 7% above its 50-day moving average. Again, the last time we saw anything close to this disconnect was the short-term top going into September 2020. Now we see the full stochastic turning downward, and the black candle at the recent top could mean that high-flying tech stocks are ready to head lower for now.\nTech Stocks Gone Wild\nThere is no shortage of froth in the tech sector today. I don't mean just technically, as fundamentally, some valuations seem absurd right now.\nNVIDIA(NVDA)\nSource: StockCharts.com\nNvidia is a great company, and the stock has performed exceptionally well lately. Possibly too well, as shares have nearly tripled in just about one year, and the company is approaching a forward P/E valuation of 80 now. Also, if you thought an RSI of 80 was high, check out Nvidia pushing up to around 90 right now. In some cases, an 80 P/E ratio could make sense, but Nvidia is not likely to show exceptional earnings growth in future years. On the contrary, projections illustrate the probability of modest EPS growth in upcoming years.\nTherefore, Nvidia with a forward P/E ratio of 80 doesn't make sense in my mind. Additionally, the company is now around a $750 billion valuation with just about $25 billion in revenues set to come in this year. Thus, Nvidia is trading at about 30 times sales right now.\nThirty times sales, what? Is Nvidia a rapidly growing small-cap tech or biotechnology firm? No, it is not. Nvidia is the top tech stock gone wild lately. It is now a mega-cap tech name, the number 7 weight wise company in the S&P 500, and it looks hugely overvalued at this point.\nI am no Nvidia bear, and I owned shares in prior quarters. Possibly the only reason I don't own Nvidia now is that I have AMD in my portfolio. However, with the stock now 36% above its 50-day MA on essentially no news, things are getting absurd.\nNvidia could drop by 33% from here, and it would still be relatively expensive at $200 with a forward multiple above $50.\nTesla(TSLA)\nSource: StockCharts.com\nIf you thought Nvidia's valuation was an end to the madness, it's not, likely only the beginning. Let's talk about Tesla for a minute. Now, I am a long-term supporter of Tesla, I've owned the company's shares for a long time, and I've written many positive articles about the company. The first article I ever wrote on Seeking Alpha was \"Will Tesla Become A Trillion Dollar Company?\" Now, Tesla became a trillion-dollar company much sooner than I anticipated, and I took profits in the stock at around $1,200 recently.\nI still like Tesla longer-term, but let's face it, we're dealing with a stock that has expanded by about 4.5X over the last year (this is on top of a remarkable runup the previous year). While it might not be fair to judge Tesla's valuation on its 190 forward P/E multiple, I think the stock is richly priced at 22 times sales.\nTechnically, the image is mind-boggling, as Tesla recently surged to 50% above its 50-day MA and hit an RSI level well above 90. Tesla is now the fifth-largest S&P 500 component and accounts for about 2.5% of the major average's weight.\nTesla is not the only stock to go wild in the EV space. We see other players like Lucid (LCID) hitting ludicrous valuations. Lucid now trades at a valuation of around $70 billion, while analysts anticipate the company to bring in about $1.7 billion in revenues next year. We're looking at a forward P/S ratio of about 40 here now. Lucid is another stock that has been up by about 4.5X over the last year, and this is another nameI took profits in recently.\nTesla could drop to around $800 - 900 support, roughly around a 25-33% pullback from recent highs. The stock would look far more attractive then.\nAdvanced Micro Devices(AMD)\nSource: StockCharts.com\nAMD has been one of my favorite stocks recently, and this is one that I'm still long for now. However, the recent runup has been intense. We see an RSI closing in on 90, and this name has nearly doubled over the last year. Yet, at about ten times sales and a forward P/E below 50, it seems relatively cheap to names like Nvidia and others right now. Incredibly, right?\nThe list of big tech stocks surging lately can go on and on, but I want to look at the most prominent tech stock in the world that is not surging lately. I think it is pretty telling what Apple's stock is doing right now.\nAMD could use about a 20% discount around here. A forward P/E ratio closer to 40 would make the stock much more attractive at approximately $120 a share. I am using spreads to hedge my position here. Otherwise, I would take profits now.\nApple(AAPL)\nSource: StockCharts.com - Apple could get its P/E ratio compressed to around 20, implying a price of about $112 for its shares.\nSo, what is Apple doing lately? Well, not much, as the stock is not skyrocketing to new ATHs as many other technology names are right now. It appears that Apple topped out in early September and has failed to make new highs since. Now, we see a lower high being put in, and Apple looks like it could trade sideways or even head lower for now.\nNow, I spoke about Apple being dead money in my previous article on the company, but there is a good reason for this, in my view. While Apple is not trading at 80 or 50 times forward earnings projections, the company is trading at about27 times forward earning sexpectations. The problem is that while AMD, Nvidia, Tesla, and others are still strong growth stories, Apple likely has minimal growth potential in the next few years.\nAnalysts are typically bullish on Apple but predict low single-digit revenue and EPS growth in future years. So, why is Apple trading at such a premium multiple? After all, 27 times forward earnings are not cheap, and even in the current environment, a company should have robust growth prospects for the next several years.\nApple seems overvalued here, and the company does not deserve such a premium multiple given the probability for stagnant growth in the next several years. Therefore, we could see multiple compression in Apple from now on, and the company's downturn could drag the broader down as well.\nThe problem is that Apple accounts for a substantial portion of the S&P 500's weight (6%). Another problem is that Apple is not alone, and this may come as a surprise to many people, but Apple is not even the most significant component of the SPX.\nMicrosoft(MSFT):\nSource: StockCharts.com -Microsoft's stock would look much more attractive with a forward P/E ratio of about 30, suggesting a 20% correction for the stock. Microsoft at $270 looks like a much better buy than it is now.\nTalk about being overbought technically. Just look at Microsoft. The RSI here is approaching 80, the stock is up by nearly 60% over the last year, and Microsoft is now the most valuable company globally. Yes, this $2.52 trillion behemoth now accounts for around 6.35% of the SPX's weight. Now, I wish I could say that Microsoft is relatively inexpensive, but that is far from true. On the contrary, Microsoft trades at a whopping37 times forward earnings expectations.\nGranted, Microsoft offers better growth prospects than Apple in future years, but nearly 40 times forward estimates for a stock that could increase earnings by about 10-15% next year is very expensive. We don't typically value huge companies relative to their sales, but Microsoft now trades at a ridiculously high 15 times TTM sales.\nI also want to emphasize the growing influence of big tech in the S&P 500 and other major averages. The top seven weighted holdings in the S&P 500 are seven giant tech companies that account for a whopping27% of the index's weight. It's not difficult to imagine what will happen to the S&P 500 and other major stock indexes when this massive tech bubble unwinds or corrects down the line.\nS&P 500 Shiller P/E ratio\nSource:multpl.com\nI spoke about Microsoft's lofty forward P/E ratio, but it is essentially in line with the Shiller/cyclically adjusted P/E ratio on the entire S&P 500 right now. So, we see that this phenomenon of remarkably high valuations is not only concentrated in tech but is widespread right now. We also see that similar valuations have only been observed once before in history. Yes, around the height of the dot-com bubble, some of us know how that turned out, and the outcome was unfavorable for stocks.\nAnother factor I want to go over is that while I use a forward P/E in many instances, no one knows what company earnings will be next year. We saw quite a few misses last quarter, far more disappointing results than was expected. Apple and Amazon (AMZN) are just a couple of examples, but many more big names missed guidance.\nTherefore, if we look at TTM P/E multiples:\n\nMicrosoft: 42\nApple: 27\nNvidia: 90\nTesla: 228\nAMD: 63\nLucid: N/A\n\nThe Bottom Line\nWe see many names trading at extremely high valuations right now. Moreover, many prominent companies and major stock market averages are grossly overbought technically. While I focused primarily on the dominant tech companies that account for a massive part of the S&P 500's total weight, the frothy valuations go well beyond technology. The stock market, in general, looks frothy here technically, as well as from a fundamental perspective. Now, we could see a dynamic where the ultra-high multiple names that have skyrocketed lately begin to pull back. Simultaneously, we could see companies like Apple trade sideways or ever move lower due to growth concerns and subsequent multiple contractions. The result could be a \"deflation\" of the current bubble, which could cause a correction or even a mini-crash to occur as we advance into next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844393598,"gmtCreate":1636386565307,"gmtModify":1636386623361,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/JUSHF\">$Jushi Holdings Inc.(JUSHF)$</a>Go go go to the moon 🌙&nbsp;","listText":"<a href=\"https://laohu8.com/S/JUSHF\">$Jushi Holdings Inc.(JUSHF)$</a>Go go go to the moon 🌙&nbsp;","text":"$Jushi Holdings Inc.(JUSHF)$Go go go to the moon 🌙","images":[{"img":"https://static.tigerbbs.com/0b2abb3a52ffee7a8be78602da8964e1","width":"1125","height":"2321"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/844393598","isVote":1,"tweetType":1,"viewCount":742,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845533786,"gmtCreate":1636348900361,"gmtModify":1636350465707,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Overall getting 6% only, are you contented to that?Do day scraping can get more than that wahahah [Happy]&nbsp;","listText":"Overall getting 6% only, are you contented to that?Do day scraping can get more than that wahahah [Happy]&nbsp;","text":"Overall getting 6% only, are you contented to that?Do day scraping can get more than that wahahah [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845533786","repostId":"2181972851","repostType":2,"repost":{"id":"2181972851","kind":"highlight","pubTimestamp":1636344447,"share":"https://www.laohu8.com/m/news/2181972851?lang=&edition=full","pubTime":"2021-11-08 12:07","market":"us","language":"en","title":"Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2181972851","media":"Motley Fool","summary":"You should be able to count on these dividends over the long term.","content":"<p>With apologies to the rock band Dire Straits, you're not going to get \"money for nothing.\" However, you can definitely get money on a regular basis by buying the right stocks.&nbsp;I'm referring, of course, to buying solid dividend stocks.</p>\n<p>Many dividend stocks don't have high enough yields to generate significant income. Others have high dividend yields but come with unacceptable levels of risk. But investing $100,000 in these three dividend stocks could give you nearly $6,000 in steady annual income.</p>\n<p><img src=\"https://static.tigerbbs.com/7646573e61c827a3d6b6e035537f5bd5\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h2>1. AbbVie</h2>\n<p>If you take <a href=\"https://laohu8.com/S/AONE.U\">one</a>-third of your initial $100,000 and buy shares of&nbsp;<b>AbbVie</b> (NYSE:ABBV), you should be able to count on at least $1,600 in annual income. The big drugmaker's dividend currently yields 4.8%.</p>\n<p>The good news, though, is that amount is highly likely to increase in the future. AbbVie ranks as a Dividend Aristocrat, members of the S&amp;P 500 that have raised their dividends for at least 25 consecutive years. With the company's recently announced dividend hike, AbbVie's streak will extend to 50 years in a row of dividend increases.</p>\n<p>Sure, the company's top-selling drug Humira faces U.S. biosimilar competition beginning in 2023. Newer autoimmune disease drug Rinvoq also faces some uncertainty with a pending label change from the U.S. Food and Drug Administration (FDA) that could negatively impact sales.</p>\n<p>However, AbbVie should be in a solid position to keep the dividends flowing and growing. The company remains confident that it will quickly return to growth after a trough year in 2023. Don't expect any blips at all with the drugmaker's dividends.</p>\n<h2>2. Easterly Government Properties</h2>\n<p><b>Easterly Government Properties</b> (NYSE:DEA) looks like a great place to park another third of your $100,000. With its dividend yield just under 5%, that investment should generate around $1,660 in additional yearly income.</p>\n<p>I recently wrote that Easterly is one of the least scary stocks to buy right now. My confidence lies in the company's business model. Easterly is a real estate investment trust (REIT) that focuses on leasing properties to the U.S. government.</p>\n<p>There is without a doubt no more stable tenant than Uncle Sam. Easterly board chairman Darrell Crate was right on target when he said in the company's Q3 conference call that properties leased to the federal government are the ultimate \"sleep well at night real estate.\"</p>\n<p>And Easterly continues to expand. So far this year, the company has acquired 10 properties either directly or through its joint venture with an unidentified global investor. It's on track to achieve the highest annual acquisition volume this year since becoming a public company.</p>\n<h2>3. Enterprise Products Partners</h2>\n<p>AbbVie and Easterly together should be able to give you $3,320 in annual income from dividends. Investing the remaining third of your $100,000 in <b>Enterprise Products Partners</b> (NYSE:EPD) should add close to $2,700 in yearly dividends with its yield of 8.1%, bringing the total to nearly $6,000.</p>\n<p>Enterprise Products Partners ranks as one of the world's leading midstream energy companies. The ongoing economic recovery serves as a strong tailwind for Enterprise with increased demand for crude oil, natural gas liquids, and petrochemicals.</p>\n<p>These dynamics are expected to continue throughout the next year. Over the long term, renewable energy sources will rise in importance. However, the demand for fossil fuels is also likely to increase as well -- albeit at slower rates than in the past.</p>\n<p>Enterprise has increased its dividend distribution for 23 consecutive years. The company will probably announce yet another distribution hike in January.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvesting $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-08 12:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/07/investing-100000-in-these-dividend-stocks-could-gi/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>With apologies to the rock band Dire Straits, you're not going to get \"money for nothing.\" However, you can definitely get money on a regular basis by buying the right stocks. I'm referring, of course...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/07/investing-100000-in-these-dividend-stocks-could-gi/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EPD":"Enterprise Products Partners L.P","DEA":"Easterly Government Properties Inc","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/11/07/investing-100000-in-these-dividend-stocks-could-gi/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181972851","content_text":"With apologies to the rock band Dire Straits, you're not going to get \"money for nothing.\" However, you can definitely get money on a regular basis by buying the right stocks. I'm referring, of course, to buying solid dividend stocks.\nMany dividend stocks don't have high enough yields to generate significant income. Others have high dividend yields but come with unacceptable levels of risk. But investing $100,000 in these three dividend stocks could give you nearly $6,000 in steady annual income.\n\nImage source: Getty Images.\n1. AbbVie\nIf you take one-third of your initial $100,000 and buy shares of AbbVie (NYSE:ABBV), you should be able to count on at least $1,600 in annual income. The big drugmaker's dividend currently yields 4.8%.\nThe good news, though, is that amount is highly likely to increase in the future. AbbVie ranks as a Dividend Aristocrat, members of the S&P 500 that have raised their dividends for at least 25 consecutive years. With the company's recently announced dividend hike, AbbVie's streak will extend to 50 years in a row of dividend increases.\nSure, the company's top-selling drug Humira faces U.S. biosimilar competition beginning in 2023. Newer autoimmune disease drug Rinvoq also faces some uncertainty with a pending label change from the U.S. Food and Drug Administration (FDA) that could negatively impact sales.\nHowever, AbbVie should be in a solid position to keep the dividends flowing and growing. The company remains confident that it will quickly return to growth after a trough year in 2023. Don't expect any blips at all with the drugmaker's dividends.\n2. Easterly Government Properties\nEasterly Government Properties (NYSE:DEA) looks like a great place to park another third of your $100,000. With its dividend yield just under 5%, that investment should generate around $1,660 in additional yearly income.\nI recently wrote that Easterly is one of the least scary stocks to buy right now. My confidence lies in the company's business model. Easterly is a real estate investment trust (REIT) that focuses on leasing properties to the U.S. government.\nThere is without a doubt no more stable tenant than Uncle Sam. Easterly board chairman Darrell Crate was right on target when he said in the company's Q3 conference call that properties leased to the federal government are the ultimate \"sleep well at night real estate.\"\nAnd Easterly continues to expand. So far this year, the company has acquired 10 properties either directly or through its joint venture with an unidentified global investor. It's on track to achieve the highest annual acquisition volume this year since becoming a public company.\n3. Enterprise Products Partners\nAbbVie and Easterly together should be able to give you $3,320 in annual income from dividends. Investing the remaining third of your $100,000 in Enterprise Products Partners (NYSE:EPD) should add close to $2,700 in yearly dividends with its yield of 8.1%, bringing the total to nearly $6,000.\nEnterprise Products Partners ranks as one of the world's leading midstream energy companies. The ongoing economic recovery serves as a strong tailwind for Enterprise with increased demand for crude oil, natural gas liquids, and petrochemicals.\nThese dynamics are expected to continue throughout the next year. Over the long term, renewable energy sources will rise in importance. However, the demand for fossil fuels is also likely to increase as well -- albeit at slower rates than in the past.\nEnterprise has increased its dividend distribution for 23 consecutive years. The company will probably announce yet another distribution hike in January.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846254346,"gmtCreate":1636089279318,"gmtModify":1636089288601,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Stay sideline first, thanks 😊&nbsp;","listText":"Stay sideline first, thanks 😊&nbsp;","text":"Stay sideline first, thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846254346","repostId":"2180989791","repostType":4,"repost":{"id":"2180989791","kind":"highlight","pubTimestamp":1636084560,"share":"https://www.laohu8.com/m/news/2180989791?lang=&edition=full","pubTime":"2021-11-05 11:56","market":"us","language":"en","title":"2 Biotech Companies That Might Be on Pfizer's Radar Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2180989791","media":"Motley Fool","summary":"These two small-cap cancer companies would be a perfect fit for Pfizer.","content":"<p><b>Pfizer</b> (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its <b>BioNTech</b>-partnered COVID-19 vaccine. While explosive revenue growth is always a good thing, Pfizer is now tasked with finding a way to keep its top line headed in the right direction over the long haul. The issue at hand is that the drugmaker's COVID-19 vaccine sales have probably already peaked. Wall Street, in fact, expects Pfizer's top line to drop by a hefty 11% next year as a direct result of declining coronavirus vaccine sales.</p>\n<p>What's more, the drugmaker will have to contend with the upcoming patent expiration for its <b>Bristol Myers Squibb</b>-partnered blood thinner Eliquis in the second half of the current decade. That's a big deal. Eliquis generated a noteworthy $1.35 billion in revenue in the third quarter alone. Pfizer has <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the better pipelines in the industry, but it doesn't sport any assets capable of offsetting rapidly falling sales for two mega-blockbuster products within a few short years of one another.</p>\n<p>The good news is that Pfizer's cash position should exceed $30 billion by year's end. The company thus has sufficient firepower to execute multiple mergers and acquisitions (M&amp;A) to address this issue. As a matter of fact, the pharma titan has seemingly already told Wall Street that it plans on being active on the M&amp;A front in the near future. During its recent third-quarter conference call, for example, Pfizer's chief business and innovation officer Aamir Malik had this to say about the company's business development strategy:</p>\n<blockquote>\n We see business development, frankly, as a very important part of our strategy, and we plan to be very active in dealmaking. Specifically, we are gonna be interested in compelling later-stage assets that can contribute positively to the top-line growth in the back half of the decade.\n</blockquote>\n<blockquote>\n And we're also gonna be interested in accessing medical breakthroughs that are in earlier stages of development. And we, frankly, see focusing in these areas as being much more value-creating than synergy-driven deals that require lots of resource-intensive integrations that can take a long time to complete. Obviously, we don't speak in absolutes, and we never say never. But right now, our focus will be, as I described, on compelling later-stage assets and earlier-stage medical breakthroughs in biopharma.\n</blockquote>\n<h2>Which biotechs might be on Pfizer's wishlist?</h2>\n<p>Biopharma acquisitions are notoriously hard to predict. But Pfizer does have a well-known interest in acquiring early-stage cancer assets, especially from companies with novel platforms. Which cutting-edge oncology companies make sense as a takeover target for the pharma giant? The following two names would dovetail nicely with the company's top-notch oncology portfolio.</p>\n<ol>\n <li><b> Adaptimmune Therapeutics</b> (NASDAQ:ADAP) is a U.K. based anti-cancer cell therapy company. The biotech's main attraction as a potential takeover target is its unique lineup of genetically modified T-cell therapies for solid tumors. Cellular immunotherapy has fallen out of favor with investors of late due to a combination of slower-than-expected commercial ramp ups for the leaders in the space, as well as some high-profile clinical flops. As a result, Adaptimmune's market cap currently stands at a meager $853 million at the time of writing. Pfizer might consider this small-cap oncology company because its platform has the potential to become a best-in-class approach for a host of solid tumors. Moreover, it could probably be bought out for less than $3 billion. The clear-cut problem with this hypothetical deal is that Adaptimmune already has multiple big pharma partners, including <b>GlaxoSmithKline</b> and <b>Roche</b>. Any deal would, therefore, have to address these entanglements.</li>\n <li><b>Affimed</b> (NASDAQ:AFMD) is a German cancer immunotherapy company. The biotech's novel approach to cancer treatment centers around so-called \"Innate Cell Engagers\" that are designed to restore a patient's innate immune system function. Affimed's lead product candidate, AFM13, is presently in a potentially pivotal trial as a monotherapy for relapsed/refractory peripheral T-cell lymphoma. Later down the line, the German biotech also has trials underway to evaluate its unique anti-cancer platform in combination with natural killer cells and checkpoint inhibitor therapies. With a market cap of $840 million, Pfizer could probably add this intriguing immunotherapy company to its lineup for about $2 billion.</li>\n</ol>\n<h2>Should investors buy these speculative buyout targets?</h2>\n<p>It is never a good idea to buy a biotech stock solely for its appeal as a takeover candidate. Adaptimmune and Affimed, though, both sport extremely attractive valuations at the moment. Moreover, each of these tiny biopharmas has the pieces in place to produce important new therapies in the fight against cancer. So while speculative in nature, aggressive investors might want to consider buying these two cancer stocks for their potential as both a buyout target and their stellar organic growth prospects.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotech Companies That Might Be on Pfizer's Radar Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotech Companies That Might Be on Pfizer's Radar Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 11:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its BioNTech-partnered COVID-19 vaccine. While explosive revenue growth is always ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","ADAP":"Adaptimmune Therapeutics plc","AFMD":"Affimed NV"},"source_url":"https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180989791","content_text":"Pfizer (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its BioNTech-partnered COVID-19 vaccine. While explosive revenue growth is always a good thing, Pfizer is now tasked with finding a way to keep its top line headed in the right direction over the long haul. The issue at hand is that the drugmaker's COVID-19 vaccine sales have probably already peaked. Wall Street, in fact, expects Pfizer's top line to drop by a hefty 11% next year as a direct result of declining coronavirus vaccine sales.\nWhat's more, the drugmaker will have to contend with the upcoming patent expiration for its Bristol Myers Squibb-partnered blood thinner Eliquis in the second half of the current decade. That's a big deal. Eliquis generated a noteworthy $1.35 billion in revenue in the third quarter alone. Pfizer has one of the better pipelines in the industry, but it doesn't sport any assets capable of offsetting rapidly falling sales for two mega-blockbuster products within a few short years of one another.\nThe good news is that Pfizer's cash position should exceed $30 billion by year's end. The company thus has sufficient firepower to execute multiple mergers and acquisitions (M&A) to address this issue. As a matter of fact, the pharma titan has seemingly already told Wall Street that it plans on being active on the M&A front in the near future. During its recent third-quarter conference call, for example, Pfizer's chief business and innovation officer Aamir Malik had this to say about the company's business development strategy:\n\n We see business development, frankly, as a very important part of our strategy, and we plan to be very active in dealmaking. Specifically, we are gonna be interested in compelling later-stage assets that can contribute positively to the top-line growth in the back half of the decade.\n\n\n And we're also gonna be interested in accessing medical breakthroughs that are in earlier stages of development. And we, frankly, see focusing in these areas as being much more value-creating than synergy-driven deals that require lots of resource-intensive integrations that can take a long time to complete. Obviously, we don't speak in absolutes, and we never say never. But right now, our focus will be, as I described, on compelling later-stage assets and earlier-stage medical breakthroughs in biopharma.\n\nWhich biotechs might be on Pfizer's wishlist?\nBiopharma acquisitions are notoriously hard to predict. But Pfizer does have a well-known interest in acquiring early-stage cancer assets, especially from companies with novel platforms. Which cutting-edge oncology companies make sense as a takeover target for the pharma giant? The following two names would dovetail nicely with the company's top-notch oncology portfolio.\n\n Adaptimmune Therapeutics (NASDAQ:ADAP) is a U.K. based anti-cancer cell therapy company. The biotech's main attraction as a potential takeover target is its unique lineup of genetically modified T-cell therapies for solid tumors. Cellular immunotherapy has fallen out of favor with investors of late due to a combination of slower-than-expected commercial ramp ups for the leaders in the space, as well as some high-profile clinical flops. As a result, Adaptimmune's market cap currently stands at a meager $853 million at the time of writing. Pfizer might consider this small-cap oncology company because its platform has the potential to become a best-in-class approach for a host of solid tumors. Moreover, it could probably be bought out for less than $3 billion. The clear-cut problem with this hypothetical deal is that Adaptimmune already has multiple big pharma partners, including GlaxoSmithKline and Roche. Any deal would, therefore, have to address these entanglements.\nAffimed (NASDAQ:AFMD) is a German cancer immunotherapy company. The biotech's novel approach to cancer treatment centers around so-called \"Innate Cell Engagers\" that are designed to restore a patient's innate immune system function. Affimed's lead product candidate, AFM13, is presently in a potentially pivotal trial as a monotherapy for relapsed/refractory peripheral T-cell lymphoma. Later down the line, the German biotech also has trials underway to evaluate its unique anti-cancer platform in combination with natural killer cells and checkpoint inhibitor therapies. With a market cap of $840 million, Pfizer could probably add this intriguing immunotherapy company to its lineup for about $2 billion.\n\nShould investors buy these speculative buyout targets?\nIt is never a good idea to buy a biotech stock solely for its appeal as a takeover candidate. Adaptimmune and Affimed, though, both sport extremely attractive valuations at the moment. Moreover, each of these tiny biopharmas has the pieces in place to produce important new therapies in the fight against cancer. So while speculative in nature, aggressive investors might want to consider buying these two cancer stocks for their potential as both a buyout target and their stellar organic growth prospects.","news_type":1},"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849539950,"gmtCreate":1635764850173,"gmtModify":1635764850294,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"It’s just keep repeating the same article [Spurting]&nbsp;","listText":"It’s just keep repeating the same article [Spurting]&nbsp;","text":"It’s just keep repeating the same article [Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849539950","repostId":"2179806221","repostType":2,"repost":{"id":"2179806221","kind":"highlight","pubTimestamp":1635759401,"share":"https://www.laohu8.com/m/news/2179806221?lang=&edition=full","pubTime":"2021-11-01 17:36","market":"us","language":"en","title":"3 Warren Buffett Stocks to Buy in November","url":"https://stock-news.laohu8.com/highlight/detail?id=2179806221","media":"Motley Fool","summary":"They're all big winners in recent years that are poised to be even bigger winners over the long term.","content":"<p>You could probably sum up the secret to Warren Buffett's success in three words: Think long term. That's what the legendary investor has done throughout his storied career -- even before he took the helm at <b>Berkshire Hathaway</b>&nbsp;(NYSE:BRK.A) (NYSE:BRK.B).</p>\n<p>It's also exactly what anyone should do when contemplating buying any of the stocks in Buffett's own portfolio. The best of those Berkshire holdings have strong long-term growth prospects. With that in mind, here are three Buffett stocks to buy in November.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F648032%2Fwarren-buffett-tmf-photo.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: The Motley Fool.</span></p>\n<h2>1. Amazon.com</h2>\n<p><b>Amazon.com</b> (NASDAQ:AMZN) founder Jeff Bezos likes to say that \"it's still Day 1.\" By that, he means that the company retains the mentality of its first day as a start-up. This is the kind of guiding philosophy that could propel this FAANG stock much higher even though Amazon's market cap already tops $1.7 trillion.</p>\n<p>There's actually a good reason for investors to think about Amazon with a \"Day 1\" perspective as well. Sure, the company reigns as the 800-pound gorilla in e-commerce. However, U.S. e-commerce sales in the second quarter of 2021 made up only 12.5% of total retail sales. Amazon still has huge growth potential in this core market.</p>\n<p>The company has even more opportunities with Amazon Web Services (AWS). This cloud business remains a tremendous growth driver despite intensifying competition.</p>\n<p>And it truly is Day 1 for Amazon in multiple other areas. The company launched its telehealth service this summer. It recently rolled out its first robot -- a dog named Astro. Amazon also has the potential to expand in video games, self-driving car technology, and more.</p>\n<h2>2. Apple</h2>\n<p>One thing Buffett never does is obsess about <a href=\"https://laohu8.com/S/AONE.U\">one</a> quarterly update. That's a lesson every investor should follow, especially in the case of&nbsp;<b>Apple</b>'s (NASDAQ:AAPL) fiscal 2021 fourth-quarter sales miss.</p>\n<p>Sure, Apple didn't generate the revenue that Wall Street expected. However, the problem was supply constraints caused by a global chip shortage and manufacturing disruptions in Southeast Asia due to COVID-19. Those are only temporary issues. And Apple still managed to grow revenue 29% year over year despite the headwinds.</p>\n<p>More important, the company's long-term prospects remain strong. Apple's iPhone ecosystem is as sticky as ever. Its services business is especially gaining momentum. The increased adoption of high-speed 5G networks continues to fuel demand for the company's products. Over the next decade, I expect that augmented reality will become another major growth driver for Apple's ecosystem.</p>\n<p>The current chip shortage and COVID-19's impact on manufacturing won't matter in the near future. You can bet that Buffett isn't selling any of his Apple shares on the latest pullback. I wouldn't be surprised if he's instead buying more of the top stock in Berkshire's portfolio.</p>\n<h2>3. Mastercard</h2>\n<p>Unlike Apple,&nbsp;<b>Mastercard</b> (NYSE:MA) beat expectations in its latest quarterly update. The financial services giant delivered 30% revenue growth with earnings soaring 59%.</p>\n<p>Again, though, the snapshot of what the company has already done isn't nearly as critical as what its future prospects are. And Mastercard's future still looks very bright, particularly with several new initiatives.</p>\n<p>Mastercard Installments puts the company at the center of the fast-growing \"buy now, pay later\" opportunity. The new service can be used anywhere across the Mastercard network, both online and in stores.</p>\n<p>The company's acquisition of CipherTrace bolsters its expansion of cryptocurrency services. Its pending buyout of European technology provider Aiia extends Mastercard's efforts in leading the way in open banking, which enables consumers and businesses to use their data to get financial services easily and securely.</p>\n<p>These new products and deals reinforce the key role that Mastercard plays in the transition from cash to digital payments. Mastercard is a Buffett stock that you can buy in November and hold forever.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Warren Buffett Stocks to Buy in November</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Warren Buffett Stocks to Buy in November\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 17:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/3-warren-buffett-stocks-to-buy-in-november/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>You could probably sum up the secret to Warren Buffett's success in three words: Think long term. That's what the legendary investor has done throughout his storied career -- even before he took the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/3-warren-buffett-stocks-to-buy-in-november/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MA":"万事达","AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2021/10/31/3-warren-buffett-stocks-to-buy-in-november/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179806221","content_text":"You could probably sum up the secret to Warren Buffett's success in three words: Think long term. That's what the legendary investor has done throughout his storied career -- even before he took the helm at Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B).\nIt's also exactly what anyone should do when contemplating buying any of the stocks in Buffett's own portfolio. The best of those Berkshire holdings have strong long-term growth prospects. With that in mind, here are three Buffett stocks to buy in November.\nImage source: The Motley Fool.\n1. Amazon.com\nAmazon.com (NASDAQ:AMZN) founder Jeff Bezos likes to say that \"it's still Day 1.\" By that, he means that the company retains the mentality of its first day as a start-up. This is the kind of guiding philosophy that could propel this FAANG stock much higher even though Amazon's market cap already tops $1.7 trillion.\nThere's actually a good reason for investors to think about Amazon with a \"Day 1\" perspective as well. Sure, the company reigns as the 800-pound gorilla in e-commerce. However, U.S. e-commerce sales in the second quarter of 2021 made up only 12.5% of total retail sales. Amazon still has huge growth potential in this core market.\nThe company has even more opportunities with Amazon Web Services (AWS). This cloud business remains a tremendous growth driver despite intensifying competition.\nAnd it truly is Day 1 for Amazon in multiple other areas. The company launched its telehealth service this summer. It recently rolled out its first robot -- a dog named Astro. Amazon also has the potential to expand in video games, self-driving car technology, and more.\n2. Apple\nOne thing Buffett never does is obsess about one quarterly update. That's a lesson every investor should follow, especially in the case of Apple's (NASDAQ:AAPL) fiscal 2021 fourth-quarter sales miss.\nSure, Apple didn't generate the revenue that Wall Street expected. However, the problem was supply constraints caused by a global chip shortage and manufacturing disruptions in Southeast Asia due to COVID-19. Those are only temporary issues. And Apple still managed to grow revenue 29% year over year despite the headwinds.\nMore important, the company's long-term prospects remain strong. Apple's iPhone ecosystem is as sticky as ever. Its services business is especially gaining momentum. The increased adoption of high-speed 5G networks continues to fuel demand for the company's products. Over the next decade, I expect that augmented reality will become another major growth driver for Apple's ecosystem.\nThe current chip shortage and COVID-19's impact on manufacturing won't matter in the near future. You can bet that Buffett isn't selling any of his Apple shares on the latest pullback. I wouldn't be surprised if he's instead buying more of the top stock in Berkshire's portfolio.\n3. Mastercard\nUnlike Apple, Mastercard (NYSE:MA) beat expectations in its latest quarterly update. The financial services giant delivered 30% revenue growth with earnings soaring 59%.\nAgain, though, the snapshot of what the company has already done isn't nearly as critical as what its future prospects are. And Mastercard's future still looks very bright, particularly with several new initiatives.\nMastercard Installments puts the company at the center of the fast-growing \"buy now, pay later\" opportunity. The new service can be used anywhere across the Mastercard network, both online and in stores.\nThe company's acquisition of CipherTrace bolsters its expansion of cryptocurrency services. Its pending buyout of European technology provider Aiia extends Mastercard's efforts in leading the way in open banking, which enables consumers and businesses to use their data to get financial services easily and securely.\nThese new products and deals reinforce the key role that Mastercard plays in the transition from cash to digital payments. Mastercard is a Buffett stock that you can buy in November and hold forever.","news_type":1},"isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":856437973,"gmtCreate":1635206825534,"gmtModify":1635206825814,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CETY\">$Clean Energy Technologies, Inc.(CETY)$</a>small nibble","listText":"<a href=\"https://laohu8.com/S/CETY\">$Clean Energy Technologies, Inc.(CETY)$</a>small nibble","text":"$Clean Energy Technologies, Inc.(CETY)$small nibble","images":[{"img":"https://static.tigerbbs.com/ce2f45ce19134947c2af63d872d10df2","width":"1170","height":"2292"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856437973","isVote":1,"tweetType":1,"viewCount":584,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":600104127,"gmtCreate":1638079360217,"gmtModify":1638079360352,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"How about just 3yrs 😂&nbsp;","listText":"How about just 3yrs 😂&nbsp;","text":"How about just 3yrs 😂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600104127","repostId":"2186432895","repostType":2,"repost":{"id":"2186432895","kind":"highlight","pubTimestamp":1638069921,"share":"https://www.laohu8.com/m/news/2186432895?lang=&edition=full","pubTime":"2021-11-28 11:25","market":"us","language":"en","title":"$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2186432895","media":"Motley Fool","summary":"A little money can go a long way.","content":"<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the&nbsp;average stock market return&nbsp;over the last 50 years of nearly 11%.&nbsp;</p>\n<p>Many companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are&nbsp;<a href=\"https://laohu8.com/S/BEP\"><b>Brookfield Renewable</b>&nbsp;</a>,&nbsp;<a href=\"https://laohu8.com/S/CCI\"><b>Crown Castle International</b>&nbsp;</a>, and&nbsp;<a href=\"https://laohu8.com/S/NEE\"><b>NextEra Energy</b>&nbsp;</a>. Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.</p>\n<h2>Benefiting from a powerful megatrend</h2>\n<p>Brookfield Renewable has enriched its investors over the years. Since its inception, the&nbsp;renewable energy&nbsp;producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. </p>\n<p>However, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.</p>\n<p>The company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. </p>\n<p>Meanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come.&nbsp;</p>\n<h2>Connected to the data supercycle</h2>\n<p>Crown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. </p>\n<p>A major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014.&nbsp; &nbsp;</p>\n<p>The company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of&nbsp;5G networks&nbsp;represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. </p>\n<p>Crown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years.&nbsp;</p>\n<h2>Plugged into several growth catalysts</h2>\n<p>NextEra Energy has also created an enormous amount of wealth for its investors over the years. The&nbsp;utility&nbsp;has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&amp;P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. </p>\n<p>A major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and&nbsp;solar energy&nbsp;producers.&nbsp;</p>\n<p>That leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's&nbsp;tapping into other sources of growth&nbsp;like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.</p>\n<h2>Grow rich slowly</h2>\n<p>Compound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$300 a Month in These 3 Stocks Could Make You a Millionaire by Retirement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CCI":"冠城","NEE":"新纪元能源","BEP":"Brookfield Renewable Partners LP"},"source_url":"https://www.fool.com/investing/2021/11/27/300-a-month-in-these-3-stocks-could-make-you-a-mil/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186432895","content_text":"Thanks to the wonders of compound interest, it doesn't take a lot of money to grow a million-dollar nest egg. For example, investing $300 a month could grow into more than $1 million in 30 years if it can generate a 12% annual return. That's slightly better than the average stock market return over the last 50 years of nearly 11%. \nMany companies have a long history of beating the market. Three companies that appear likely to continue doing so in the decades ahead are Brookfield Renewable , Crown Castle International , and NextEra Energy . Because of that, $100 invested in each one every month could grow into a $1 million nest egg by retirement.\nBenefiting from a powerful megatrend\nBrookfield Renewable has enriched its investors over the years. Since its inception, the renewable energy producer has generated an annualized total return of 19%. The company had done that by investing billions of dollars into expanding its renewable energy portfolio. That has powered more than 10% annual growth in its cash flow per share, supporting 6% annual dividend increases over the last decade. \nHowever, Brookfield's best days appear to lie ahead. The global economy needs to invest trillions of dollars to decarbonize the energy sector over the next 30 years. That should enable Brookfield to continue to invest in expanding its renewable energy portfolio.\nThe company currently has 36 gigawatts (GW) of renewable energy projects in development. That's bigger than the company's current operating portfolio of about 21 GW. Combined with rising power rates, and its growing scale, these projects should support up to 11% annual cash flow per share growth through at least 2026. \nMeanwhile, Brookfield sees up to another 9% yearly boost from future acquisitions. Add that growing renewable-powered cash flow stream to the company's 3%-yielding dividend, and Brookfield appears to have the power to produce double-digit annual returns for decades to come. \nConnected to the data supercycle\nCrown Castle has been an exceptional value creator over the years. The infrastructure-focused real estate investment trust (REIT) has delivered a more than 13% annual total return over the two-plus decades since its initial public offering. \nA major driver of those returns has been the billions of dollars the company has poured into expanding its communications infrastructure portfolio. Over the last decade alone, the REIT spent $31 billion on acquisitions and capital expenditures (capex), powering 9% annual dividend growth since 2014.   \nThe company still sees significant investment opportunities ahead. Crown Castle noted that the telecom industry's rollout of 5G networks represents a decade-long investment cycle. Meanwhile, some see a 100-year data infrastructure upgrade investment opportunity to support the digital economy. Because of that, Crown Castle has a lot of growth ahead of it, which should drive continued strong returns. \nCrown Castle expects to grow its 3.2%-yielding dividend at a 7% to 8% annual rate in the near term. That suggests the company could deliver double-digit total returns in the coming years. \nPlugged into several growth catalysts\nNextEra Energy has also created an enormous amount of wealth for its investors over the years. The utility has generated a roughly 700% total return over the last decade alone, crushing the 276% total return produced by the S&P 500. Powering the company's robust results has been its ability to deliver above-average earnings and dividend growth. It has increased its earnings per share at an 8.7% compound annual rate since 2005, supporting 9.6% compound annual dividend growth. \nA major catalyst has been the company's leadership in renewable energy. It has grown into one of the world's largest wind and solar energy producers. \nThat leadership should continue since it has one of the world's biggest backlogs of wind and solar energy development projects. In addition to tried-and-true technologies like wind and solar, NextEra is a leader in emerging technologies, including battery storage and green hydrogen. Meanwhile, it's tapping into other sources of growth like water infrastructure. Because of that, NextEra should have plenty of power to continue growing its earnings and dividend in the decades ahead.\nGrow rich slowly\nCompound interest can do wonders for your retirement. Steadily investing a few hundred dollars each month into high-performing stocks can create an enormous amount of wealth. One of the keys to finding stocks that can deliver decades of strong returns is focusing on those benefiting from megatrends. Few are as big and enduring as renewable energy and data, making Brookfield Renewable, Crown Castle, and NextEra Energy stand out as stocks that could mint their share of millionaires in the decades ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":167197508,"gmtCreate":1624250948404,"gmtModify":1634008859911,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"So long article talk a lot but still is contradicting conclusions&nbsp;","listText":"So long article talk a lot but still is contradicting conclusions&nbsp;","text":"So long article talk a lot but still is contradicting conclusions","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/167197508","repostId":"1175906479","repostType":4,"repost":{"id":"1175906479","kind":"news","pubTimestamp":1624242000,"share":"https://www.laohu8.com/m/news/1175906479?lang=&edition=full","pubTime":"2021-06-21 10:20","market":"us","language":"en","title":"Apple: Winter Is Coming","url":"https://stock-news.laohu8.com/highlight/detail?id=1175906479","media":"seekingalpha","summary":"Apple's stock has rallied 449% in the last five years, outperforming the 102% rise in the S&P 500 over the same period.I initiate Apple with a Neutral rating and a fair value of $111.42/share .In the enterprise market, customers across many industries are accelerating their adoption of iPhone 12 and 5G as a key platform for the future of their business. Delta Airlines, for example, is putting iPhone 12 and 5G connectivity into the hands of flight attendants so they can provide the best passenger","content":"<p><b>Summary</b></p>\n<ul>\n <li>Apple's stock has rallied 449% in the last five years, outperforming the 102% rise in the S&amp;P 500 over the same period.</li>\n <li>I initiate Apple with a Neutral rating and a fair value of $111.42/share (vs. the current price of $131.7/share).</li>\n <li>From the technical analysis point of view, the stock price is following its ascending triangle pattern and it is heading to the price target of $137/share.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a4dc5052119e6bbc5b693cf7385d8738\" tg-width=\"768\" tg-height=\"512\" referrerpolicy=\"no-referrer\"><span>Michael M. Santiago/Getty Images NewsCompany Overview</span></p>\n<p>Apple Inc (AAPL) stock has rallied 449% in the last five years, outperforming the 102% rise in the S&amp;P 500 over the same period. An outstanding return supported by underlying fundamentals. In particular, I would like to start the analysis with the latter.</p>\n<p>Over the last two decades, the dominant driver of Apple's success has been the iPhone. In 2016, iPhones accounted for 63% of total sales. This was a problem for Apple, and they knew it. The problem existed due to two main factors: first, the smartphone business was mature (with low growth rates); second, it was (and it is) a highly competitive business. However, Apple had something other competitors didn't have, a big iPhone owner base (which allows to sell more services for instance). Through the years Apple has been able to effectively diversify its revenue stream and it currently presents the structure represented below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4602be0c6fa92191baf04a7496c4e024\" tg-width=\"640\" tg-height=\"363\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>Let's now take a look at each of these segments:</p>\n<p><b>1. iPhone</b></p>\n<p>From 2016 to 2020, the iPhone segment grew at a CAGR of 0.20% and it changed from representing 63.4% (2016) of total sales to 51% (\"TTM\"). I present below the growth rate for the iPhone segment over the last 5 years (2016-TTM).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/916b48499e3e3ed2c0c167af3ba62bdb\" tg-width=\"607\" tg-height=\"363\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest10-K report</span></p>\n<p>So far this year the iPhone segment is showing a growth rate of 18.5% TTM, fueled by the new family of iPhone12 with 5G capabilities, and with interesting data coming from China. I believe that the transition to 5G will be the main driver of the growth in this segment. In this manner, I would like to report a piece of the transcript from theQ2 earnings call.</p>\n<blockquote>\n <i>In the enterprise market, customers across many industries are accelerating their adoption of iPhone 12 and 5G as a key platform for the future of their business. Delta Airlines, for example, is putting iPhone 12 and 5G connectivity into the hands of flight attendants so they can provide the best passenger service possible as air travel rebounds.Openreach in the U.K. has started equipping tens of thousands of field engineers with iPhone 12 to speed up their deployment of broadband services to homes around the country. And UCHealth, a large health care provider in Colorado, was able to reduce per patient vaccination time from 3 minutes to only 30 seconds largely by moving from PC stations to iPhones. This has allowed their staff to rapidly scan and register new patients and vastly increase their daily vaccination capacity.</i>\n</blockquote>\n<p><b>2. iPad</b></p>\n<p>As it was in the past, the iPad segment is more or less a constant number as a % of total sales, 9.6% in 2016 vs 9.1% TTM. From 2016 to 2020, the iPad segment grew at a CAGR of 3.56% (with an improving overall trend). I present below the growth rate for the iPad segment over the last 5 years (2016-TTM).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6faf9ddb8d29d662fcaa46bbda862f48\" tg-width=\"616\" tg-height=\"360\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>The TTM numbers show us an interesting picture with a growth rate of 24.9% TTM for the iPad segment which are driven by 3 factors: the M1 chip, the new 5G capabilities, and the fact that we were all at home. I see a lot of ways in which this new generation of iPads can be implemented. However, I also have to admit that there is a big player swimming in the same sea, the new 2-1 Laptops. The new 2-1 Laptops are a very interesting solution for those looking to have the best of the two worlds. In this last view, the iPad segment may represent a lower % of total sales, around 7.8% (vs current 9.1%).</p>\n<p><b>3. Mac</b></p>\n<p>From 2016 to 2020, the Mac segment grew at a CAGR of 5.81%, and also here, as it is for the iPad segment, the Mac segment represents a more or less constant number as % of total sales 10.6% in 2016 vs 10.4% TTM. I present below the growth rate for the Mac segment over the last 5 years (2016-TTM).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2494d89c1d5cd70a4cf0c5fb31fb20a\" tg-width=\"614\" tg-height=\"363\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>The generation of new Macs powered by the M1 chip seems to be appreciated by the customers, in fact, the Mac segment presents a growth rate of 18.4% TTM so far this year. I personally tried this new generation of Macs and I have to admit, Apple knows very well how to delight its customers. Personal PCs are a highly competitive market and, even if I like and I use Apple products, I prefer to work with a Lenovo.</p>\n<p><b>4. Wearables, Home, and Accessories (WH&amp;A)</b></p>\n<p>The Wearables, Home, and Accessories segment includes sales of AirPods, Apple TV, Apple Watch, Beats products, HomePod, etc. This is where it gets interesting. From 2016 to 2020, the WH&amp;A segment grew at a CAGR of 28.78%, and it changed from representing only 5.2% of total sales in 2016 to represent 10.8% TTM. I present below the growth rate for the WH&amp;A segment over the last 5 years (2016-TTM).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e16432a1ae66aa9dda7a4f969a9cfcdf\" tg-width=\"607\" tg-height=\"357\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>The WH&amp;A segment is showing a growth rate of 14.7% TTM driven by a strong performance from both Apple Watch Series 6 and Apple Watch SE. Apple Watch may have a very bright future in the years ahead, driven by Apple entering into the healthcare market. In fact, it can be used to monitor the health status of the person. Imagine you being close to having a heart attack, your Apple Watch may call an ambulance and save your life, not bad no? Finally, let's don't forget also the launch of Apple TV 4K and of the newest accessory, AirTag (I don't see a market for the latter, but I may be wrong).</p>\n<p><b>5. Services</b></p>\n<p>Services include sales from the Company’s advertising, AppleCare, digital content, and other services. From 2016 to 2020, the Services segment grew at a CAGR of 21.9% and it changed from representing 11.3% of total sales in 2016 to represent 18.6% TTM. I present below the growth rate for the Services segment over the last 5 years (2016-TTM).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/af34eb1ba8fffd690a75318f8cf805f7\" tg-width=\"610\" tg-height=\"363\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>To date, the Services segment is showing a growth rate of 12.3% TTM. The growth is driven by App Store, Cloud Services, Music, Advertising, and Payment Services. The new services, Apple TV+, Apple Arcade, Apple News+, and Apple Card, are also starting to contribute to overall services growth, and continue to add users, content, and features. I believe that in the future, the Services segment will be the company's dominant segment. Below I present an interesting part I extrapolated from theQ4 earnings call.</p>\n<blockquote>\n <i>First, our installed base continues to grow and is at an all-time high across each major product category. Second, the number of both transacting and paid accounts on our digital content stores reached a new all-time high during the September quarter, with paid accounts increasing double digits in each of our geographic segments.Third, paid subscriptions grew more than 35 million sequentially, and we now have over 585 million paid subscriptions across the services on our platform, up 135 million from just a year ago. With this momentum, we are very confident to reach and exceed our increased target of 600 million paid subscriptions before the end of calendar 2020.</i>\n</blockquote>\n<p><b>Company Analysis</b></p>\n<p>I initiate Apple with a Neutral rating and a fair value of $111.42/share (vs. the current price of $131.7/share). The fair value is an algorithm-adjusted value that accounts for different factors, fundamental and technical (e.g. DCF fair value, Momentum, etc.), and so it takes into consideration the Mr. Market mood. At the same time, the fair value which I obtained through the DCF model is equal to $105.68/share. Now before showing the results, the numbers used as the base are the trailing twelve-month numbers. Moreover, I also restated the financials since I capitalized on R&amp;D expenses with an amortizable life of 3 years. I don't believe that in the case of Apple, R&amp;D is an operating expense and for this reason, I treat it as CapEx. By taking into account the R&amp;D, the following metrics have been restated (all numbers in $mm).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f7a2222a8e8b9088e619b0b971193a1f\" tg-width=\"569\" tg-height=\"262\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>It is very important to capitalize on R&amp;D expense, if we don't, we are just keeping the company's biggest asset off-balance sheet.</p>\n<p><b>Discounted Cash Flow Model</b></p>\n<p>Now, let's turn to the discounted cash flow valuation part. Below, you can see the results with the relative assumptions I have made.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b2da633d931f51b493d897d9c87ecee5\" tg-width=\"640\" tg-height=\"262\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p>Now, this time I also present along with my estimates three possible scenarios:</p>\n<ul>\n <li><i>Base Case Scenario</i>: The above DCF model represents my base case scenario. In the base case scenario, I assume the drivers of growth to be: the iPhone segment (driven by 5G transition), the Services segment (driven by a broader customer base), and the new powered M1 Macs segment. Under this scenario, I assume a Y1 growth rate of 12%, a CAGR Y2-Y5 of 7.1%, and a target operating margin in Y10 of 27%. The DCF fair value under this scenario is $105.68/share.</li>\n <li><i>Best Case Scenario</i>: The business is booming! In the best-case scenario, I see again as the main drivers the one which I described for the base case scenario, however, in addition, I see a greater market penetration in China. Over the last 5 years, we can observe a falling pattern for sales in China, however, this year sales jumped 39.7% (with the iPhone segment rising substantially). Under this scenario, I assume a Y1 growth rate of 14%, a CAGR Y2-Y5 of 9.1%, and a target operating margin in Y10 of 30%. The DCF fair value under this scenario is $130.32/share.</li>\n <li><i>Worst Case Scenario</i>: Well, this is a scenario that I would like to call like \"mature company scenario\". Under this scenario I see Apple growing a little above the growth rate of the economy and for this reason, I assume a Y1 growth rate of 10%, a CAGR Y2-Y5 of 3.1%, and a target operating margin in Y10 of 25%. The DCF fair value under this scenario is $81.03/share.</li>\n</ul>\n<p>Finally, for each scenario, I see Apple entering into the health care market with its Apple Watch. As you can imagine, I assign a different likelihood of market penetration in each of these scenarios.</p>\n<p><b>Sensitivity Analysis</b></p>\n<p>Moreover, I also would like to provide the sensitivity analysis for the base case scenario.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/95f00eba768526d07d68fd846ecf998d\" tg-width=\"640\" tg-height=\"462\" referrerpolicy=\"no-referrer\"><span>Source:Author's estimates using data from the latest 10-K report</span></p>\n<p><b>Technical Analysis</b></p>\n<p>From the technical analysis point of view, I don't see any problem yet. The stock price is in a bullish mode, currently within an ascending triangle pattern. As of right now, the stock price is following its pattern and it is heading to the price target of $137/share or point D, where it is likely to bounce and head back to point E. If this scenario happens, point E is usually the point where stock price bounces once again and from that point, the stock goes higher (it is just a technical analysis assumption, take it as is).</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ecf3e5f45dcb5e30b092c02bbf94d6f9\" tg-width=\"640\" tg-height=\"317\" referrerpolicy=\"no-referrer\"><span>Source:TradingView.com</span></p>\n<p><b>Final Thoughts</b></p>\n<p>Apple is a mature company that is able to see a problem and solve it years ahead. By looking at the fair value, computed under the base case scenario, we can argue that the stock is currently overvalued but not by that much. For what concern risks, the difference between the best-case and the worst-case scenario can be used as a proxy of risk. Taking this into consideration I don't see big reasoning to panic, however, it is also true that I see an upcoming correction for the market. Many indicators, technical and fundamental, are suggesting to me that the market is too heavy right now (even if the S&amp;P500 may go higher, perhaps in the 4400 area). To conclude, I don't think to close out my whole Apple position, however, I will close out 60% of it once it reaches my price target.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: Winter Is Coming</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: Winter Is Coming\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-21 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435760-apple-stock-aapl-winter-is-coming><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple's stock has rallied 449% in the last five years, outperforming the 102% rise in the S&P 500 over the same period.\nI initiate Apple with a Neutral rating and a fair value of $111.42/...</p>\n\n<a href=\"https://seekingalpha.com/article/4435760-apple-stock-aapl-winter-is-coming\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4435760-apple-stock-aapl-winter-is-coming","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175906479","content_text":"Summary\n\nApple's stock has rallied 449% in the last five years, outperforming the 102% rise in the S&P 500 over the same period.\nI initiate Apple with a Neutral rating and a fair value of $111.42/share (vs. the current price of $131.7/share).\nFrom the technical analysis point of view, the stock price is following its ascending triangle pattern and it is heading to the price target of $137/share.\n\nMichael M. Santiago/Getty Images NewsCompany Overview\nApple Inc (AAPL) stock has rallied 449% in the last five years, outperforming the 102% rise in the S&P 500 over the same period. An outstanding return supported by underlying fundamentals. In particular, I would like to start the analysis with the latter.\nOver the last two decades, the dominant driver of Apple's success has been the iPhone. In 2016, iPhones accounted for 63% of total sales. This was a problem for Apple, and they knew it. The problem existed due to two main factors: first, the smartphone business was mature (with low growth rates); second, it was (and it is) a highly competitive business. However, Apple had something other competitors didn't have, a big iPhone owner base (which allows to sell more services for instance). Through the years Apple has been able to effectively diversify its revenue stream and it currently presents the structure represented below.\nSource:Author's estimates using data from the latest 10-K report\nLet's now take a look at each of these segments:\n1. iPhone\nFrom 2016 to 2020, the iPhone segment grew at a CAGR of 0.20% and it changed from representing 63.4% (2016) of total sales to 51% (\"TTM\"). I present below the growth rate for the iPhone segment over the last 5 years (2016-TTM).\nSource:Author's estimates using data from the latest10-K report\nSo far this year the iPhone segment is showing a growth rate of 18.5% TTM, fueled by the new family of iPhone12 with 5G capabilities, and with interesting data coming from China. I believe that the transition to 5G will be the main driver of the growth in this segment. In this manner, I would like to report a piece of the transcript from theQ2 earnings call.\n\nIn the enterprise market, customers across many industries are accelerating their adoption of iPhone 12 and 5G as a key platform for the future of their business. Delta Airlines, for example, is putting iPhone 12 and 5G connectivity into the hands of flight attendants so they can provide the best passenger service possible as air travel rebounds.Openreach in the U.K. has started equipping tens of thousands of field engineers with iPhone 12 to speed up their deployment of broadband services to homes around the country. And UCHealth, a large health care provider in Colorado, was able to reduce per patient vaccination time from 3 minutes to only 30 seconds largely by moving from PC stations to iPhones. This has allowed their staff to rapidly scan and register new patients and vastly increase their daily vaccination capacity.\n\n2. iPad\nAs it was in the past, the iPad segment is more or less a constant number as a % of total sales, 9.6% in 2016 vs 9.1% TTM. From 2016 to 2020, the iPad segment grew at a CAGR of 3.56% (with an improving overall trend). I present below the growth rate for the iPad segment over the last 5 years (2016-TTM).\nSource:Author's estimates using data from the latest 10-K report\nThe TTM numbers show us an interesting picture with a growth rate of 24.9% TTM for the iPad segment which are driven by 3 factors: the M1 chip, the new 5G capabilities, and the fact that we were all at home. I see a lot of ways in which this new generation of iPads can be implemented. However, I also have to admit that there is a big player swimming in the same sea, the new 2-1 Laptops. The new 2-1 Laptops are a very interesting solution for those looking to have the best of the two worlds. In this last view, the iPad segment may represent a lower % of total sales, around 7.8% (vs current 9.1%).\n3. Mac\nFrom 2016 to 2020, the Mac segment grew at a CAGR of 5.81%, and also here, as it is for the iPad segment, the Mac segment represents a more or less constant number as % of total sales 10.6% in 2016 vs 10.4% TTM. I present below the growth rate for the Mac segment over the last 5 years (2016-TTM).\nSource:Author's estimates using data from the latest 10-K report\nThe generation of new Macs powered by the M1 chip seems to be appreciated by the customers, in fact, the Mac segment presents a growth rate of 18.4% TTM so far this year. I personally tried this new generation of Macs and I have to admit, Apple knows very well how to delight its customers. Personal PCs are a highly competitive market and, even if I like and I use Apple products, I prefer to work with a Lenovo.\n4. Wearables, Home, and Accessories (WH&A)\nThe Wearables, Home, and Accessories segment includes sales of AirPods, Apple TV, Apple Watch, Beats products, HomePod, etc. This is where it gets interesting. From 2016 to 2020, the WH&A segment grew at a CAGR of 28.78%, and it changed from representing only 5.2% of total sales in 2016 to represent 10.8% TTM. I present below the growth rate for the WH&A segment over the last 5 years (2016-TTM).\nSource:Author's estimates using data from the latest 10-K report\nThe WH&A segment is showing a growth rate of 14.7% TTM driven by a strong performance from both Apple Watch Series 6 and Apple Watch SE. Apple Watch may have a very bright future in the years ahead, driven by Apple entering into the healthcare market. In fact, it can be used to monitor the health status of the person. Imagine you being close to having a heart attack, your Apple Watch may call an ambulance and save your life, not bad no? Finally, let's don't forget also the launch of Apple TV 4K and of the newest accessory, AirTag (I don't see a market for the latter, but I may be wrong).\n5. Services\nServices include sales from the Company’s advertising, AppleCare, digital content, and other services. From 2016 to 2020, the Services segment grew at a CAGR of 21.9% and it changed from representing 11.3% of total sales in 2016 to represent 18.6% TTM. I present below the growth rate for the Services segment over the last 5 years (2016-TTM).\nSource:Author's estimates using data from the latest 10-K report\nTo date, the Services segment is showing a growth rate of 12.3% TTM. The growth is driven by App Store, Cloud Services, Music, Advertising, and Payment Services. The new services, Apple TV+, Apple Arcade, Apple News+, and Apple Card, are also starting to contribute to overall services growth, and continue to add users, content, and features. I believe that in the future, the Services segment will be the company's dominant segment. Below I present an interesting part I extrapolated from theQ4 earnings call.\n\nFirst, our installed base continues to grow and is at an all-time high across each major product category. Second, the number of both transacting and paid accounts on our digital content stores reached a new all-time high during the September quarter, with paid accounts increasing double digits in each of our geographic segments.Third, paid subscriptions grew more than 35 million sequentially, and we now have over 585 million paid subscriptions across the services on our platform, up 135 million from just a year ago. With this momentum, we are very confident to reach and exceed our increased target of 600 million paid subscriptions before the end of calendar 2020.\n\nCompany Analysis\nI initiate Apple with a Neutral rating and a fair value of $111.42/share (vs. the current price of $131.7/share). The fair value is an algorithm-adjusted value that accounts for different factors, fundamental and technical (e.g. DCF fair value, Momentum, etc.), and so it takes into consideration the Mr. Market mood. At the same time, the fair value which I obtained through the DCF model is equal to $105.68/share. Now before showing the results, the numbers used as the base are the trailing twelve-month numbers. Moreover, I also restated the financials since I capitalized on R&D expenses with an amortizable life of 3 years. I don't believe that in the case of Apple, R&D is an operating expense and for this reason, I treat it as CapEx. By taking into account the R&D, the following metrics have been restated (all numbers in $mm).\nSource:Author's estimates using data from the latest 10-K report\nIt is very important to capitalize on R&D expense, if we don't, we are just keeping the company's biggest asset off-balance sheet.\nDiscounted Cash Flow Model\nNow, let's turn to the discounted cash flow valuation part. Below, you can see the results with the relative assumptions I have made.\nSource:Author's estimates using data from the latest 10-K report\nNow, this time I also present along with my estimates three possible scenarios:\n\nBase Case Scenario: The above DCF model represents my base case scenario. In the base case scenario, I assume the drivers of growth to be: the iPhone segment (driven by 5G transition), the Services segment (driven by a broader customer base), and the new powered M1 Macs segment. Under this scenario, I assume a Y1 growth rate of 12%, a CAGR Y2-Y5 of 7.1%, and a target operating margin in Y10 of 27%. The DCF fair value under this scenario is $105.68/share.\nBest Case Scenario: The business is booming! In the best-case scenario, I see again as the main drivers the one which I described for the base case scenario, however, in addition, I see a greater market penetration in China. Over the last 5 years, we can observe a falling pattern for sales in China, however, this year sales jumped 39.7% (with the iPhone segment rising substantially). Under this scenario, I assume a Y1 growth rate of 14%, a CAGR Y2-Y5 of 9.1%, and a target operating margin in Y10 of 30%. The DCF fair value under this scenario is $130.32/share.\nWorst Case Scenario: Well, this is a scenario that I would like to call like \"mature company scenario\". Under this scenario I see Apple growing a little above the growth rate of the economy and for this reason, I assume a Y1 growth rate of 10%, a CAGR Y2-Y5 of 3.1%, and a target operating margin in Y10 of 25%. The DCF fair value under this scenario is $81.03/share.\n\nFinally, for each scenario, I see Apple entering into the health care market with its Apple Watch. As you can imagine, I assign a different likelihood of market penetration in each of these scenarios.\nSensitivity Analysis\nMoreover, I also would like to provide the sensitivity analysis for the base case scenario.\nSource:Author's estimates using data from the latest 10-K report\nTechnical Analysis\nFrom the technical analysis point of view, I don't see any problem yet. The stock price is in a bullish mode, currently within an ascending triangle pattern. As of right now, the stock price is following its pattern and it is heading to the price target of $137/share or point D, where it is likely to bounce and head back to point E. If this scenario happens, point E is usually the point where stock price bounces once again and from that point, the stock goes higher (it is just a technical analysis assumption, take it as is).\nSource:TradingView.com\nFinal Thoughts\nApple is a mature company that is able to see a problem and solve it years ahead. By looking at the fair value, computed under the base case scenario, we can argue that the stock is currently overvalued but not by that much. For what concern risks, the difference between the best-case and the worst-case scenario can be used as a proxy of risk. Taking this into consideration I don't see big reasoning to panic, however, it is also true that I see an upcoming correction for the market. Many indicators, technical and fundamental, are suggesting to me that the market is too heavy right now (even if the S&P500 may go higher, perhaps in the 4400 area). To conclude, I don't think to close out my whole Apple position, however, I will close out 60% of it once it reaches my price target.","news_type":1},"isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":600972130,"gmtCreate":1638061720309,"gmtModify":1638061720402,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]&nbsp;","listText":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]&nbsp;","text":"5K really cannot do much given the stocks price of both, just focus on one of have to[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600972130","repostId":"2186340224","repostType":2,"repost":{"id":"2186340224","kind":"highlight","pubTimestamp":1638059445,"share":"https://www.laohu8.com/m/news/2186340224?lang=&edition=full","pubTime":"2021-11-28 08:30","market":"us","language":"en","title":"Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2186340224","media":"Motley Fool","summary":"Both of these businesses could be in much better shape a year from now.","content":"<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.</p>\n<p>That's exactly what I think of with&nbsp;<a href=\"https://laohu8.com/S/AZN\"><b>AstraZeneca&nbsp;</b></a> and&nbsp;<a href=\"https://laohu8.com/S/BYND\"><b>Beyond Meat&nbsp;</b></a>. Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.</p>\n<h4><b>1. AstraZeneca</b></h4>\n<p>Shares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the <b>S&amp;P 500</b> has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.</p>\n<p>But next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.</p>\n<p>That means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.</p>\n<p>For the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker <b>Moderna</b> reported $4.8 billion in product sales for the same period, and <b>Pfizer</b>'s COVID-19 vaccine generated $13 billion in revenue, also during the same interval.</p>\n<p>While it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.</p>\n<p>Although AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)</p>\n<p>As it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.</p>\n<h4><b>2. Beyond Meat</b></h4>\n<p>Beyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.</p>\n<p>The company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.</p>\n<p>There's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.</p>\n<p>Beyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.</p>\n<p>However, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant <b>McDonald's</b> recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.</p>\n<p>Although the growth stock is beaten up today, a year from now, today's price could look like a bargain.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? These 2 Stocks Could Be Bargain Buys in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 08:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN":"阿斯利康","BYND":"Beyond Meat, Inc."},"source_url":"https://www.fool.com/investing/2021/11/27/these-2-stocks-could-be-bargain-buys-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186340224","content_text":"Investing in stocks that are falling can be tough to do; nobody wants to look at their portfolio and see red. But if you're investing for the long haul, you know that short-term trends could subside, and this year's sell-off stock could be next year's top performer.\nThat's exactly what I think of with AstraZeneca  and Beyond Meat . Both of these stocks have been falling recently, but heading into next year, things could look a lot better. If you can afford to invest $5,000 into these stocks, here's why you should consider doing so.\n1. AstraZeneca\nShares of COVID-19 vaccine-maker AstraZeneca are down 5% over the past three months, while the S&P 500 has soared by more than 5%. The company released its third-quarter results on Nov. 12, which disappointed investors as it fell short of earnings expectations. The stock sank more than 6% on the day.\nBut next year, things could look much different. Up until now, AstraZeneca hasn't been trying to make a profit from its COVID-19 vaccine. But now that the pandemic is turning into more of an endemic, the company is going to focus on turning a profit on the vaccine on any new orders.\nThat means an increase in price. The company has been selling its vaccine for just a few dollars per dose, well below what other COVID-19 vaccine makers are charging countries.\nFor the period ending Sept. 30, the company's COVID-19 vaccine generated over $1 billion in revenue. Meanwhile, rival vaccine-maker Moderna reported $4.8 billion in product sales for the same period, and Pfizer's COVID-19 vaccine generated $13 billion in revenue, also during the same interval.\nWhile it's unclear just how much higher AstraZeneca's COVID-19-related revenue may climb on an increase in the vaccine's price, its top line is likely to get a boost next year nonetheless. Plus, it completed the acquisition of healthcare-company Alexion Pharmaceuticals in July, which has already started contributing to AstraZeneca's financials this past quarter to the tune of $1.3 billion in new revenue. Alexion's focus on rare diseases expands AstraZeneca's product mix and can set it up for some great gains over the long term.\nAlthough AstraZeneca incurred a net loss of $1.7 billion this past quarter, that's largely due to the acquisition of Alexion, as its operations are typically profitable. (In each of the previous four quarters, AstraZeneca has reported a profit margin of at least 6%.)\nAs it integrates Alexion into its business and eliminates inefficiencies and redundancies, the company's financials will improve. That, combined with the additional revenue from the new business plus an increase in COVID-19 sales, could set the stock up for a terrific performance in 2022.\n2. Beyond Meat\nBeyond Meat's stock has been falling fast as it's down 36% in just three months. What was looking like it might be a promising year for the company amid reopenings has stalled due to the delta variant causing a spike in COVID-19 cases.\nThe company had a bad earnings report and the stock has become a better buy in November. Although sales of $106.4 million for the period ending Oct. 2 rose 13% year over year, the company disappointed investors with a net loss of $54.8 million that was more than double the $19.3 million loss it reported in the same period in 2020. Beyond Meat doesn't project a picture of getting much better in the final quarter of the year, as it expects net revenue to fall within a range of just $85 million to $110 million.\nThere's no shortage of bearishness surrounding Beyond Meat right now. But heading into next year, a lot can change. What's important is that the company has some great growth opportunities in place.\nBeyond's sales were up 13% this past quarter, but that was driven primarily by growth in the international markets, where revenue more than doubled to $38.9 million. In the U.S. market, sales of $67.5 million declined by 14%.\nHowever, if supply-chain issues resolve next year and COVID-19 case numbers come down as people receive booster shots, there's reason to believe that the U.S. numbers could strengthen with a return to normalcy in the economy. And fast-food restaurant McDonald's recently launched its McPlant burger (which features a Beyond Meat patty) in multiple U.S. cities. If successful, that could also lead to some improved financials for Beyond in 2022.\nAlthough the growth stock is beaten up today, a year from now, today's price could look like a bargain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865624564,"gmtCreate":1632978794380,"gmtModify":1632978903871,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/865624564","repostId":"2171986054","repostType":4,"repost":{"id":"2171986054","kind":"highlight","pubTimestamp":1632973200,"share":"https://www.laohu8.com/m/news/2171986054?lang=&edition=full","pubTime":"2021-09-30 11:40","market":"us","language":"en","title":"3 Vanguard ETFs I'm Buying if the Stock Market Crashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2171986054","media":"Motley Fool","summary":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.","content":"<blockquote>\n <b>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.</b>\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>The Vanguard S&amp;P 500 ETF can be a great option for withstanding market volatility.</li>\n <li>The Vanguard Total Stock Market ETF can help reduce your risk.</li>\n <li>The Vanguard Growth ETF can supercharge your investments.</li>\n</ul>\n<p>Over the past year and a half, the stock market has experienced <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the greatest growth streaks in history. The <b>S&amp;P 500</b> is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.</p>\n<p>Some experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.</p>\n<p>Nobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.</p>\n<p><img src=\"https://static.tigerbbs.com/9c5cb96961b54db9d77a960894b88df7\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>1. Vanguard S&amp;P 500 ETF (VOO)</h3>\n<p>It may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.</p>\n<p>One ETF I'm planning to invest in heavily if the market crashes is the <b>Vanguard S&amp;P 500 ETF</b> (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&amp;P 500 and includes all the stocks within the index itself.</p>\n<p>The S&amp;P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.</p>\n<h3>2. Vanguard Total Stock Market ETF (VTI)</h3>\n<p>The <b>Vanguard Total Stock Market ETF</b> (NYSEMKT:VTI) is similar to the S&amp;P 500 ETF, but it includes more stocks from more diverse companies.</p>\n<p>The S&amp;P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.</p>\n<p>Another advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.</p>\n<h3>3. Vanguard Growth ETF (VUG)</h3>\n<p>The <b>Vanguard Growth ETF</b> (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.</p>\n<p>This fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like <b>Amazon</b>, <b>Apple</b>, and <b>Microsoft</b> -- companies that are very likely to survive market volatility.</p>\n<p>One of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&amp;P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.</p>\n<p>Investing in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Vanguard ETFs I'm Buying if the Stock Market Crashes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Vanguard ETFs I'm Buying if the Stock Market Crashes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF","VTI":"大盘指数ETF-Vanguard MSCI","SPXU":"三倍做空标普500ETF","VUG":"成长股指数ETF-Vanguard MSCI","OEX":"标普100",".SPX":"S&P 500 Index","IVV":"标普500指数ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","VOO":"Vanguard标普500ETF","SSO":"两倍做多标普500ETF","SH":"标普500反向ETF"},"source_url":"https://www.fool.com/investing/2021/09/29/3-vanguard-etfs-buy-if-the-stock-market-crashes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171986054","content_text":"Nobody knows whether the market will crash. But if it does, I'm stocking up on these investments.\n\nKey Points\n\nThe Vanguard S&P 500 ETF can be a great option for withstanding market volatility.\nThe Vanguard Total Stock Market ETF can help reduce your risk.\nThe Vanguard Growth ETF can supercharge your investments.\n\nOver the past year and a half, the stock market has experienced one of the greatest growth streaks in history. The S&P 500 is up nearly 100% since March 2020, and investors have seen their portfolios skyrocket during that time.\nSome experts believe, however, that it's only a matter of time before prices fall. Market downturns may be intimidating, but they're normal. In fact, it's healthy for the market to experience corrections every so often, because stock prices can't continue climbing forever.\nNobody knows for sure whether a crash is on the horizon, or, if it does happen, how significant it will be. However, if the market does take a turn for the worse, there are a few exchange-traded funds (ETFs) I'll be buying.\n\nImage source: Getty Images.\n1. Vanguard S&P 500 ETF (VOO)\nIt may seem counterintuitive to buy when the market is down, but crashes can be a fantastic opportunity to invest when prices are lower. ETFs trade like stocks, so when the market is down, their share prices are typically lower as well.\nOne ETF I'm planning to invest in heavily if the market crashes is the Vanguard S&P 500 ETF (NYSEMKT:VOO). Like its name suggests, this fund tracks the S&P 500 and includes all the stocks within the index itself.\nThe S&P 500 ETF is one of the most dependable investments out there. Historically, the index itself has faced countless crashes and corrections, and it has recovered from each and every one. If the market crashes again, there's a very good chance this ETF will be able to bounce back. And by buying when prices are lower, you'll reap the rewards once the market recovers and prices increase once again.\n2. Vanguard Total Stock Market ETF (VTI)\nThe Vanguard Total Stock Market ETF (NYSEMKT:VTI) is similar to the S&P 500 ETF, but it includes more stocks from more diverse companies.\nThe S&P 500 ETF includes stocks from 500 large companies, while the Total Stock Market ETF includes nearly 4,000 stocks from small, midsize, and large corporations. This provides greater diversification and can decrease your risk.\nAnother advantage of this fund is that it's designed to follow the market as a whole. Again, the stock market has a strong track record when it comes to recovering from downturns, so by investing in this ETF, it's likely your investments will recover as well.\n3. Vanguard Growth ETF (VUG)\nThe Vanguard Growth ETF (NYSEMKT:VUG) includes 285 stocks from companies that are expected to grow at a faster-than-average pace.\nThis fund includes the fewest holdings of the three ETFs on the list, which does make it slightly riskier. However, many of the biggest stocks in the fund are from behemoth tech corporations like Amazon, Apple, and Microsoft -- companies that are very likely to survive market volatility.\nOne of the primary advantages of growth ETFs is that they're designed to earn above-average returns. This particular ETF has earned an average rate of return of around 12% per year since its inception, for example. By comparison, the S&P 500 has historically earned a 10% average annual return, and the Vanguard Total Stock Market ETF has earned an average return of around 9% per year.\nInvesting in ETFs can be a fantastic way to build wealth with less effort, and buying during a market downturn can make investing more affordable. While nobody knows for certain whether a market crash is coming, by making a list now of the investments you want to buy, you can snag them at a discount later.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":863682115,"gmtCreate":1632386031437,"gmtModify":1632800755579,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Boston beer 🍺 yeah","listText":"Boston beer 🍺 yeah","text":"Boston beer 🍺 yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/863682115","repostId":"1137784790","repostType":4,"repost":{"id":"1137784790","kind":"news","pubTimestamp":1632369156,"share":"https://www.laohu8.com/m/news/1137784790?lang=&edition=full","pubTime":"2021-09-23 11:52","market":"us","language":"en","title":"5 Stocks to Buy in the September Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1137784790","media":"Motley Fool","summary":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.I can't tell you where Adobe,Markel,Take Two Interactive Software,Vertex Pharmaceuticals, and BostonBeerwill trade next week or next month. But I'm confident they will significantly outperform the market o","content":"<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.</p>\n<p>I&nbsp;can't&nbsp;tell&nbsp;you&nbsp;where&nbsp;<b>Adobe</b>(NASDAQ:ADBE),<b>Markel</b>(NYSE:MKL),<b>Take Two Interactive Software</b>(NASDAQ:TTWO),<b>Vertex Pharmaceuticals</b>(NASDAQ:VRTX), and&nbsp;<b>BostonBeer</b>(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.</p>\n<h3>Adobe</h3>\n<p>At a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.</p>\n<p>Digital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.</p>\n<p>The business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better than<b>Microsoft</b>.</p>\n<p>CEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.</p>\n<h3>Markel</h3>\n<p>Markel has been called the \"baby Berkshire\" for its resemblance to&nbsp;<b>Berkshire Hathaway</b>. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.</p>\n<p>One big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/263e423c73746672c28109121ec6d687\" tg-width=\"720\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>MKLDATA BYYCHARTS</span></p>\n<p>At less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.</p>\n<h3>Take Two Interactive</h3>\n<p>Take Two has one of the most popular video game franchises of all time --<i>Grand Theft Auto</i>. As of last year, the fifth installment in the series --<i>GTA V</i>-- was the third-best-selling video game ever. It trailed only<i>Minecraft</i>and<i>Tetris</i>. Want more proof? It took<i>GTA V</i>three days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performing<i>Harry Potter</i>movie, and<i>Avatar</i>. And the company has more in its stable.</p>\n<p>Another of its popular games -- the<i>NBA2K</i>series -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.</p>\n<p>Since 2012, sales have grown 308%. That compares favorably to<b>Activision Blizzard</b>'s 70% and<b>Electronic Arts</b>' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b89d7f36b549065b4545a0fa5c997d02\" tg-width=\"720\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>EA REVENUE (ANNUAL)DATA BYYCHARTS</span></p>\n<h3>Vertex Pharmaceuticals</h3>\n<p>Some drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.</p>\n<p>Management believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.</p>\n<p>It has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration with<b>CRISPR Therapeutics</b>-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs with<b>Moderna</b>and Arbor Biotechnologies. It's a robust pipeline with a lot of potential.</p>\n<p>Despite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.</p>\n<h3>Boston Beer</h3>\n<p>Riding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2f60342c3cab8471f9e4dbd370f401b1\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"><span>SAMDATA BYYCHARTS</span></p>\n<p>It's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.</p>\n<p>Of course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks to Buy in the September Sell-Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks to Buy in the September Sell-Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 11:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MKL":"Markel Corp","SAM":"波斯顿啤酒","TTWO":"Take-Two Interactive Software","VRTX":"福泰制药","ADBE":"Adobe"},"source_url":"https://www.fool.com/investing/2021/09/22/5-stocks-to-buy-in-the-september-sell-off/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137784790","content_text":"History has shown that a market sell-off is a great time to add quality companies to your portfolio. Although no one can predict when that will happen, a 10% drop occurs about once every two years. That's why I'm highlighting five high-quality companies to buy if the most recent swoon persists.\nI can't tell you where Adobe(NASDAQ:ADBE),Markel(NYSE:MKL),Take Two Interactive Software(NASDAQ:TTWO),Vertex Pharmaceuticals(NASDAQ:VRTX), and BostonBeer(NYSE:SAM)will trade next week or next month. But I'm confident they will significantly outperform the market over the next three-plus years. Here's why.\nAdobe\nAt a market capitalization of $300 billion, Adobe is one of the largest software companies in the world. Its applications are the backbone of a lot of the content creative professionals produce. Through the years, it has also given them the ability to manage, measure, and monetize their output. The company breaks its results into three categories.\nDigital media encompasses the company's creative cloud offering. It's a subscription service that houses applications for virtually anyone creating or delivering content. The digital experience segment is a cloud platform that helps companies deliver the most engaging customer experiences. It provides everything from marketing management and automation to digital commerce and predictive analytics. Finally, its publishing and advertising division contains legacy products in addition to its advertising cloud offerings.\nThe business has performed amazingly well. Over the past decade, sales and free cash flow have grown 241% and 281%, respectively. Through the first nine months of its fiscal 2021, it posted revenue of $11.7 billion. That was up 24% from the same period last year and 43% over 2019. It carries little debt and its return on invested capital is 33%. That's slightly better thanMicrosoft.\nCEO Shantanu Narayen sees strength across the business and believes the digital transformation will power the company's financial performance even while it invests in what it calls \"massive market opportunities.\" There is no question the runway is long. That's why I believe any significant sell-off is a gift to investors. Take advantage if you get it andbuy shares of Adobe.\nMarkel\nMarkel has been called the \"baby Berkshire\" for its resemblance to Berkshire Hathaway. It is also an insurance company that uses some of its float -- premiums collected on policies that haven't been paid out in claims -- to invest in stocks and buy businesses. It also manages those businesses in a similar way, treating its holding period as forever.\nOne big difference is that Markel is only a $16.5 billion company. That gives it more flexibility in what it can buy and offers the potential for decades of steady, market-beating returns for shareholders. Want proof? Would it surprise you to find out Markel's stock has outperformed Berkshire Hathaway since 1990? It has.\nMKLDATA BYYCHARTS\nAt less than 37 times the size of Warren Buffett's behemoth, Markel still has an almost limitless opportunity to employ the same model. It might not be an exciting technology stock or double your investment over a short time, but it is a proven market-beating company that can add ballast to a portfolio. If you get a chance to add shares during a sell-off, take it.\nTake Two Interactive\nTake Two has one of the most popular video game franchises of all time --Grand Theft Auto. As of last year, the fifth installment in the series --GTA V-- was the third-best-selling video game ever. It trailed onlyMinecraftandTetris. Want more proof? It tookGTA Vthree days to reach $1 billion in sales. That's more than five times faster than the closest video game, the best-performingHarry Pottermovie, andAvatar. And the company has more in its stable.\nAnother of its popular games -- theNBA2Kseries -- is also praised for both its polish and commercial success. But what excites me about Take Two is what those games have in common. They both offer an immersive experience in a virtual world where the possibilities seem endless. As talk of a metaverse becomes more mainstream, the company has already proven it can create engaging virtual worlds where users participate in crafting their own experience, as well as the experience of others. It has set the company apart financially.\nSince 2012, sales have grown 308%. That compares favorably toActivision Blizzard's 70% andElectronic Arts' 36%. Of course, those publishers were already more established. Still, it helps highlight why I think Take Two is the game maker to buy in a market sell-off.\nEA REVENUE (ANNUAL)DATA BYYCHARTS\nVertex Pharmaceuticals\nSome drugmakers have a portfolio of treatments across many disease areas. Others focus on one type of ailment and work to dominate the space. That's how Vertex has built a market capitalization of $48 billion and annual revenue of $6.7 billion. The company has four approved drugs for cystic fibrosis -- a disease that causes mucus to build up in organs -- and treats roughly half of the 83,000 patients in the U.S., Europe, Australia, and Canada.\nManagement believes it can treat an additional 30,000 of those patients by successfully commercializing drugs in markets where it recently gained approval, obtaining approval in new markets, and rolling out its newest CF drug in the U.S. and Europe.\nIt has also partnered with other biotechs to maintain its position in CF and explore new growth opportunities. It spent $900 million to purchase a controlling interest in CTX001 -- its collaboration withCRISPR Therapeutics-- for treating sickle cell disease and beta thalassemia. The company also has a non-opioid pain treatment, a drug targeting kidney disease, and a stem cell-derived therapy for type 1 diabetes in clinical trials. Vertex also has pre-clinical gene-based programs withModernaand Arbor Biotechnologies. It's a robust pipeline with a lot of potential.\nDespite that, Wall Street isn't giving the company a lot of credit. Itsprice-to-sales ratiois the lowest it has been since 2012 -- the year it began selling its first CF drug. Analysts expect sales to climb this year and next, making the discount even more pronounced. With a strong foundation in CF and so much potential in the pipeline, Vertex Pharmaceuticals might already be a steal.\nBoston Beer\nRiding the trends in the alcoholic beverage industry is like being on a rollercoaster. Tastes in the U.S. have shifted over the years with wine, whiskey, hard cider, craft beers, and hard seltzer each taking a turn as the drink of choice. For the most part, Boston Beer has been able to succeed no matter what was in vogue. But it's been an up and down journey for shareholders. The stock has experienced drops of at least 60% three times in the last 20 years.\nSAMDATA BYYCHARTS\nIt's in one of those slumps now as Truly -- its hard seltzer brand -- underperforms amid an avalanche of competition. After the decline, the stock is offering investors an opportunity they don't get very often. Analysts still expect revenue of $2.16 billion this year. That makes the projected P/S ratio of less than three close to the lowest level since the beginning of 2019.\nOf course, it could get worse before it gets better. Management slashed its earnings forecast in July and then pulled guidance earlier this month, saying it would incur write-offs and fees associated with the product. As scary as that is, I'm betting Boston Beer will repeat its history of surviving a downturn, finding a new trend, and powering to new all-time highs in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869293398,"gmtCreate":1632288149314,"gmtModify":1632801466405,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Is time to sell off for me[Sly]&nbsp;","listText":"Is time to sell off for me[Sly]&nbsp;","text":"Is time to sell off for me[Sly]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869293398","repostId":"2169639321","repostType":4,"repost":{"id":"2169639321","kind":"highlight","pubTimestamp":1632282060,"share":"https://www.laohu8.com/m/news/2169639321?lang=&edition=full","pubTime":"2021-09-22 11:41","market":"us","language":"en","title":"1 Growth Stock That Could Produce 10X Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2169639321","media":"Motley Fool","summary":"The future looks bright for this e-commerce company.","content":"<p><b>Global-E Online</b> (NASDAQ:GLBE) went public in mid-May at $25 per share. Since then, the stock's price has soared over 200%, as investors have bought shares of this e-commerce company hand over fist, and it's easy to see why. Online shopping is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the most pervasive trends of our time, and the market is far from tapped out.</p>\n<p>However, even though the share price has tripled, it's not too late to add Global-E to your own portfolio. In fact, I think this recent IPO stock could still grow tenfold over the next 10 years. Here's why.</p>\n<h2>Managing cross-border commerce is a big market opportunity</h2>\n<p>Domestic e-commerce is fairly straightforward, but cross-border sales are a different story. Merchants have to navigate the complexities of international logistics, language barriers, and various regulatory requirements. Traditionally, businesses have relied upon several service providers to solve these problems, but Global-E takes a more comprehensive&nbsp;approach.</p>\n<p>The company offers an end-to-end solution for cross-border commerce. Its platform integrates with a seller's online storefront, localizing details like the language, pricing, and shipping options on a market-by-market basis. Global-E also manages import duties and taxes, and it provides after-sale customer service and returns management.</p>\n<p>Why does this matter? International shoppers typically represent 30%&nbsp;of web traffic to global e-commerce sites, but international sales usually comprise just 5% to 10%&nbsp;of total revenue. In other words, current solutions fail to help sellers fully capitalize on that opportunity -- and it's a big opportunity. According to <b>Forrester Research</b>, cross-border e-commerce spend will reach $736 billion&nbsp;in 2023.</p>\n<h2>Global-E has a strong competitive edge</h2>\n<p>Global-E has a more holistic solution than any of its rivals, and the company's numbers back that claim. By optimizing the shopping experience for international consumers in over 200 destination markets, Global-E helps businesses accelerate cross-border conversions, often by more than&nbsp;60%.</p>\n<p>This creates a flywheel effect. By facilitating transactions and logistics across a range of geographies, Global-E collects market-specific data relating to consumer preferences. Using that data, its platform leans on artificial intelligence to surface relevant insights for merchants, helping them further boost international conversion rates.</p>\n<p>This accomplishes two things: First, Global-E makes money by taking a cut of gross merchandise value, so it wins when its merchants succeed. Second, as Global-E's AI models become more intelligent, its ability to drive cross-border sales should improve, drawing even more merchants to its platform.</p>\n<p>This virtuous cycle has already been a powerful growth driver. As of the most recent quarter, Global-E had 522 merchants on its platform, up 85% from the end of 2019. That uptick in adoption has powered an impressive top-line performance.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>Change</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$90.1 million</p></td>\n   <td width=\"156\"><p>$190.3 million</p></td>\n   <td width=\"156\"><p>111%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Global-E SEC filings. TTM: trailing-12-months. CAGR: compound annual growth rate.</p>\n<p>Global-E's gross profit margin has expanded dramatically over time, rising from 22% in 2018&nbsp;to 36%&nbsp;in the most recent quarter. Management attributes&nbsp;this to the growing volume of its market-specific data. And the company is well-positioned to maintain that momentum.</p>\n<p>The Global-E platform is a very sticky product. Gross retention has been over 98% since 2018, meaning less than 2% of customers cancel service each year. And net retention hit 172%&nbsp;in 2020, indicating a 72% uptick in average customer spend. In both cases, these impressive figures evidence the value that Global-E creates for its clients.</p>\n<p>Moreover, the company recently signed a partnership agreement with <b>Shopify</b>, the most popular&nbsp;e-commerce software vendor in the United States, whereby Global-E will be the exclusive provider of cross-border solutions for Shopify merchants. This could be a significant growth driver for both companies -- the Shopify platform currently supports 1.7 million merchants, each of which could easily become a Global-E customer.</p>\n<h2>The bottom line</h2>\n<p>Global-E stock trades at a pricey 59 times sales, but given the company's strong competitive position and massive market opportunity, that valuation may not look so crazy in hindsight.</p>\n<p>Consider this scenario: To produce tenfold returns, Global-E would need to achieve a market cap of $110 billion, and I think that's possible. If the company can grow sales at 40% per year through 2031, total revenue would reach $5.5 billion. Assuming the stock trades for a more reasonable 20 times sales at that point, Global-E would have a market cap of exactly $110 billion.</p>\n<p>Of course, no one knows the future, and I've speculated on several metrics over a great length of time. But it's not hard for me to imagine this scenario playing out over the next decade. That's why I think this growth stock is a smart long-term investment.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Growth Stock That Could Produce 10X Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Growth Stock That Could Produce 10X Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-22 11:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/21/1-growth-stock-that-could-produce-10x-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Global-E Online (NASDAQ:GLBE) went public in mid-May at $25 per share. Since then, the stock's price has soared over 200%, as investors have bought shares of this e-commerce company hand over fist, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/21/1-growth-stock-that-could-produce-10x-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GLBE":"Global-E Online Ltd."},"source_url":"https://www.fool.com/investing/2021/09/21/1-growth-stock-that-could-produce-10x-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169639321","content_text":"Global-E Online (NASDAQ:GLBE) went public in mid-May at $25 per share. Since then, the stock's price has soared over 200%, as investors have bought shares of this e-commerce company hand over fist, and it's easy to see why. Online shopping is one of the most pervasive trends of our time, and the market is far from tapped out.\nHowever, even though the share price has tripled, it's not too late to add Global-E to your own portfolio. In fact, I think this recent IPO stock could still grow tenfold over the next 10 years. Here's why.\nManaging cross-border commerce is a big market opportunity\nDomestic e-commerce is fairly straightforward, but cross-border sales are a different story. Merchants have to navigate the complexities of international logistics, language barriers, and various regulatory requirements. Traditionally, businesses have relied upon several service providers to solve these problems, but Global-E takes a more comprehensive approach.\nThe company offers an end-to-end solution for cross-border commerce. Its platform integrates with a seller's online storefront, localizing details like the language, pricing, and shipping options on a market-by-market basis. Global-E also manages import duties and taxes, and it provides after-sale customer service and returns management.\nWhy does this matter? International shoppers typically represent 30% of web traffic to global e-commerce sites, but international sales usually comprise just 5% to 10% of total revenue. In other words, current solutions fail to help sellers fully capitalize on that opportunity -- and it's a big opportunity. According to Forrester Research, cross-border e-commerce spend will reach $736 billion in 2023.\nGlobal-E has a strong competitive edge\nGlobal-E has a more holistic solution than any of its rivals, and the company's numbers back that claim. By optimizing the shopping experience for international consumers in over 200 destination markets, Global-E helps businesses accelerate cross-border conversions, often by more than 60%.\nThis creates a flywheel effect. By facilitating transactions and logistics across a range of geographies, Global-E collects market-specific data relating to consumer preferences. Using that data, its platform leans on artificial intelligence to surface relevant insights for merchants, helping them further boost international conversion rates.\nThis accomplishes two things: First, Global-E makes money by taking a cut of gross merchandise value, so it wins when its merchants succeed. Second, as Global-E's AI models become more intelligent, its ability to drive cross-border sales should improve, drawing even more merchants to its platform.\nThis virtuous cycle has already been a powerful growth driver. As of the most recent quarter, Global-E had 522 merchants on its platform, up 85% from the end of 2019. That uptick in adoption has powered an impressive top-line performance.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nChange\n\n\n\n\nRevenue\n$90.1 million\n$190.3 million\n111%\n\n\n\nData source: Global-E SEC filings. TTM: trailing-12-months. CAGR: compound annual growth rate.\nGlobal-E's gross profit margin has expanded dramatically over time, rising from 22% in 2018 to 36% in the most recent quarter. Management attributes this to the growing volume of its market-specific data. And the company is well-positioned to maintain that momentum.\nThe Global-E platform is a very sticky product. Gross retention has been over 98% since 2018, meaning less than 2% of customers cancel service each year. And net retention hit 172% in 2020, indicating a 72% uptick in average customer spend. In both cases, these impressive figures evidence the value that Global-E creates for its clients.\nMoreover, the company recently signed a partnership agreement with Shopify, the most popular e-commerce software vendor in the United States, whereby Global-E will be the exclusive provider of cross-border solutions for Shopify merchants. This could be a significant growth driver for both companies -- the Shopify platform currently supports 1.7 million merchants, each of which could easily become a Global-E customer.\nThe bottom line\nGlobal-E stock trades at a pricey 59 times sales, but given the company's strong competitive position and massive market opportunity, that valuation may not look so crazy in hindsight.\nConsider this scenario: To produce tenfold returns, Global-E would need to achieve a market cap of $110 billion, and I think that's possible. If the company can grow sales at 40% per year through 2031, total revenue would reach $5.5 billion. Assuming the stock trades for a more reasonable 20 times sales at that point, Global-E would have a market cap of exactly $110 billion.\nOf course, no one knows the future, and I've speculated on several metrics over a great length of time. But it's not hard for me to imagine this scenario playing out over the next decade. That's why I think this growth stock is a smart long-term investment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":30,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834209613,"gmtCreate":1629803298332,"gmtModify":1631889868338,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Okay buy to support abit","listText":"Okay buy to support abit","text":"Okay buy to support abit","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/834209613","repostId":"1129329518","repostType":4,"isVote":1,"tweetType":1,"viewCount":256,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":822117653,"gmtCreate":1634101064984,"gmtModify":1634101065164,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Can consider 🤔&nbsp;","listText":"Can consider 🤔&nbsp;","text":"Can consider 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/822117653","repostId":"2175273130","repostType":4,"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":141070701,"gmtCreate":1625828536003,"gmtModify":1631889816785,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AABB\">$Asia Broadband, Inc.(AABB)$</a>Get ready, rocket to launch soon","listText":"<a href=\"https://laohu8.com/S/AABB\">$Asia Broadband, Inc.(AABB)$</a>Get ready, rocket to launch soon","text":"$Asia Broadband, Inc.(AABB)$Get ready, rocket to launch soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/141070701","isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":879156743,"gmtCreate":1636694218794,"gmtModify":1636694472903,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Support BABA","listText":"Support BABA","text":"Support BABA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879156743","repostId":"1137718483","repostType":2,"repost":{"id":"1137718483","kind":"news","pubTimestamp":1636677707,"share":"https://www.laohu8.com/m/news/1137718483?lang=&edition=full","pubTime":"2021-11-12 08:41","market":"hk","language":"en","title":"Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137718483","media":"Motley Fool","summary":"$Alibaba$ Group has plummeted 49% since peaking 13 months ago.Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.Alibaba and two other U.S. former market darlings have a strong chance to bounce back from here.Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day c","content":"<p>Key Points</p>\n<ul>\n <li><a href=\"https://laohu8.com/S/BABA\">Alibaba</a> Group has plummeted 49% since peaking 13 months ago.</li>\n <li>Alibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.</li>\n <li>Alibaba&nbsp;and two other U.S. former market darlings have a strong chance to bounce back from here.</li>\n</ul>\n<p>The market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.</p>\n<p>Shares of<b><a href=\"https://laohu8.com/S/09988\">Alibaba</a> Group Holding</b>(NYSE:BABA),<b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</b>, and&nbsp;<a href=\"https://laohu8.com/S/PINS\"><b>Pinterest</b></a>&nbsp;have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.</p>\n<p>1. Alibaba</p>\n<p>Thursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.</p>\n<p>Singles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.</p>\n<p>Alibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.</p>\n<p>2. <a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video</p>\n<p>The rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?</p>\n<p>The market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.</p>\n<p>However, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.</p>\n<p>3. Pinterest</p>\n<p>A year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.</p>\n<p>Everything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.</p>\n<p>Last month&nbsp;<b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.</p>\n<p>PayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.</p>\n<p>Alibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Wait for a Crash to Buy? These 3 Top Stocks Are Already Down More Than 40%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-12 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PINS":"Pinterest, Inc.","BABA":"阿里巴巴","ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2021/11/11/why-wait-for-a-crash-to-buy-these-3-top-stocks-are/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137718483","content_text":"Key Points\n\nAlibaba Group has plummeted 49% since peaking 13 months ago.\nAlibaba's Singles' Day isn't what it used to be now given China's \"common prosperity\" initiative.\nAlibaba and two other U.S. former market darlings have a strong chance to bounce back from here.\n\nThe market's getting volatile, but it's still trading close to its recent all-time highs. Are you waiting for the market to take a big hit before putting your money on the sidelines to work? Well, a lot of last year's biggest stars have already crashed.\nShares ofAlibaba Group Holding(NYSE:BABA),Zoom Video, and Pinterest have all plummeted at least 40% since hitting all-time highs. The markdowns seem overdone. Let's take a closer look.\n1. Alibaba\nThursday should've been a big day for China's online retailers. It's Singles' Day! Alibaba created the shopping holiday that takes place every year on Nov. 11 -- called Singles' Day because of the 11/11 date -- but it has since been widely adopted by smaller e-tailers.\nSingles' Day is hitting different this year. China's government push for \"common prosperity\" finds it unfashionable to tout commerce and consumption. Alibaba is highly unlikely to match the $74 billion it rang up in sales during last year's \"Double 11\" celebration.\nAlibaba enters Singles' Day trading 49% below the all-time high it hit late last year. Investors have steered clear of China's growth stocks in the wake of the government's crackdown on several industries, but the real bargain for Singles' Day could be shares of Alibaba itself. It has grown revenue by at least 32% every year over the past decade. Even now as Alibaba grapples with the COVID-19 crisis and the country's common prosperity objectives, trailing revenue has climbed 40%.\n2. Zoom Video\nThe rise and fall of Zoom Video is well known. The videoconferencing platform skyrocketed in popularity during the early months of the pandemic when in-person classes, work meetings, and gatherings of friends and family weren't safe. Now that we're largely vaccinated and case counts are lower is there really a future for Zoom?\nThe market seems to think that the future will be bleak. Like Alibaba, shares of Zoom peaked 13 months ago. Zoom stock has plummeted 57% since that high. The twist here is that Zoom is still growing. Revenue rose 54% inits latest quarter. Sure, revenue is decelerating. We're not going to return to the triple-digit top-line growth that Zoom posted in each of the five previous quarterly reports.\nHowever, Zoom is still growing in the recovery climate. Video meetings will continue to be a cost-effective way to gather and get things done. Zoom is fleshing out its offerings, and a recently fumbled acquisition attempt won't stop the evolutionary process. There was a crazy time last year when Zoom was trading for more than 100 times trailing revenue. The one-two punch of heady sales growth and the cascading stock price finds that multiple whittled down to just 20 right now.\n3. Pinterest\nA year ago we were leaning on Pinterest to get crafty. The visual discovery engine was a valuable resource for recipes, decorating tips, and daydreaming about destinations we wanted to visit once we were able to safely travel after the pandemic.\nEverything was going swimmingly for Pinterest until we were cool to toss out our sourdough starter and head outside to eat someone else's bread. Pinterest has now stunned investors with back-to-back sequential declines in active users. The stock has plummeted 49% from February's peak.\nLast month PayPal Holdings was reportedly negotiating to buy Pinterest in a largely stock deal that would value Pinterest at$70 a share. Pinterest investors who were cocky about holding out for more would love a chance to get back there, as the stock has fallen sharply since the proposed combination came undone. Pinterest would have to appreciate by 53% to get to $70 now.\nPayPal stock sold off on the initial chatter, but it continues to fall even now that a deal is not on the table. It probably won't come back on bended knee now that both stocks are out of favor, but Pinterest still has a vibrant platform with improving monetization. Revenue is still growing as advertisers flock its marketing opportunities to reach the lucrative Pinterest audience.\nAlibaba, Zoom, and Pinterest are still thrivinggrowth stocks. The shares just happen to be trading between 49% and 57% off their all-time highs. You don't need to wait for the market crash to happen to pick up bargains. They're out there now.","news_type":1},"isVote":1,"tweetType":1,"viewCount":211,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846254346,"gmtCreate":1636089279318,"gmtModify":1636089288601,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Stay sideline first, thanks 😊&nbsp;","listText":"Stay sideline first, thanks 😊&nbsp;","text":"Stay sideline first, thanks 😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846254346","repostId":"2180989791","repostType":4,"repost":{"id":"2180989791","kind":"highlight","pubTimestamp":1636084560,"share":"https://www.laohu8.com/m/news/2180989791?lang=&edition=full","pubTime":"2021-11-05 11:56","market":"us","language":"en","title":"2 Biotech Companies That Might Be on Pfizer's Radar Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2180989791","media":"Motley Fool","summary":"These two small-cap cancer companies would be a perfect fit for Pfizer.","content":"<p><b>Pfizer</b> (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its <b>BioNTech</b>-partnered COVID-19 vaccine. While explosive revenue growth is always a good thing, Pfizer is now tasked with finding a way to keep its top line headed in the right direction over the long haul. The issue at hand is that the drugmaker's COVID-19 vaccine sales have probably already peaked. Wall Street, in fact, expects Pfizer's top line to drop by a hefty 11% next year as a direct result of declining coronavirus vaccine sales.</p>\n<p>What's more, the drugmaker will have to contend with the upcoming patent expiration for its <b>Bristol Myers Squibb</b>-partnered blood thinner Eliquis in the second half of the current decade. That's a big deal. Eliquis generated a noteworthy $1.35 billion in revenue in the third quarter alone. Pfizer has <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the better pipelines in the industry, but it doesn't sport any assets capable of offsetting rapidly falling sales for two mega-blockbuster products within a few short years of one another.</p>\n<p>The good news is that Pfizer's cash position should exceed $30 billion by year's end. The company thus has sufficient firepower to execute multiple mergers and acquisitions (M&amp;A) to address this issue. As a matter of fact, the pharma titan has seemingly already told Wall Street that it plans on being active on the M&amp;A front in the near future. During its recent third-quarter conference call, for example, Pfizer's chief business and innovation officer Aamir Malik had this to say about the company's business development strategy:</p>\n<blockquote>\n We see business development, frankly, as a very important part of our strategy, and we plan to be very active in dealmaking. Specifically, we are gonna be interested in compelling later-stage assets that can contribute positively to the top-line growth in the back half of the decade.\n</blockquote>\n<blockquote>\n And we're also gonna be interested in accessing medical breakthroughs that are in earlier stages of development. And we, frankly, see focusing in these areas as being much more value-creating than synergy-driven deals that require lots of resource-intensive integrations that can take a long time to complete. Obviously, we don't speak in absolutes, and we never say never. But right now, our focus will be, as I described, on compelling later-stage assets and earlier-stage medical breakthroughs in biopharma.\n</blockquote>\n<h2>Which biotechs might be on Pfizer's wishlist?</h2>\n<p>Biopharma acquisitions are notoriously hard to predict. But Pfizer does have a well-known interest in acquiring early-stage cancer assets, especially from companies with novel platforms. Which cutting-edge oncology companies make sense as a takeover target for the pharma giant? The following two names would dovetail nicely with the company's top-notch oncology portfolio.</p>\n<ol>\n <li><b> Adaptimmune Therapeutics</b> (NASDAQ:ADAP) is a U.K. based anti-cancer cell therapy company. The biotech's main attraction as a potential takeover target is its unique lineup of genetically modified T-cell therapies for solid tumors. Cellular immunotherapy has fallen out of favor with investors of late due to a combination of slower-than-expected commercial ramp ups for the leaders in the space, as well as some high-profile clinical flops. As a result, Adaptimmune's market cap currently stands at a meager $853 million at the time of writing. Pfizer might consider this small-cap oncology company because its platform has the potential to become a best-in-class approach for a host of solid tumors. Moreover, it could probably be bought out for less than $3 billion. The clear-cut problem with this hypothetical deal is that Adaptimmune already has multiple big pharma partners, including <b>GlaxoSmithKline</b> and <b>Roche</b>. Any deal would, therefore, have to address these entanglements.</li>\n <li><b>Affimed</b> (NASDAQ:AFMD) is a German cancer immunotherapy company. The biotech's novel approach to cancer treatment centers around so-called \"Innate Cell Engagers\" that are designed to restore a patient's innate immune system function. Affimed's lead product candidate, AFM13, is presently in a potentially pivotal trial as a monotherapy for relapsed/refractory peripheral T-cell lymphoma. Later down the line, the German biotech also has trials underway to evaluate its unique anti-cancer platform in combination with natural killer cells and checkpoint inhibitor therapies. With a market cap of $840 million, Pfizer could probably add this intriguing immunotherapy company to its lineup for about $2 billion.</li>\n</ol>\n<h2>Should investors buy these speculative buyout targets?</h2>\n<p>It is never a good idea to buy a biotech stock solely for its appeal as a takeover candidate. Adaptimmune and Affimed, though, both sport extremely attractive valuations at the moment. Moreover, each of these tiny biopharmas has the pieces in place to produce important new therapies in the fight against cancer. So while speculative in nature, aggressive investors might want to consider buying these two cancer stocks for their potential as both a buyout target and their stellar organic growth prospects.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Biotech Companies That Might Be on Pfizer's Radar Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Biotech Companies That Might Be on Pfizer's Radar Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 11:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its BioNTech-partnered COVID-19 vaccine. While explosive revenue growth is always ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","ADAP":"Adaptimmune Therapeutics plc","AFMD":"Affimed NV"},"source_url":"https://www.fool.com/investing/2021/11/04/2-biotech-companies-that-might-be-on-pfizers-radar/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2180989791","content_text":"Pfizer (NYSE:PFE) has a unique problem. The company's annual revenue haul was upped in a big way this year, thanks to its BioNTech-partnered COVID-19 vaccine. While explosive revenue growth is always a good thing, Pfizer is now tasked with finding a way to keep its top line headed in the right direction over the long haul. The issue at hand is that the drugmaker's COVID-19 vaccine sales have probably already peaked. Wall Street, in fact, expects Pfizer's top line to drop by a hefty 11% next year as a direct result of declining coronavirus vaccine sales.\nWhat's more, the drugmaker will have to contend with the upcoming patent expiration for its Bristol Myers Squibb-partnered blood thinner Eliquis in the second half of the current decade. That's a big deal. Eliquis generated a noteworthy $1.35 billion in revenue in the third quarter alone. Pfizer has one of the better pipelines in the industry, but it doesn't sport any assets capable of offsetting rapidly falling sales for two mega-blockbuster products within a few short years of one another.\nThe good news is that Pfizer's cash position should exceed $30 billion by year's end. The company thus has sufficient firepower to execute multiple mergers and acquisitions (M&A) to address this issue. As a matter of fact, the pharma titan has seemingly already told Wall Street that it plans on being active on the M&A front in the near future. During its recent third-quarter conference call, for example, Pfizer's chief business and innovation officer Aamir Malik had this to say about the company's business development strategy:\n\n We see business development, frankly, as a very important part of our strategy, and we plan to be very active in dealmaking. Specifically, we are gonna be interested in compelling later-stage assets that can contribute positively to the top-line growth in the back half of the decade.\n\n\n And we're also gonna be interested in accessing medical breakthroughs that are in earlier stages of development. And we, frankly, see focusing in these areas as being much more value-creating than synergy-driven deals that require lots of resource-intensive integrations that can take a long time to complete. Obviously, we don't speak in absolutes, and we never say never. But right now, our focus will be, as I described, on compelling later-stage assets and earlier-stage medical breakthroughs in biopharma.\n\nWhich biotechs might be on Pfizer's wishlist?\nBiopharma acquisitions are notoriously hard to predict. But Pfizer does have a well-known interest in acquiring early-stage cancer assets, especially from companies with novel platforms. Which cutting-edge oncology companies make sense as a takeover target for the pharma giant? The following two names would dovetail nicely with the company's top-notch oncology portfolio.\n\n Adaptimmune Therapeutics (NASDAQ:ADAP) is a U.K. based anti-cancer cell therapy company. The biotech's main attraction as a potential takeover target is its unique lineup of genetically modified T-cell therapies for solid tumors. Cellular immunotherapy has fallen out of favor with investors of late due to a combination of slower-than-expected commercial ramp ups for the leaders in the space, as well as some high-profile clinical flops. As a result, Adaptimmune's market cap currently stands at a meager $853 million at the time of writing. Pfizer might consider this small-cap oncology company because its platform has the potential to become a best-in-class approach for a host of solid tumors. Moreover, it could probably be bought out for less than $3 billion. The clear-cut problem with this hypothetical deal is that Adaptimmune already has multiple big pharma partners, including GlaxoSmithKline and Roche. Any deal would, therefore, have to address these entanglements.\nAffimed (NASDAQ:AFMD) is a German cancer immunotherapy company. The biotech's novel approach to cancer treatment centers around so-called \"Innate Cell Engagers\" that are designed to restore a patient's innate immune system function. Affimed's lead product candidate, AFM13, is presently in a potentially pivotal trial as a monotherapy for relapsed/refractory peripheral T-cell lymphoma. Later down the line, the German biotech also has trials underway to evaluate its unique anti-cancer platform in combination with natural killer cells and checkpoint inhibitor therapies. With a market cap of $840 million, Pfizer could probably add this intriguing immunotherapy company to its lineup for about $2 billion.\n\nShould investors buy these speculative buyout targets?\nIt is never a good idea to buy a biotech stock solely for its appeal as a takeover candidate. Adaptimmune and Affimed, though, both sport extremely attractive valuations at the moment. Moreover, each of these tiny biopharmas has the pieces in place to produce important new therapies in the fight against cancer. So while speculative in nature, aggressive investors might want to consider buying these two cancer stocks for their potential as both a buyout target and their stellar organic growth prospects.","news_type":1},"isVote":1,"tweetType":1,"viewCount":400,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":187556422,"gmtCreate":1623760082066,"gmtModify":1634028852306,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Yess&nbsp;","listText":"Yess&nbsp;","text":"Yess","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/187556422","repostId":"1127660571","repostType":4,"repost":{"id":"1127660571","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623760680,"share":"https://www.laohu8.com/m/news/1127660571?lang=&edition=full","pubTime":"2021-06-15 20:38","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1127660571","media":"Tiger Newspress","summary":"Stock futures edge up ahead of retail sales data.\nS&P 500 index is headed toward its 30th record clo","content":"<ul>\n <li>Stock futures edge up ahead of retail sales data.</li>\n <li>S&amp;P 500 index is headed toward its 30th record close of the year, bolstered by gains in tech stocks.</li>\n <li><b>Increase in in PPI over past 12 months rises to 6.6% from 6.2%.</b></li>\n <li><b>U.S. retail sales minus gas and autos fall 0.8% in May.</b></li>\n <li><b>U.S. retail sales minus gas and autos fall 0.8% in May.</b></li>\n</ul>\n<p>(June 15)&nbsp;<b>Producer prices climb 6.6% in May on annual basis, largest 12-month increase on record.</b>&nbsp;Producer prices rose at their fastest annual clip in nearly 11 years in May as inflation continued to build in the U.S. economy, the Labor Department reported Tuesday.</p>\n<p>On a monthly basis, the producer price index for final demand rose 0.8%, ahead of the Dow Jones estimate of 0.6%.</p>\n<p><b>Stock&nbsp;Market</b></p>\n<p>U.S. stock futures edged higher Tuesday ahead of fresh data that will indicate how much Americans spent in stores, at restaurants and online last month.</p>\n<p>Futures tied to the S&amp;P 500 ticked up 0.1%, indicating that the broad benchmark index is on track to notch its thirtieth record close of the year. Nasdaq-100 futures gained 0.2%, pointing togains in technology stocksafter the opening bell.</p>\n<p>At 8:38&nbsp;a.m. ET, Dow e-minis were up 18 points, or 0.05%, S&amp;P 500 e-minis were up 5.5 points, or 0.13%, and Nasdaq 100 e-minis were up 24.75 points, or 0.18%.</p>\n<p><img src=\"https://static.tigerbbs.com/86af5e5e5e4faf68b304fa020ca3a033\" tg-width=\"1242\" tg-height=\"487\"></p>\n<p>Investors expect that stocks will climb through the rest of the year due to easy monetary policies. Many people are also betting thathigher inflation, due to the easing of economic restrictions and supply-chain bottlenecks, will be temporary. Signs that inflation will be elevated for a prolonged period or that theFederal Reserve may retrace its supportcould shake that confidence, money managers said.</p>\n<p><b>Stocks making the biggest moves in the premarket: Vroom, Ping Identity, Sage Therapeutics &amp; more</b></p>\n<p><b>1)&nbsp;Vroom(VRM)</b> – Vroom intends to offer $500 million in convertible senior notes due in 2026. The used-vehicle e-commerce platform provider plans to use the proceeds for a variety of corporate purposes as well as investing in or acquiring new technologies. Its shares slid 6.1% in premarket trading.</p>\n<p><b>2)&nbsp;Ping Identity(PING) </b>– Ping Identity announced a 6 million share common stock offering, in a sale of shares held by investment funds affiliated with Vista Equity Partners. The identity management solutions company will not receive any proceeds from the offering. The stock tumbled 4.2% in premarket action.</p>\n<p><b>3)&nbsp;Sage Therapeutics(SAGE)</b> – The drugmaker’s shares tanked 17.5% in premarket trading following the release of study results for Sage’s experimental depression drug. The treatment resulted in a statistically significant improvement in symptoms, although it could take up to six weeks to be effective and treatment may be required for months.</p>\n<p><b>4)&nbsp;Boeing(BA) </b>– The U.S. and European Union announced aresolution of the long-standing disputeover aircraft subsidies involving Boeing and European rival Airbus. The deal suspends World Trade Organization-authorized tariffs for five years, and U.S. Trade Representative Katherine Tai said it could serve as a model for resolving future disputes.</p>\n<p><b>5)&nbsp;Exxon Mobil(XOM) </b>– Bank of America reiterated a “buy” rating on the energy giant’s stock, predicting that Exxon Mobil would hike its dividend before the end of the year following cost-cutting measures and a rebound in oil prices.</p>\n<p><b>6)&nbsp;Spirit Airlines(SAVE)</b> – Spirit Airlines said in a Securities and Exchange Commission filing that leisure demand has continued to improve throughout the second quarter, and that it has seen operating yields strengthen as well. Citi upgraded the stock to “buy” from “neutral” following that update, and shares rallied 2.6% in the premarket.</p>\n<p><b>7)&nbsp;Fastenal(FAST)</b> – The maker of industrial and construction supplies was downgraded to “underweight” from “equal-weight” at Morgan Stanley, which notes a lull in customer acquisition as well as a stock that is already near an all-time high. The stock slid 2.2% in the premarket.</p>\n<p><b>8)&nbsp;AstraZeneca(AZN) </b>– AstraZeneca said an experimental monoclonal antibody treatment did not meet its main goal of preventing Covid-19 in patients who had been exposed to the virus. The company also said, however, that its Covid-19 vaccine is 92% effective against the so-called “Delta” variant of the virus.</p>\n<p><b>9)&nbsp;Cracker Barrel(CBRL)</b> – Cracker Barrel announced a $275 million private offering of convertible senior notes due in 2026. The restaurant chain will use the proceeds to pay debt and for general corporate purposes.</p>\n<p><b>10)&nbsp;Novavax(NVAX)</b> – Novavax announced positive results from its first study of its Covid-19 vaccine and a flu vaccine administered simultaneously. The study suggested that simultaneous vaccination may be a viable strategy.</p>\n<p><b>11)&nbsp;Intuit(INTU)</b> – The financial software company revealed in an SEC filing that its QuickBooks online service saw new customer acquisition grow by more than 25% year-over-year for the nine months ended April 30. Intuit shares had hit an all-time high in Monday’s trading.</p>\n<p><b>12)&nbsp;Vimeo(VMEO)</b> – Vimeo reported that total revenue in May rose 42% from a year ago, with the video services company also seeing average revenue per user up 18%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-15 20:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Stock futures edge up ahead of retail sales data.</li>\n <li>S&amp;P 500 index is headed toward its 30th record close of the year, bolstered by gains in tech stocks.</li>\n <li><b>Increase in in PPI over past 12 months rises to 6.6% from 6.2%.</b></li>\n <li><b>U.S. retail sales minus gas and autos fall 0.8% in May.</b></li>\n <li><b>U.S. retail sales minus gas and autos fall 0.8% in May.</b></li>\n</ul>\n<p>(June 15)&nbsp;<b>Producer prices climb 6.6% in May on annual basis, largest 12-month increase on record.</b>&nbsp;Producer prices rose at their fastest annual clip in nearly 11 years in May as inflation continued to build in the U.S. economy, the Labor Department reported Tuesday.</p>\n<p>On a monthly basis, the producer price index for final demand rose 0.8%, ahead of the Dow Jones estimate of 0.6%.</p>\n<p><b>Stock&nbsp;Market</b></p>\n<p>U.S. stock futures edged higher Tuesday ahead of fresh data that will indicate how much Americans spent in stores, at restaurants and online last month.</p>\n<p>Futures tied to the S&amp;P 500 ticked up 0.1%, indicating that the broad benchmark index is on track to notch its thirtieth record close of the year. Nasdaq-100 futures gained 0.2%, pointing togains in technology stocksafter the opening bell.</p>\n<p>At 8:38&nbsp;a.m. ET, Dow e-minis were up 18 points, or 0.05%, S&amp;P 500 e-minis were up 5.5 points, or 0.13%, and Nasdaq 100 e-minis were up 24.75 points, or 0.18%.</p>\n<p><img src=\"https://static.tigerbbs.com/86af5e5e5e4faf68b304fa020ca3a033\" tg-width=\"1242\" tg-height=\"487\"></p>\n<p>Investors expect that stocks will climb through the rest of the year due to easy monetary policies. Many people are also betting thathigher inflation, due to the easing of economic restrictions and supply-chain bottlenecks, will be temporary. Signs that inflation will be elevated for a prolonged period or that theFederal Reserve may retrace its supportcould shake that confidence, money managers said.</p>\n<p><b>Stocks making the biggest moves in the premarket: Vroom, Ping Identity, Sage Therapeutics &amp; more</b></p>\n<p><b>1)&nbsp;Vroom(VRM)</b> – Vroom intends to offer $500 million in convertible senior notes due in 2026. The used-vehicle e-commerce platform provider plans to use the proceeds for a variety of corporate purposes as well as investing in or acquiring new technologies. Its shares slid 6.1% in premarket trading.</p>\n<p><b>2)&nbsp;Ping Identity(PING) </b>– Ping Identity announced a 6 million share common stock offering, in a sale of shares held by investment funds affiliated with Vista Equity Partners. The identity management solutions company will not receive any proceeds from the offering. The stock tumbled 4.2% in premarket action.</p>\n<p><b>3)&nbsp;Sage Therapeutics(SAGE)</b> – The drugmaker’s shares tanked 17.5% in premarket trading following the release of study results for Sage’s experimental depression drug. The treatment resulted in a statistically significant improvement in symptoms, although it could take up to six weeks to be effective and treatment may be required for months.</p>\n<p><b>4)&nbsp;Boeing(BA) </b>– The U.S. and European Union announced aresolution of the long-standing disputeover aircraft subsidies involving Boeing and European rival Airbus. The deal suspends World Trade Organization-authorized tariffs for five years, and U.S. Trade Representative Katherine Tai said it could serve as a model for resolving future disputes.</p>\n<p><b>5)&nbsp;Exxon Mobil(XOM) </b>– Bank of America reiterated a “buy” rating on the energy giant’s stock, predicting that Exxon Mobil would hike its dividend before the end of the year following cost-cutting measures and a rebound in oil prices.</p>\n<p><b>6)&nbsp;Spirit Airlines(SAVE)</b> – Spirit Airlines said in a Securities and Exchange Commission filing that leisure demand has continued to improve throughout the second quarter, and that it has seen operating yields strengthen as well. Citi upgraded the stock to “buy” from “neutral” following that update, and shares rallied 2.6% in the premarket.</p>\n<p><b>7)&nbsp;Fastenal(FAST)</b> – The maker of industrial and construction supplies was downgraded to “underweight” from “equal-weight” at Morgan Stanley, which notes a lull in customer acquisition as well as a stock that is already near an all-time high. The stock slid 2.2% in the premarket.</p>\n<p><b>8)&nbsp;AstraZeneca(AZN) </b>– AstraZeneca said an experimental monoclonal antibody treatment did not meet its main goal of preventing Covid-19 in patients who had been exposed to the virus. The company also said, however, that its Covid-19 vaccine is 92% effective against the so-called “Delta” variant of the virus.</p>\n<p><b>9)&nbsp;Cracker Barrel(CBRL)</b> – Cracker Barrel announced a $275 million private offering of convertible senior notes due in 2026. The restaurant chain will use the proceeds to pay debt and for general corporate purposes.</p>\n<p><b>10)&nbsp;Novavax(NVAX)</b> – Novavax announced positive results from its first study of its Covid-19 vaccine and a flu vaccine administered simultaneously. The study suggested that simultaneous vaccination may be a viable strategy.</p>\n<p><b>11)&nbsp;Intuit(INTU)</b> – The financial software company revealed in an SEC filing that its QuickBooks online service saw new customer acquisition grow by more than 25% year-over-year for the nine months ended April 30. Intuit shares had hit an all-time high in Monday’s trading.</p>\n<p><b>12)&nbsp;Vimeo(VMEO)</b> – Vimeo reported that total revenue in May rose 42% from a year ago, with the video services company also seeing average revenue per user up 18%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127660571","content_text":"Stock futures edge up ahead of retail sales data.\nS&P 500 index is headed toward its 30th record close of the year, bolstered by gains in tech stocks.\nIncrease in in PPI over past 12 months rises to 6.6% from 6.2%.\nU.S. retail sales minus gas and autos fall 0.8% in May.\nU.S. retail sales minus gas and autos fall 0.8% in May.\n\n(June 15) Producer prices climb 6.6% in May on annual basis, largest 12-month increase on record. Producer prices rose at their fastest annual clip in nearly 11 years in May as inflation continued to build in the U.S. economy, the Labor Department reported Tuesday.\nOn a monthly basis, the producer price index for final demand rose 0.8%, ahead of the Dow Jones estimate of 0.6%.\nStock Market\nU.S. stock futures edged higher Tuesday ahead of fresh data that will indicate how much Americans spent in stores, at restaurants and online last month.\nFutures tied to the S&P 500 ticked up 0.1%, indicating that the broad benchmark index is on track to notch its thirtieth record close of the year. Nasdaq-100 futures gained 0.2%, pointing togains in technology stocksafter the opening bell.\nAt 8:38 a.m. ET, Dow e-minis were up 18 points, or 0.05%, S&P 500 e-minis were up 5.5 points, or 0.13%, and Nasdaq 100 e-minis were up 24.75 points, or 0.18%.\n\nInvestors expect that stocks will climb through the rest of the year due to easy monetary policies. Many people are also betting thathigher inflation, due to the easing of economic restrictions and supply-chain bottlenecks, will be temporary. Signs that inflation will be elevated for a prolonged period or that theFederal Reserve may retrace its supportcould shake that confidence, money managers said.\nStocks making the biggest moves in the premarket: Vroom, Ping Identity, Sage Therapeutics & more\n1) Vroom(VRM) – Vroom intends to offer $500 million in convertible senior notes due in 2026. The used-vehicle e-commerce platform provider plans to use the proceeds for a variety of corporate purposes as well as investing in or acquiring new technologies. Its shares slid 6.1% in premarket trading.\n2) Ping Identity(PING) – Ping Identity announced a 6 million share common stock offering, in a sale of shares held by investment funds affiliated with Vista Equity Partners. The identity management solutions company will not receive any proceeds from the offering. The stock tumbled 4.2% in premarket action.\n3) Sage Therapeutics(SAGE) – The drugmaker’s shares tanked 17.5% in premarket trading following the release of study results for Sage’s experimental depression drug. The treatment resulted in a statistically significant improvement in symptoms, although it could take up to six weeks to be effective and treatment may be required for months.\n4) Boeing(BA) – The U.S. and European Union announced aresolution of the long-standing disputeover aircraft subsidies involving Boeing and European rival Airbus. The deal suspends World Trade Organization-authorized tariffs for five years, and U.S. Trade Representative Katherine Tai said it could serve as a model for resolving future disputes.\n5) Exxon Mobil(XOM) – Bank of America reiterated a “buy” rating on the energy giant’s stock, predicting that Exxon Mobil would hike its dividend before the end of the year following cost-cutting measures and a rebound in oil prices.\n6) Spirit Airlines(SAVE) – Spirit Airlines said in a Securities and Exchange Commission filing that leisure demand has continued to improve throughout the second quarter, and that it has seen operating yields strengthen as well. Citi upgraded the stock to “buy” from “neutral” following that update, and shares rallied 2.6% in the premarket.\n7) Fastenal(FAST) – The maker of industrial and construction supplies was downgraded to “underweight” from “equal-weight” at Morgan Stanley, which notes a lull in customer acquisition as well as a stock that is already near an all-time high. The stock slid 2.2% in the premarket.\n8) AstraZeneca(AZN) – AstraZeneca said an experimental monoclonal antibody treatment did not meet its main goal of preventing Covid-19 in patients who had been exposed to the virus. The company also said, however, that its Covid-19 vaccine is 92% effective against the so-called “Delta” variant of the virus.\n9) Cracker Barrel(CBRL) – Cracker Barrel announced a $275 million private offering of convertible senior notes due in 2026. The restaurant chain will use the proceeds to pay debt and for general corporate purposes.\n10) Novavax(NVAX) – Novavax announced positive results from its first study of its Covid-19 vaccine and a flu vaccine administered simultaneously. The study suggested that simultaneous vaccination may be a viable strategy.\n11) Intuit(INTU) – The financial software company revealed in an SEC filing that its QuickBooks online service saw new customer acquisition grow by more than 25% year-over-year for the nine months ended April 30. Intuit shares had hit an all-time high in Monday’s trading.\n12) Vimeo(VMEO) – Vimeo reported that total revenue in May rose 42% from a year ago, with the video services company also seeing average revenue per user up 18%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":856998912,"gmtCreate":1635137685947,"gmtModify":1635142161183,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Pump n dump, do not get trap. Stay away if you can&nbsp;","listText":"Pump n dump, do not get trap. Stay away if you can&nbsp;","text":"Pump n dump, do not get trap. Stay away if you can","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/856998912","repostId":"1163651002","repostType":4,"repost":{"id":"1163651002","kind":"news","pubTimestamp":1635131314,"share":"https://www.laohu8.com/m/news/1163651002?lang=&edition=full","pubTime":"2021-10-25 11:08","market":"us","language":"en","title":"DWAC Stock: Will Trump's Social Media SPAC Climb Or Crash?","url":"https://stock-news.laohu8.com/highlight/detail?id=1163651002","media":"Seeking Alpha","summary":"Summary\n\nSentiment and Blue Sky potential are driving DWAC’s share price, and sentiment is a pretty ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Sentiment and Blue Sky potential are driving DWAC’s share price, and sentiment is a pretty poor factor for forecasting long-term performance. But during a cycle of herd intensity, it has the potential to rocket a stock. Even George Soros would partake, \"When I see a bubble forming, I rush in to buy, adding fuel to the fire\".</li>\n <li>Here is a list of Meme and SPAC stocks on our Portfolio Tool to show performance. We also offer stocks screened by Seeking Alpha for solid fundamentals and quant scores.</li>\n <li>DWAC and most other Meme stocks and SPACs are very risky: They are being driven not by fundamentals or quantitative metrics but by short-term (daily) sentiment.</li>\n <li>If you want to rest easy, with a time horizon beyond one trading day, our Top Stocks screen gives you stocks with excellent fundamentals and quantitative metrics.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cebc5414201caea2c9c2b05ad14b22e8\" tg-width=\"1536\" tg-height=\"1025\" width=\"100%\" height=\"auto\"><span>Gearstd/iStock via Getty Images</span></p>\n<p>The newest flavor of the month is hot stock Digital World Acquisition Corp. (DWAC), the SPAC merging with Donald Trump's new and public social-media platform. Established via Special Purpose Acquisition Company (SPAC), a buying frenzy has taken DWAC from $10/share to over $130/share, following a deal announced on October 20, 2021. Trump Media &amp; Technology Group will combine with DWAC to launch a new social network called TRUTH Social, a deal valuing the media company at approximately $875 million.</p>\n<p>DWAC lacks fundamentals because it has no revenues or earnings - like all SPACs, it is a shell company established to raise capital through IPO. Like meme stocks, SPACs thrive on investor craze and are often driven by FOMO (fear of missing out). It is a real thing! So, as the Head of Quantitative Strategy at Seeking Alpha, sentiment is certainly among the data points I monitor.</p>\n<p>For those of us who are inclined towards long-term investing, however, sentiment is a pretty poor predictor of long-term price performance. Fundamentals do matter. And from a valuation perspective, SPACs - like meme stocks - are risky investments. The difference is meme stocks are viewed as emerging growth stocks from dying industries, but at least they have a track record, history, and fundamentals. SPACs are not profitable on the opposite end because they are newly formed and have no operating history. But SPACs are all the craze because they are new and forward-thinking companies establishing cutting-edge offerings, businesses, and business models.</p>\n<p>Many SPACs form without an underlying company. They are private equity-backed IPOs that can circumvent the traditional IPO process in a low-cost expedited fashion and require less syndication from investment banks; they tend to ride the wave of more of a high-flying IPO than meme stocks. Once a SPAC prices its stock, they typically list at $10, as evidenced by DWAC.</p>\n<p>Many investors believe all meme stocks and SPACs will go to the moon when they actually follow the trajectory of a recent flight to space conducted by a former SPAC, Virgin Galactic (SPCE), which only lasted about 12 minutes. SPACs may have their day in the sun now; they're usually short-lived! It's a cautionary tale of why sentiment, and the stock momentum it produces, need to be balanced with other factors of long-term performance: value, growth, profitability, and analyst estimates. This is the lens we'll apply to meme stocks and SPACs in this article, to fairly gauge the opportunities here.</p>\n<p><b>Meme and SPAC Stocks: Speculative Euphoria and Emotion as Drivers?</b></p>\n<p>Any investor or trader in a stock driven by strong sentiment needs to know it is a gamble and that the risk is high. Many years ago, the economist Hyman Minsky proposed a theory that suggests that stability is destabilizing. During economically prosperous times, there's a state of speculative euphoria that spreads through groups of investors. After taking profits, they create their seeds of destruction by risk-taking, creating financial instability or panic and crisis.</p>\n<p>Nevertheless, people always say this time is different. Hence, sentiment and herding remain one amazing driver of stock price performance. Many of the Meme and SPAC stocks listed below were driven by emotion at some point. Should individuals choose to invest in any of the stocks, they need to recognize it is a bet similar to that made in a casino.</p>\n<p>Investors that want to rest easy, and desire a time horizon beyond a single trading day, can find stocks with excellent fundamentals and quantitative metrics on our&nbsp;Top Stocks By Quant screen. The screen is updated every day and is grounded in the recommendations of SA Quantitative metrics. Our Very Bullish Quant recommendations are up YTD 46.81% compared with the S&amp;P 500, up 24.29%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7aad11ced9409e3a7ed2ebc491436d03\" tg-width=\"1243\" tg-height=\"419\" width=\"100%\" height=\"auto\"><span>Source: S&amp;P Cap IQ and Seeking Alpha.</span></p>\n<p>Sentiment can be viewed as a single financial factor. Sometimes single factors work great - until they don't. The \"don't\" is one of the reasons we use a multi-faceted and multi-factor approach to our quantitative algorithms. Years of experience managing money for a hedge fund and a proprietary trading desk have taught me that putting all your eggs into a single investment theme is very dangerous over a long period. We do not want to get pigeonholed when investors' irrational exuberance for the month's factor turns into fervor for another element. When the investment cycle on a factor turns, investors can take a beating.</p>\n<p>Instead of focusing on a single metric, sentiment, we blend investment metrics based on value, growth, profitability, earnings, and momentum. This balanced approach has worked very well over the long term, as seen in the graph below.</p>\n<p>Below is a table of 15 meme stocks and 15 SPACs showing how much they have traded off from peak sentiment levels. While euphoria and huge gains may draw in investors, the table below depicts that with meme stocks comes volatility and huge gains quickly wiped out.</p>\n<p><b>Meme Stocks Fall Hard From Highs</b></p>\n<p><img src=\"https://static.tigerbbs.com/4af3892ec5e74d87bb7dd3c0de4b7e44\" tg-width=\"564\" tg-height=\"462\" width=\"100%\" height=\"auto\"></p>\n<p>Meme stocks do not offer strong growth, and the valuation framework is weak. While their prices may appeal to investors, these beaten-down stocks have negative fundamentals. The pump-and-dump price manipulation has taught many investors to invest in stocks with the best investment characteristics of growth, profitability, value, momentum, and rising analysts' earnings estimates.</p>\n<p><b>SA Ratings And Grades On Meme Stocks</b></p>\n<p><img src=\"https://static.tigerbbs.com/851d36762e10cca05279e8484a0a8ce1\" tg-width=\"919\" tg-height=\"400\" width=\"100%\" height=\"auto\"></p>\n<p>As we witnessed earlier in the year, SPAC mania took a plunge. When prices skyrocket quicker than the fundamentals can explain, investors get nervous. David Solomon, Chief Executive of major SPAC underwriter Goldman Sachs,warned&nbsp;earlier this year that the boom is not \"sustainable in the medium term.\" If you don't believe it, Here's a look at several SPAC stocks off from their 52-week highs.</p>\n<p><b>Will Trump SPAC Shares Decline As Others Have Fallen?</b></p>\n<p><img src=\"https://static.tigerbbs.com/d8737c7addf0e931ffa04721b2975aa1\" tg-width=\"560\" tg-height=\"634\" width=\"100%\" height=\"auto\"></p>\n<p><b>Seeking Alpha's Quant Ratings and Factor Grades</b></p>\n<p>Seeking Alpha's Quant Ratings Factor Grades provide investors with an instant characterization of each stock. This makes it easy to find or rule out stocks based on your investment criteria. Below is an example of how the Quant Factor Grades, overall rating, and Quant Ranking within the relevant sector are displayed.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0d22400aa5cbc0df5d4f442f4e04cc4b\" tg-width=\"333\" tg-height=\"749\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha Premium</span></p>\n<p>Top Rated Stocks by Quant&nbsp;look strong and are recommended by our Quant team, Seeking Alpha Authors, and Wall Street and have good grades on fundamental factors. With a proven backtested track record, our Quant Ratings, which refresh daily, beat the market. The suggestions below are derived from a model that selects very bullish quant recommendations from a sophisticated trading algorithm. As shown above, from January 4, 2010, to June 30, 2021, our very bullish Quant Stocks have beaten the S&amp;P 500 index by 1755% vs. 379%.</p>\n<p><b>SA Top Rated Stocks By Quant</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7288ef171ab528f0303f43f71fe38a95\" tg-width=\"1204\" tg-height=\"690\" width=\"100%\" height=\"auto\"><span>Source: Seeking Alpha</span></p>\n<p><b>Conclusion: Volatility vs. Upside</b></p>\n<p>Meme stocks and SPACs are risky and prone to wild and volatile swings centered around rumors and social media message boards like Reddit and Twitter. Primarily traded by retail investors looking for a quick trade, there's little regard for quant grades, investment metrics, or a company's fundamentals. The only real commonality is the power of retail investors to drive up market prices. When you look at meme stocks this past year, the performance was driven by a combination of retail sentiment sticking it to Wall Street and surmounting an attack against hedge funds shorting said Meme stocks, resulting in a short squeeze, and it is unclear if this is the case with DWAC, Trump's new social media SPAC.</p>\n<p>Whether holding long or short positions with high levels of short interest surrounding securities, investing in those stocks is risky. As I mentioned in a&nbsp;GameStop article&nbsp;earlier this year, \"The risk is so great that many traders will not carry the positions overnight and look to reestablish positions each morning. When investing in these stocks, one of Wall Street's oldest adages comes to mind. Bulls can make money. Bears can make money. Pigs get slaughtered.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DWAC Stock: Will Trump's Social Media SPAC Climb Or Crash?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDWAC Stock: Will Trump's Social Media SPAC Climb Or Crash?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-25 11:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4461606-dwac-stock-donald-trump-social-media-spac-climb-crash><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nSentiment and Blue Sky potential are driving DWAC’s share price, and sentiment is a pretty poor factor for forecasting long-term performance. But during a cycle of herd intensity, it has the ...</p>\n\n<a href=\"https://seekingalpha.com/article/4461606-dwac-stock-donald-trump-social-media-spac-climb-crash\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/article/4461606-dwac-stock-donald-trump-social-media-spac-climb-crash","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163651002","content_text":"Summary\n\nSentiment and Blue Sky potential are driving DWAC’s share price, and sentiment is a pretty poor factor for forecasting long-term performance. But during a cycle of herd intensity, it has the potential to rocket a stock. Even George Soros would partake, \"When I see a bubble forming, I rush in to buy, adding fuel to the fire\".\nHere is a list of Meme and SPAC stocks on our Portfolio Tool to show performance. We also offer stocks screened by Seeking Alpha for solid fundamentals and quant scores.\nDWAC and most other Meme stocks and SPACs are very risky: They are being driven not by fundamentals or quantitative metrics but by short-term (daily) sentiment.\nIf you want to rest easy, with a time horizon beyond one trading day, our Top Stocks screen gives you stocks with excellent fundamentals and quantitative metrics.\n\nGearstd/iStock via Getty Images\nThe newest flavor of the month is hot stock Digital World Acquisition Corp. (DWAC), the SPAC merging with Donald Trump's new and public social-media platform. Established via Special Purpose Acquisition Company (SPAC), a buying frenzy has taken DWAC from $10/share to over $130/share, following a deal announced on October 20, 2021. Trump Media & Technology Group will combine with DWAC to launch a new social network called TRUTH Social, a deal valuing the media company at approximately $875 million.\nDWAC lacks fundamentals because it has no revenues or earnings - like all SPACs, it is a shell company established to raise capital through IPO. Like meme stocks, SPACs thrive on investor craze and are often driven by FOMO (fear of missing out). It is a real thing! So, as the Head of Quantitative Strategy at Seeking Alpha, sentiment is certainly among the data points I monitor.\nFor those of us who are inclined towards long-term investing, however, sentiment is a pretty poor predictor of long-term price performance. Fundamentals do matter. And from a valuation perspective, SPACs - like meme stocks - are risky investments. The difference is meme stocks are viewed as emerging growth stocks from dying industries, but at least they have a track record, history, and fundamentals. SPACs are not profitable on the opposite end because they are newly formed and have no operating history. But SPACs are all the craze because they are new and forward-thinking companies establishing cutting-edge offerings, businesses, and business models.\nMany SPACs form without an underlying company. They are private equity-backed IPOs that can circumvent the traditional IPO process in a low-cost expedited fashion and require less syndication from investment banks; they tend to ride the wave of more of a high-flying IPO than meme stocks. Once a SPAC prices its stock, they typically list at $10, as evidenced by DWAC.\nMany investors believe all meme stocks and SPACs will go to the moon when they actually follow the trajectory of a recent flight to space conducted by a former SPAC, Virgin Galactic (SPCE), which only lasted about 12 minutes. SPACs may have their day in the sun now; they're usually short-lived! It's a cautionary tale of why sentiment, and the stock momentum it produces, need to be balanced with other factors of long-term performance: value, growth, profitability, and analyst estimates. This is the lens we'll apply to meme stocks and SPACs in this article, to fairly gauge the opportunities here.\nMeme and SPAC Stocks: Speculative Euphoria and Emotion as Drivers?\nAny investor or trader in a stock driven by strong sentiment needs to know it is a gamble and that the risk is high. Many years ago, the economist Hyman Minsky proposed a theory that suggests that stability is destabilizing. During economically prosperous times, there's a state of speculative euphoria that spreads through groups of investors. After taking profits, they create their seeds of destruction by risk-taking, creating financial instability or panic and crisis.\nNevertheless, people always say this time is different. Hence, sentiment and herding remain one amazing driver of stock price performance. Many of the Meme and SPAC stocks listed below were driven by emotion at some point. Should individuals choose to invest in any of the stocks, they need to recognize it is a bet similar to that made in a casino.\nInvestors that want to rest easy, and desire a time horizon beyond a single trading day, can find stocks with excellent fundamentals and quantitative metrics on our Top Stocks By Quant screen. The screen is updated every day and is grounded in the recommendations of SA Quantitative metrics. Our Very Bullish Quant recommendations are up YTD 46.81% compared with the S&P 500, up 24.29%.\nSource: S&P Cap IQ and Seeking Alpha.\nSentiment can be viewed as a single financial factor. Sometimes single factors work great - until they don't. The \"don't\" is one of the reasons we use a multi-faceted and multi-factor approach to our quantitative algorithms. Years of experience managing money for a hedge fund and a proprietary trading desk have taught me that putting all your eggs into a single investment theme is very dangerous over a long period. We do not want to get pigeonholed when investors' irrational exuberance for the month's factor turns into fervor for another element. When the investment cycle on a factor turns, investors can take a beating.\nInstead of focusing on a single metric, sentiment, we blend investment metrics based on value, growth, profitability, earnings, and momentum. This balanced approach has worked very well over the long term, as seen in the graph below.\nBelow is a table of 15 meme stocks and 15 SPACs showing how much they have traded off from peak sentiment levels. While euphoria and huge gains may draw in investors, the table below depicts that with meme stocks comes volatility and huge gains quickly wiped out.\nMeme Stocks Fall Hard From Highs\n\nMeme stocks do not offer strong growth, and the valuation framework is weak. While their prices may appeal to investors, these beaten-down stocks have negative fundamentals. The pump-and-dump price manipulation has taught many investors to invest in stocks with the best investment characteristics of growth, profitability, value, momentum, and rising analysts' earnings estimates.\nSA Ratings And Grades On Meme Stocks\n\nAs we witnessed earlier in the year, SPAC mania took a plunge. When prices skyrocket quicker than the fundamentals can explain, investors get nervous. David Solomon, Chief Executive of major SPAC underwriter Goldman Sachs,warned earlier this year that the boom is not \"sustainable in the medium term.\" If you don't believe it, Here's a look at several SPAC stocks off from their 52-week highs.\nWill Trump SPAC Shares Decline As Others Have Fallen?\n\nSeeking Alpha's Quant Ratings and Factor Grades\nSeeking Alpha's Quant Ratings Factor Grades provide investors with an instant characterization of each stock. This makes it easy to find or rule out stocks based on your investment criteria. Below is an example of how the Quant Factor Grades, overall rating, and Quant Ranking within the relevant sector are displayed.\nSource: Seeking Alpha Premium\nTop Rated Stocks by Quant look strong and are recommended by our Quant team, Seeking Alpha Authors, and Wall Street and have good grades on fundamental factors. With a proven backtested track record, our Quant Ratings, which refresh daily, beat the market. The suggestions below are derived from a model that selects very bullish quant recommendations from a sophisticated trading algorithm. As shown above, from January 4, 2010, to June 30, 2021, our very bullish Quant Stocks have beaten the S&P 500 index by 1755% vs. 379%.\nSA Top Rated Stocks By Quant\nSource: Seeking Alpha\nConclusion: Volatility vs. Upside\nMeme stocks and SPACs are risky and prone to wild and volatile swings centered around rumors and social media message boards like Reddit and Twitter. Primarily traded by retail investors looking for a quick trade, there's little regard for quant grades, investment metrics, or a company's fundamentals. The only real commonality is the power of retail investors to drive up market prices. When you look at meme stocks this past year, the performance was driven by a combination of retail sentiment sticking it to Wall Street and surmounting an attack against hedge funds shorting said Meme stocks, resulting in a short squeeze, and it is unclear if this is the case with DWAC, Trump's new social media SPAC.\nWhether holding long or short positions with high levels of short interest surrounding securities, investing in those stocks is risky. As I mentioned in a GameStop article earlier this year, \"The risk is so great that many traders will not carry the positions overnight and look to reestablish positions each morning. When investing in these stocks, one of Wall Street's oldest adages comes to mind. Bulls can make money. Bears can make money. Pigs get slaughtered.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":170636709,"gmtCreate":1626425495001,"gmtModify":1631893741473,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Keep holding do not sell till 70 min","listText":"Keep holding do not sell till 70 min","text":"Keep holding do not sell till 70 min","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/170636709","repostId":"1119858603","repostType":4,"repost":{"id":"1119858603","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626424612,"share":"https://www.laohu8.com/m/news/1119858603?lang=&edition=full","pubTime":"2021-07-16 16:36","market":"us","language":"en","title":"MEME stocks gains in premarket trading,AMC shares surges more than 5%.","url":"https://stock-news.laohu8.com/highlight/detail?id=1119858603","media":"Tiger Newspress","summary":"MEME stocks gains in premarket trading,AMC shares surges more than 5%,GME shares rises 4.3%.","content":"<p>MEME&nbsp;stocks&nbsp;gains in premarket&nbsp;trading,AMC&nbsp;shares&nbsp;surges&nbsp;more&nbsp;than&nbsp;5%,GME&nbsp;shares&nbsp;rises&nbsp;4.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/211e21d173a4fba3743bf3dd2c9a8744\" tg-width=\"1294\" tg-height=\"608\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEME stocks gains in premarket trading,AMC shares surges more than 5%.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEME stocks gains in premarket trading,AMC shares surges more than 5%.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-16 16:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MEME&nbsp;stocks&nbsp;gains in premarket&nbsp;trading,AMC&nbsp;shares&nbsp;surges&nbsp;more&nbsp;than&nbsp;5%,GME&nbsp;shares&nbsp;rises&nbsp;4.3%.</p>\n<p><img src=\"https://static.tigerbbs.com/211e21d173a4fba3743bf3dd2c9a8744\" tg-width=\"1294\" tg-height=\"608\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119858603","content_text":"MEME stocks gains in premarket trading,AMC shares surges more than 5%,GME shares rises 4.3%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":71,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":820955167,"gmtCreate":1633345298220,"gmtModify":1633345298467,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Conclusion?[Observation]&nbsp;","listText":"Conclusion?[Observation]&nbsp;","text":"Conclusion?[Observation]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820955167","repostId":"1139003361","repostType":4,"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":884311038,"gmtCreate":1631855714324,"gmtModify":1631889868318,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Let’s support and hold till $45 [Happy]&nbsp;","listText":"Let’s support and hold till $45 [Happy]&nbsp;","text":"Let’s support and hold till $45 [Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/884311038","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://www.laohu8.com/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b>&nbsp;is trading higher Thursday morning on above-average volume&nbsp;amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million&nbsp;over a 100-day period. Palantir's daily trading volume was already approaching 30&nbsp;million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects&nbsp;revenue growth of 30% or greater&nbsp;through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b>&nbsp;is trading higher Thursday morning on above-average volume&nbsp;amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million&nbsp;over a 100-day period. Palantir's daily trading volume was already approaching 30&nbsp;million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects&nbsp;revenue growth of 30% or greater&nbsp;through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1},"isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811158882,"gmtCreate":1630300796146,"gmtModify":1704958065136,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/811158882","repostId":"1153646467","repostType":4,"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894225405,"gmtCreate":1628831959507,"gmtModify":1631889868345,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Only EOG worth buying, the rest is for you to enter while they exit [Sly]&nbsp;","listText":"Only EOG worth buying, the rest is for you to enter while they exit [Sly]&nbsp;","text":"Only EOG worth buying, the rest is for you to enter while they exit [Sly]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/894225405","repostId":"1101202302","repostType":4,"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171474810,"gmtCreate":1626760923530,"gmtModify":1631893741463,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Opportunity for averaging down&nbsp;","listText":"Opportunity for averaging down&nbsp;","text":"Opportunity for averaging down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/171474810","repostId":"1116573791","repostType":4,"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148616685,"gmtCreate":1625970976947,"gmtModify":1631884663878,"author":{"id":"3575102877976288","authorId":"3575102877976288","name":"Chaishen","avatar":"https://static.tigerbbs.com/b8bb167c6f990b4a02d66313039eb021","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575102877976288","authorIdStr":"3575102877976288"},"themes":[],"htmlText":"Target 230 first","listText":"Target 230 first","text":"Target 230 first","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/148616685","repostId":"2150326565","repostType":4,"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}